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Abstract 
The incidences of obesity and type 2 diabetes and their complications are 
increasing globally. The presence of elevated circulating free fatty acids has been 
associated with the initial dysfunction of pancreatic beta cells and microvascular 
endothelial cells followed later by their demise. The aim of this thesis was to 
investigate the mechanisms by which demise occurs, and how it may be 
prevented. 
Palmitate, a saturated fatty acid, caused cell death in both INS-1 beta cells 
and HCMec/D3 microvascular cells, whereas the unsaturated fatty acid oleic acid 
did not cause cell death, and also protected against palmitate-induced toxicity. 
Etomoxir, the mitochondrial CPT1 inhibitor did not rescue INS-1 or HCMec/D3 
cells from palmitate-induced toxicity suggesting that palmitate-induced toxicity 
does not occur via entry into the mitochondria. Cells were exposed to 2-
bromopalmitate, a non-metabolisable fatty acid used to reduce the pool of 
cytoplasmic CoA, to determine whether palmitate-induced toxicity might be 
mediated by its ability to be activated. Pre-incubation with 2-bromopalmitate in 
INS-1 cells significantly prevented palmitate-induced cell death. These data 
suggest that the activation of palmitate with CoA might mediate cell death. 
Cell cycle analysis found that neither oleic acid nor palmitate caused an 
increase or decrease in cell proliferation in both INS-1 and HCMec/D3 cells. The 
data suggest that the mechanism of oleic acid-induced cytoprotection might not 
be via a pro-proliferative mechanism. 
INS-1 cells were imaged using spontaneous Raman microspectroscopy 
after 24-hour exposure to esterified and non-esterified fatty acids. Uni- and multi-
variate analysis and spectral decomposition were carried out using a 
methodology optimised and validated which is presented in this thesis. The aim 
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was to quantify changes, if any, in lipid disposition: distribution, intensity (as a 
measure of concentration) and composition after exogenous exposure to these 
fatty acids. Exposure to 0.125 mM palmitate showed a significant decrease in the 
percentage of lipid within the cells and a corresponding increase in the intensity 
of this lipid. This suggests that palmitate, alone, might be shuttled into lipid 
droplets. This was not observed when the cells were exposed to oleic acid, 
whereby an increase in the intensity of lipid was observed even though no 
significant change was observed in the percentage of lipid within the cells. When 
palmitate and oleic acid were combined, the composition of the lipid droplets 
changed such that the levels of palmitate decreased and the levels of oleic acid 
increased. These data suggest that oleic acid does not shuttle palmitate into lipid 
droplets. These data do not support the hypothesis that oleic acid protects against 
palmitate-induced cytotoxicity by shuttling palmitate into lipid droplets. 
The methyl esters of palmitate and oleic acid were employed to determine 
whether they would affect lipid disposition. No change in lipid distribution or 
intensity was observed when the cells were exposed to these fatty acids, 
validating the requirement for the free carboxyl oxygen for the covalent binding 
to glycerol for the formation of lipid droplets. These data also suggest that INS-1 
cells cannot de-esterify esterified fatty acids.  
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1 Introduction 
This thesis is concerned with the mechanisms of fatty acid (FA) 
interactions within cells that may be relevant to the development of type 2 
diabetes (T2D) and any associated complications. The precise causes of T2D 
and its complications are not known, however the presence of elevated levels of 
free FAs and glucose in the circulation, coupled with insulin resistance, are 
implicated in the death and dysfunction of both beta cells and endothelial cells. 
In this Chapter I shall review some of the literature regarding the mechanisms 
of saturated fatty acid (SFA)-induced cytotoxicity (cell death) and the 
mechanisms of unsaturated fatty acid (UFA)-induced cytoprotection (when 
coupled with SFAs) in various cell types in vitro and in vivo. It should be noted 
that research on the dysfunction of beta cells, i.e. the inability for beta cells to 
synthesise and secrete insulin, will not be presented in this thesis. Further, the 
justifications for the work undertaken for this thesis will be explained throughout 
this Chapter and additionally at the end of this Chapter. 
Each research-chapter begins with a detailed introductory section outlining 
the literature for that specific area of research. Rather than including this material 
in Chapter 1, I decided to describe the relevant literature for each area of research 
within its corresponding Chapter. I anticipate this approach to be of benefit as it 
contextualises the results and discussion sections of those Chapters, thus aiding 
the flow of arguments. 
1.1 Diabetes Mellitus 
Beta cells are one of the three principal types of endocrine cells present in 
the islets of Langerhans in the pancreas. Beta cells synthesise and secrete the 
hormone insulin which is one of the hormones responsible for regulating blood 
glucose levels. T2D is a metabolic syndrome characterised by beta-cell death 
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and dysfunction and impaired glucose-stimulated insulin secretion (Reaven 1988; 
Morgan 2009; Cerf 2013). In addition, peripheral cells can become insulin 
resistant, reducing their ability to take up glucose for normal cellular function. The 
relationship is complex between glucose and insulin, beta cell dysfunction and 
death and insulin resistance. Obesity is a risk factor for T2D as the exposure to 
certain SFAs can induce beta cell death and dysfunction (Cerf 2013). The onset 
of beta cell death is also associated with elevated levels of circulating glucose. In 
this instance, beta cells become exhausted from the continuous synthesis and 
secretion of insulin, resulting in them losing functionality which leads to beta cell 
death (Cerf 2013). In addition, glucose recipient organs become desensitised to 
the elevated circulating glucose which increases insulin demand. This demand 
for insulin also leads to the hyperfunction and subsequent exhaustion of beta 
cells which leads to further loss of beta cell function and beta cell death (Cerf 
2013). It is clear that exposing beta cells and peripheral cells to chronic levels of 
glucose and SFAs can have detrimental effects, effects which are linked to one 
another and perpetuated by one another. In addition to the loss of viability of beta 
cells implicated in T2D, complications from diabetes can arise such as 
retinopathy, nephropathy and neuropathy (Horani & Mooradian 2003; Prasad et. 
al. 2014). These secondary complications are probably caused by altered 
functional properties of microvascular endothelial cells. These cells line micro-
vessels and therefore come into contact with hormones, metabolites, cytokines 
and fatty acids present in the blood. 
The prevalence of T2D currently accounts for approximately 90 % of all 
diagnosed cases of diabetes in the UK which equates to about 3.3 million people 
(Diabetes UK: facts and figures 2018). The cost of diabetes to the UK is estimated 
to have been £23.7bn in 2010/11 (Hex et al. 2012), similar to the cost of cancer 
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(Featherstone & Whitham 2010), and is expected to rise to £39.8bn in 2035/36 
as a result of the expected, increasing prevalence of T2D (Hex et al. 2012). It is 
clear that the study of both beta and endothelial cells is of great importance. 
Understanding the mechanisms by which these detrimental effects occur to beta 
and endothelial cells can enable researchers to determine how to reverse or 
prevent these effects, which in turn may lead to improved patient care, thus 
relieving the burden of this disease. 
1.2 Fatty acids and diabetes 
The consumption of certain FAs, most notably SFAs, have been found to 
be implicated in the dysfunction and death of beta cells. However, it must be 
clarified that not all SFAs cause detrimental effects to these cells in vitro (Harvey 
et al. 2009; Welters et al. 2004) or in vivo (Legrand & Rioux 2015) (and will be 
further described in Chapter 3). Therefore, it cannot be said that all SFAs are 
detrimental to human health or that some FAs should be avoided in the diet. 
However, since detrimental effects have been observed in vitro with some SFAs, 
such as PA, at chronic, elevated concentrations, these observations warrant 
further investigation. By contrast, UFAs, have been shown to be non-toxic at 
chronic, elevated concentrations, and have also shown to be cytoprotective 
against the cytotoxic effects of some FAs. How these two classes of chemically 
similar compounds can exert such profoundly different effects in biological 
systems is astounding and has led many researchers to investigate these 
differences. The following sections will outline the chemical differences between 
these two classes of compounds and will be begin to describe the differential 
effects observed in vitro and in vivo. 
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1.3 Fatty acid biochemistry 
FAs are organic compounds that consist of a hydrocarbon (alkyl) chain with 
a carboxylic acid functional group at one end. FAs are classified depending on 
the number of carbon atoms in the alkyl chain, whereby short-chain FAs consist 
of ≥ 6 carbon atoms (Schönfeld & Wojtczak 2016), medium-chain FAs consist of 
between 7 and 13 carbon atoms (Schönfeld & Wojtczak 2016), long-chain FAs 
consist of between 14 and 20 carbon atoms (Harvey et al 2009), and very long-
chain FAs consist of ≥ 21 carbon atoms (Sassa & Kihara 2014). 
An UFA is one that contains at least one carbon-carbon double bond, 
whereby the double bond is oriented in one of two possible conformations (1) cis, 
whereby the alkyl chains on either side of the double bond are orientated such 
that they are on the same side. This orientation is written in shorthand as Z 
isomerisation, or (2) trans whereby the alkyl chains on either side of the double 
bond are orientated such that that they either are on either side of the double 
bond. This orientation is written in shorthand as E isomerisation. The free rotation 
about a carbon-carbon double bond is zero because of the π-orbitals which 
overlap. Single bonds consist of σ-orbitals which have a degree of free-rotation, 
unlike double bonds which have none. SFAs, however, do not contain any double 
bonds and therefore have greater degrees of rotation than their unsaturated 
counterparts. In addition, the orientation of the double bond determines the space 
which all other bonds within the molecules can occupy. 
The diet is the only exogenous source of FAs. Lipids, such as triacylglycerol 
(TAG)/ neutral lipid droplets (NLDs), are degraded in the small intestine by lipases, 
secreted from the exocrine tissue of the pancreas, into their constituent FAs 
(Wang et al. 2013). In the circulation, some FAs bind to serum albumin, some 
remain unbound (and are therefore termed ‘free’) and some are re-esterified to 
form TAG contained in very low density lipoproteins and chylomicrons (Balaban 
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et al. 2014). FAs must be in their ‘free’ form to enter cells. This occurs via the 
dissociation of FA from albumin or via the hydrolysis of chylomicrons via 
lipoprotein lipases (Goodman 1958). Since minute concentrations of free FAs 
exist in the circulation (between nM and μM) (Paris et al. 1978), the dissociation 
of FAs from FA-albumin follows Le Chatelier’s principle, whereby the equilibrium 
shifts to counter the decrease in [FA-albumin]. 
Long-chain FAs (LCFAs) are degraded (catabolised), via mitochondrial 
beta-oxidation for the production of ATP. The entry of LCFAs into mitochondria 
occurs via a series of reduction-oxidation (REDOX)-coupled reactions. Firstly, 
LCFAs must be activated in the cytoplasm by forming a thioester with Co-enzyme 
A (CoA/ HS-CoA), via the enzyme acetyl-CoA synthetase (ACS), forming FA-CoA 
(Voet et al. 2000). FA-CoA then reacts with carnitine in the presence of the 
enzyme carnitine palmitoyltransferase I (CPT1). CPT1 resides in the outer 
mitochondrial membrane (OMM) and catalyses this reaction to produce FA-
carnitine (Voet et al. 2000). FA-carnitine subsequently enters the intermembrane 
space of the mitochondria from where a series of steps transports the FA-
carnitine complex into the inner mitochondrial membrane (IMM), generates FA-
CoA and then releases the original FA. The enzymes involved in this process are 
essential for the influx and degradation of LCFAs in the mitochondria. Once inside 
the matrix of the mitochondria, FAs are beta-oxidised. Unlike LCFAs, short- and 
medium-chain FAs can pass through the mitochondrial membrane via passive 
diffusion, while very long-chain and branched chain FAs are initially degraded in 
the peroxisomes via alpha- and beta-oxidation prior to entry into the mitochondria 
(Waterham et al. 2016). 
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1.4 Cellular effects of long-chain saturated and unsaturated 
fatty acids 
All mammalian cells require the uptake of FAs to maintain physiological 
health. For example, FAs are essential for the maintenance of plasma membrane 
integrity (Ibarguren, López & Escribá 2014), intracellular signalling and as an 
energy source when glucose levels are insufficient. Palmitate (PA), a long-chain 
SFA (C16:0), and oleic acid (OA), a long-chain cis (Z) mono-UFA (C18:1), are 
the predominant FAs present in serum of both non-obese (Yli-Jama 2002) and 
obese individuals (Ubhayasekera et al. 2013). At low concentrations (nM range), 
PA has acutely beneficial effects within cells. The fates of PA include: (1) 
degradation for energy production via mitochondrial fatty acid oxidation (FAO), 
(2) protein S-palmitoylation on the cytoplasmic face of the Golgi apparatus, 
(Aicart-Ramos et al. 2011), (3) incorporation into phospholipids and other lipid 
species for maintaining plasma- and organelle-membrane stability (Ibarguren, 
López & Escribá 2014), and (4) conversion to palmitoleic acid (16:1) via Δ-9-
desaturase enzymes in the endoplasmic reticulum (Eynard 1997). 
Chronic, elevated levels of some FAs, such as PA, have been shown to 
induce cell death in vitro. As stated by Paracelsus (1493 – 1541) “the dose makes 
the poison” (Gilbert 2012, p. 42). However, the mechanism by which cytotoxicity 
is induced is unclear. ‘Lipotoxicity’ refers to the phenomenon of increased cell 
death caused by the presence of certain FAs. The process of cell death may be 
via apoptosis or necrosis. Programmed cell death includes apoptosis, autophagy 
and necroptosis, and is triggered either through intracellular or extracellular 
signals (Voet et al. 2000). For example, the induction of the intrinsic pathway, 
induced by some chemical compounds, results in the disruption of the 
mitochondrial membrane potential and the release of cytochrome C (Cyt C) from 
the IMM. This then activates a downstream signalling cascade of caspase 
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enzymes, the result of which is cell death (Voet et al. 2000). By contrast, many 
mono-UFAs have been shown to be non-toxic to cells in vitro at chronic, elevated 
concentrations. Further, OA, and other UFA species such as palmitoleic acid, 
have been shown to exhibit cytoprotective effects when added exogenously to 
cells in vitro, in combination with PA (Çimen et al. 2016; Diakogiannaki et al. 2007; 
Maedler et al. 2001; Morgan et al. 2008; Sargsyan et al. 2016). However, the 
mechanism of cytoprotection has been debated. The following sections provide 
a more detailed insight into the cellular effects induced by both long-chain SFAs 
and long-chain UFAs. 
1.4.1 Enzyme release, activation and regulation 
Many studies have shown that the caspase cascade is induced by SFAs, 
clearly showing that the mitochondrion is implicated in cell death (Hardy et al. 
2003; Johnson et al. 2012). However, evidence suggests that the mitochondrion 
may not be the principal driver of cell death and that the induction of cell death 
may be as a result of a caspase-independent process (Mishra & Simonson 2005; 
Patková et al. 2014; Ulloth et al. 2003). For example, this has been implied by 
Patková et al. (2014) who exposed myoblasts and myotubes to PA co-incubated 
with specific mitochondrial antioxidants. They measured cell viability, 
mitochondrial DNA damage and reactive oxygen species levels. Although they 
found that the antioxidants prevented both mitochondrial DNA damage and the 
rise of reactive oxygen species levels, there was no improvement in viability 
compared to PA on its own. 
The study of the mitochondrion in beta cells and its possible role in 
mediating FA-induced cell death has attracted much attention over the years. 
This is particularly true for the study of diabetes due to the close interplay 
between FA metabolism and glucose metabolism. Malonyl-CoA is a substrate of 
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FA synthesis, produced via the metabolism of glucose, and acts as an inhibitor 
of FAO by inhibiting CPT1 (Wakil & Abu-Elheiga 2009). This enables the cell to 
signal to itself to stop breaking down FAs so that the cell can continue to 
synthesise FAs, otherwise there would be no net change in the concentration of 
FAs in the cell – a futile use of energy. Inhibiting CPT1, via the use of a chemical 
inhibitor for example, and thus inhibiting mitochondrial FA transport, results in 
increased glucose metabolism. This ensures the cell is still able to generate 
energy to continue its cellular processes. The reverse is also true, whereby an 
increase in FAO results in a decrease in glucose metabolism. This interplay 
between FAs and glucose is important because some FAs are essential for 
glucose-stimulated insulin secretion (Nolan et al. 2006). This coaction is 
presented schematically in figure 1.1.  
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Figure 1.1 Interplay between fatty acid oxidation and glucose 
metabolism 
The diagram shows the complex interplay between fatty acid oxidation and 
glucose metabolism. The breakdown of glucose produces the substrate 
malonyl-CoA which inhibits beta-oxidation of fatty acids (image taken 
directly from Nolan et al. 2006, Interactions between glucose and fatty acid 
metabolism in nutrient-secretion coupling, figure 1). 
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As previously stated, PA can be converted to palmitoleic acid via Δ-9-
desaturase enzymes in the Golgi apparatus of beta cells (Eynard 1997), however, 
at elevated concentrations of PA, these enzymes become saturated. Busch et al. 
(2005) upregulated Δ-9-desaturases in MIN6 beta cells and found this to protect 
against PA-induced toxicity. Although this work suggests that these enzymes 
may become saturated and may induce cytotoxicity, the mechanism of PA-
induced toxicity remains unclear. 
Studies have shown that elevated levels of PA disrupt endoplasmic 
reticulum function, induce the unfolded protein response (a response driven by 
the accumulation of misfolded or unfolded proteins in the lumen of the 
endoplasmic reticulum) and induces cell death in INS-1 and primary beta cells 
(Cunha et al. 2008; Volmer & Ron 2015). By contrast, it has been shown that OA 
activates the pro-survival pathways of the endoplasmic reticulum stress response 
when in combination with PA (Diakogiannaki et al. 2008; Sargsyan et al. 2016). 
It is clear from the literature described above that SFAs have been shown 
to induce multiple negative effects on organelles within different cell types. It has 
been argued that certain pharmacological compounds can target organelles, 
such as the mitochondria, and can improve the viability of cells in vitro. I decided 
to further investigate these claims to: (1) understand how these agents exert their 
effects on cells, and (2) better understand the structural requirements for PA-
induced toxicity via the mitochondria. A review of the literature and also research 
I have conducted is presented in Chapter 3. 
1.4.2 Cell cycle progression 
A eukaryotic organism’s or organ’s ability to duplicate its cells accurately 
is an essential function. This enables it to continue to grow and function. Upon 
cell division, the cell grows, and its DNA, protein and organelle content doubles. 
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The cell then goes through a series of steps to ensure the process of cell division 
does not incur mistakes, and where it can it eliminates those mistakes. This 
process of cell division in eukaryotic cells is shown in figure 1.2 and is further 
explained in Chapter 4.  
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Figure 1.2 Cell cycle progression 
The diagram shows the various stages of the cell cycle: 
G0+G1, S, G2 and M. The phases between G0+G1 and G2 
are known as interphase. During this time, the cell prepares 
itself for cell division, including duplicating the DNA, protein 
and organelle content with the cell. The M phase is where 
mitosis (nuclear division) occurs and is when the cell 
divides into two identical daughter cells (image taken 
directly from Alberts et al. 2002, An overview of the cell 
cycle, figure 17.3). 
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As previously discussed, FAs play important roles in maintaining cell 
health and can have various effects on cellular processes. Therefore, studying 
the effects of FAs on the cell cycle, a fundamental cellular process, would only 
seem fitting. Furthermore, the effects on the cell cycle could help elucidate 
whether these effects are related to the mechanisms by which some FAs may 
cause harm and others may not. 
Upon reading the literature regarding the effects which FAs have on cell 
cycle progression, it was clear that many contradictions were apparent.  Studies 
in vitro have shown that some physiological molecules, such as incretins 
(Friedrichsen et al. 2006), can stimulate beta cell proliferation. LCFAs have also 
been found to affect cell proliferation, but in the reverse direction; thus, SFAs 
cause cell death and this may be mediated, in part, by inhibition of DNA 
replication or cell cycle progression (Artwohl et al. 2003; Ben-Harosh et al. 2017; 
Diakogiannaki et al. 2007; Lamers et al. 2011; Pascoe et al. 2012). The effects 
of UFAs may be different since OA can be pro-proliferative in human vascular 
smooth muscle cells (HVSMCs) (Lamers et al. 2011), BRIN-BD11 rat beta cells 
(Diakogiannaki et al. 2007) and rat islets (Brelje et al. 2017). However, this is 
contentious as others have shown no significant difference between OA-treated 
and untreated cells in human umbilical vein endothelial cells (HUVECs) (Artwohl 
et al. 2003), murine islets (Pascoe et al. 2012) and pancreatic stellate cells (Ben-
Harosh et al. 2017). 
I therefore decided to further investigate the contentious issue of whether 
PA affects cell cycle progression in vitro. I also decided to investigate the effects 
of OA, alone and in combination with PA, to determine whether the mechanism 
of OA-induced cytoprotection might be induced via a pro-proliferative mechanism. 
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I further address these contradictions in Chapter 4 by critically reviewing the 
literature with a focus on beta and endothelial cells. 
1.4.3 Lipid composition 
FAs are incorporated into phospholipids – these are lipid structures, 
composed of SFAs and UFAs, which are essential for the synthesis of the plasma 
and organelle membranes of cells. Membranes are composed of different types 
of phospholipids depending on their function, e.g. some membranes may need 
to be more permeable or flexible than others. Since the functionality of biological 
membranes is dependent upon its composition, it can be said that phospholipids 
and the FAs they are composed of are considerably important for maintaining 
cellular health. 
The ‘Membrane Theory of Diabetes’, by Pilon (2016), hypothesises that 
changes in phospholipid composition and thus membrane structure, due to 
excess SFAs, alters the function of the beta cell. Pilon (2016) suggests that SFAs 
reduce the degree of membrane curvature and subsequently decrease 
membrane permeability due to their close packing in space. In addition, studies 
in human erythrocytes suggest that the phospholipids in the outer membrane of 
the plasma membrane are more saturated than the inner membrane, making the 
outer membrane less fluid and less permeable than the inner membrane 
(Emmelot & Van Hoeven 1974). It could, therefore, be hypothesised that the 
rigidification of the outer membrane of the plasma membrane of beta cells, via 
the incorporation of SFAs, could impair insulin signalling and glucose uptake 
(Pilon 2016). By contrast, unsaturated cis FAs, such as OA, increase the degree 
of membrane curvature and increase membrane permeability (Rawicz et al. 
2000). Thus, it is important to be exposed to healthy levels of FA to maintain the 
appropriate composition of biological membranes to maintain cell health. 
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Cyt C is normally bound to the IMM via cardiolipin, a phospholipid 
embedded within the IMM containing four (predominantly unsaturated) FA chains 
(Paradies et al. 2014). It has been suggested that the incorporation of SFAs within 
cardiolipin, or other phospholipids within the membrane may facilitate the partial 
unfolding and release of Cyt C from the IMM, resulting in the induction of the 
caspase cascade (Paradies et al. 2014). 
Sphingolipids are a class of lipid which comprise a sphingosine and FA 
moiety. Other components can be incorporated onto sphingolipids such as 
phosphocholine (an intermediary product in the formation of phosphatidylcholine) 
and sugar residues. Ceramide is a sphingolipid which contains a single 
sphingosine molecule and a FA, e.g. PA (Galadari et al. 2013). Sphingolipids are 
important components of membranes and influence their stability. However, they 
can also play a role in signalling (Bartke & Hannun 2009), cellular differentiation 
and proliferation (Ohanian & Ohanian 2001). The presence of ceramide is clearly 
vital for maintaining normal physiological health, however, elevated levels of 
ceramide can have detrimental cellular consequences. The mechanism remains 
unclear. The study by Robblee et al. (2016) has shown that elevated levels of 
ceramide can cause endoplasmic reticulum stress, activate the unfolded protein 
response and mediate apoptosis in macrophage cells. Similarly, Gjoni et al. (2014) 
hypothesise that PA-induced toxicity in INS-1 cells is mediated via the 
accumulation of ceramide and the dysregulation of ceramide metabolism in the 
endoplasmic reticulum. Further, the study by Guo et al. (2009) shows that 
elevated levels of ceramide induce INS-1-cell apoptosis via the extrinsic death 
receptor, the intrinsic mitochondrial pathways and the intrinsic endoplasmic 
reticulum pathway. Guo et al. (2009) went further and showed that inhibiting 
ceramide metabolism rescued cells from PA-induced toxicity in INS-1 cells, 
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showing the important role that ceramide synthesis plays in the mediation of beta-
cell toxicity. Since PA is required for the synthesis of ceramide, it has been 
hypothesised that exposure of cells to elevated FA levels mediates beta-cell 
toxicity through the increased production of ceramide. The mechanism of 
ceramide-induced toxicity has been further explored. Studies have shown that 
pro-inflammatory cytokines, such as interleukin-1β and interferon-γ, may mediate 
beta-cell toxicity as a consequence of the formation of ceramide, however, 
differential responses have been observed between different beta-cell lines 
(Galadari et al. 2013). It has also been hypothesised that ceramide-enriched 
membrane microdomains alter the spatial distribution of plasma membrane-
bound proteins, and that these microdomains may rigidify the plasma membrane. 
It has also been suggested that enhanced clustering of certain proteins, such as 
receptors, in the plasma membrane, could promote beta-cell apoptosis, however, 
the full role that receptor clustering plays in diabetes is not clear (Galadari et al. 
2013). 
By contrast, the study by Listenberger et al. (2001) has suggested that FA-
induced apoptosis can also be mediated through a ceramide-independent 
mechanism. The study employed the use of Chinese hamster ovary (CHO) cells 
(a cell line widely used in cell biology as it can be readily genetically manipulated 
to study differential effects in disease states) showed that PA-mediated apoptosis 
was not prevented when de novo ceramide synthesis was prevented 
(Listenberger et al. 2001). These data suggest that there are either species- or 
cell-specific mechanisms of PA-induced toxicity, or that there are varying effects 
of ceramide formation in cells. 
Interestingly, Listenberger et al. (2003) has proposed that when CHO cells 
are exposed to PA and OA in combination, OA enables the storage of PA in the 
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form of TAG/ NLDs within these cells, therefore preventing PA from exerting its 
detrimental effects on the cell. Whether this is the case in other cell types has 
prompted other researchers to investigate this effect and the mechanism by 
which this occurs in more detail. This effect inspired me to investigate this 
hypothesis further in beta cells. Research presented in Chapter 5 describes a 
methodology using spontaneous Raman microspectroscopy, a label-less 
technique, to quantify the distribution and composition of lipid within beta cells 
treated with PA and OA alone and in combination, the results of which are 
presented in Chapter 6. 
In conclusion, not all long-chain SFA are toxic to cells in vitro. However, 
PA, the most abundant SFA in the diet is toxic to many cell types during chronic, 
elevated concentrations (μM range) in vitro, including beta cells (Dhayal et al. 
2008; Maedler et al. 2001), vascular endothelial cells (Artwohl et al. 2003; Harvey 
et al. 2009), osteoblasts (Gunaratnam et al. 2013) and smooth muscle cells (Rho 
et al. 2007). Many effects have been measured upon SFA exposure, such as cell 
viability, changes in cytoplasmic caspase levels, reactive oxygen species 
production (Gehrmann et al. 2015; Newsholme et al. 2007) and endoplasmic 
reticulum stress (Cazanave et al. 2010). These data suggest that the mechanism 
of toxicity may not be limited to the demise of one organelle, indicating that the 
mechanism of action may be extremely complex. By contrast, mono-UFAs, such 
as OA, has been shown to not only be non-toxic to cells at chronic levels in vitro, 
but it has also been shown to prevent the toxic effects induced by some SFAs, 
when combined, most notably with PA (Çimen et al. 2016; Diakogiannaki et al. 
2007; Maedler et al. 2001; Morgan et al. 2008; Sargsyan et al. 2016). 
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1.5 Synopsis of the work presented in this thesis 
The research presented in this thesis focuses on the following three areas: 
(1) the structural requirements for FA-mediated effects on beta cell and 
microvascular endothelial cell viability, and the requirement for SFAs to enter 
mitochondria to mediate cytotoxicity, (2) the effects of SFAs and UFAs on beta 
cell and microvascular endothelial cell cycle progression, and (3) the changes in 
lipid disposition (distribution, intensity and composition) of beta cells exposed to 
exogenously supplied SFAs and UFAs. A methodology was developed to study 
these cellular changes using spontaneous Raman microspectroscopy. The 
robustness of this method was validated using the equivalent esterified FAs to 
the parent FAs. Finally, the results of these experiments are presented, the 
technical limitations are discussed, and further work is described.  
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Routine materials and methods 
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2 Routine materials and methods 
2.1 Cell culture 
All cell culture procedures were carried out in a Class 2 microbiological 
safety cabinet. All cells were grown in an incubator with 95 % air and 5 % CO2 in 
a humidified atmosphere at 37 °C. Aseptic technique was followed whereby all 
instruments and reagents were autoclaved prior to use and all relevant materials 
were disinfected thoroughly with 70 % (v/v) EtOH (Fisher Chemical). 
2.1.1 Rat-derived beta-cell line 
The INS-1 beta-cell line was derived from a rat insulinoma by methods 
reported by Asfari et al. (1992). The approximate doubling time of the INS-1 cells 
was 48 hours in my hands. The INS-1 cells were cultured in RPMI-1640 medium 
containing 11 mM glucose, supplemented with 10 % (v/v) fetal bovine serum 
(FBS) (Sigma), 2 mM L-glutamine (Gibco), 100 U/ ml penicillin (Gibco), 100 µg/ 
ml streptomycin (Gibco) and 50 µM β-mercaptoethanol (Fisher Chemical). 
Culture medium containing the above components will be known herein as ‘beta 
cell complete medium’. Any deviations from the composition of this medium will 
be made explicit.  
2.1.1.1 Culture of cryopreserved beta cells 
Prior to the thawing of beta cells, beta cell complete medium was pre-
warmed to 37 °C. Cells were defrosted by incubating at 37 °C in a water bath for 
1 – 2 minutes. Once the cells were defrosted, 10 ml beta cell complete medium 
pre-warmed to 37 °C was added to the flask. The cells from the cryogenic vial 
were added to a T75 flask (Sarstedt, 75 cm2). The vial was washed thoroughly 
with beta cell complete medium to ensure all cells were transferred to the flask. 
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The medium was then removed and replaced with fresh beta cell complete 
medium every 48 hours. 
2.1.1.2 Sub-culture of proliferating beta cells 
The cells were sub-cultured when they had reached 80 – 90 % confluency. 
The medium was removed and discarded. The cells were dissociated from the 
T75 flask by incubating with 2 ml trypsin-EDTA solution (0.05 % (w/v) trypsin, 
0.53 mM EDTA•4Na) (ThermoFischer Scientific) pre-warmed for 3 minutes at 
37 °C. 10 ml beta cell complete medium pre-warmed to 37 °C was then added to 
the flask to neutralise the trypsin. The cell-solution was then transferred to a 50 
ml centrifuge tube (Sarstedt). The dissociated cells were pelleted by 
centrifugation at 188 g for 5 minutes. The supernatant was removed and 
discarded and the pellet was re-suspended in maximum 4 ml beta cell complete 
medium pre-warmed to 37 °C. 1 ml cell suspension and 10 ml beta cell complete 
medium was added to a T75 flask. Cells were used up to passage 40. 
2.1.1.3 Cryopreserving beta cells 
Cells that were not immediately needed for experimentation were 
cryopreserved. When cells had reached 90 – 100 % confluency, the medium was 
removed from the flask and discarded. The method for sub-culturing was followed, 
as described in section 2.1.1.2, however, instead of re-suspending the pellet in 
beta cell complete medium, the pellet was re-suspended (1:2) in freezing medium 
DMSO:FBS (16.6 %/ 83.3 %; v/v) (Sigma) pre-warmed to 37 °C. The cells were 
stored at - 80 °C for 24 hours before being transferred to liquid nitrogen and 
stored at - 175 °C until required. 
2.1.1.4 Seeding of beta cells for fatty acid treatment 
Flasks that were fully confluent were sub-cultured into 6-well plates 
(Sarstedt). The method for sub-culturing was followed, as described in section 
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2.1.1.2. The cell pellet was re-suspended in 1 ml beta cell complete medium pre-
warmed to 37 °C. 20 µl of the cell-suspension was removed and placed in a 
haemocytometer with a 1 µl counting-chamber (figure 2.1). The cells were 
counted under a light microscope at a magnification of 100x. The number of live 
cells was counted in each corner square and averaged.  
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Figure 2.1 Counting of cells on a haemocytometer 
Trypan blue (Sigma) made up in phosphate buffered saline 
(PBS) (Lonza) was used as the vital dye stain because of its 
ability to cross the plasma membrane and be retained within 
non-viable cells. A haemocytometer was used to count the 
number of viable cells to ensure accurate seeding of plates for 
treatment with fatty acids. Cells in all four chambers (indicated 
by the dark blue arrows) outlined in blue were counted and 
averaged. Viable cells appeared yellow in colour, and dead cells 
appeared dark blue/ black. The number of viable cells 
represented the number of cells/ μl fluid. Based on the average 
number of viable cells, the desired number of cells required for 
seeding could be calculated. This method was also adapted to 
calculate cell viability and the total average cell number. 
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For example, an average of 150 viable cells in all four corner-squares of 
the haemocytometer constitutes 1.5 x106 cells/ ml in 10 ml beta cell complete 
medium. For beta-cell experiments, 0.4 x106 cells were added to each well of a 
6-well plate, 0.2 x106 cells/ well in a 12-well plate, and 0.1 x106 cells/ well in a 24-
well plate. To obtain the correct seeding density, the cell suspension was diluted. 
See equation 2.1 and subsequent calculations below. 
Equation 2.1 Calculating the correct seeding density for cells for experimentation 
𝐶1 𝑋 𝑉1 = 𝐶2 𝑋 𝑉2 
 
Whereby: 
C1 = number of viable cells x106/ ml; 
V1 = initial volume of complete medium added to cells to create cell suspension; 
C2 = desired number of cells/ ml in final cell suspension; 
V2 = final volume of complete medium added to cells. 
 
Example: 
 
𝑉2 =
𝐶1 𝑋 𝑉1
𝐶2
 
𝑉2 = (
1.5 𝑥106𝑋 10 𝑚𝑙 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒 𝑚𝑒𝑑𝑖𝑎
0.4 𝑥106 𝑐𝑒𝑙𝑙𝑠/ 𝑚𝑙
) 
𝑉2 = 37.5 𝑚𝑙 
 
2.1.2 Human-derived endothelial-cell line 
The HCMec/D3 microvascular endothelial-cell line was derived from 
microvessels constituting the human blood brain barrier by methods reported by 
Weksler et al. (2005). The HCMec/D3 cells were cultured in endothelial cell basal 
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medium MV-2 containing 5.55 mM glucose and 10 mM L-glutamine (PromoCell) 
supplemented with 5 % (v/v) foetal calf serum (PromoCell), 0.01 mg/ ml 
gentamicin (Sigma), 1.25 ng/ ml epidermal growth factor (recombinant human), 
2.5 ng/ ml basic fibroblast growth factor (recombinant human) (PromoCell), 5 ng/ 
ml insulin-like growth factor LR3 (PromoCell), 0.125 ng/ ml vascular endothelial 
growth factor 165 (recombinant human) (PromoCell), 0.25 µg/ ml ascorbic acid 
(PromoCell) and 0.05 µg/ ml hydrocortisone (PromoCell). Culture medium 
containing the above components will be known herein as ‘endothelial cell 
complete medium’. Any deviations from the composition of this medium will be 
made explicit. 
2.1.2.1 Culture of cryopreserved endothelial cells 
Prior to thawing of endothelial cells, endothelial cell complete medium was 
pre-warmed to 37 °C and a T75 flask was incubated with 3 ml collagen stock 
solution (1:29, rat tail collagen (Sigma) in PBS (Lonza, without Ca + Mg, 0.0067 
M PO4, sterile filtered) (v/v)). Cells were defrosted by incubating at 37 °C in a 
water bath for 1 – 2 minutes. Once the cells were defrosted, the collagen solution 
was removed from the T75 flask and retained for future use. 10 ml endothelial 
cell complete medium pre-warmed to 37 °C was added to the flask. The cells 
from the cryogen vial were added to the flask. The vial was washed thoroughly 
with endothelial cell complete medium to ensure all cells were transferred to the 
flask. The endothelial cell complete medium was removed and replaced with 
fresh medium every 48 hours and sub-cultured when they reached 80 – 90 % 
confluency. 
2.1.2.2 Subculture of proliferating endothelial cells 
The monolayer was rinsed once with pre-warmed 5 ml PBS (Lonza), then 
the PBS was removed and discarded. The cells were dissociated from the T75 
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flask by incubating with 3 ml trypsin-EDTA solution (0.25 % (w/v) trypsin, 0.02 % 
(w/v) EDTA) (Sigma) for 3 minutes at 37 °C. 10 ml PBS (Lonza) was added to 
the flask to neutralise the trypsin. The cell-solution was then transferred to a 50 
ml centrifuge tube (Sarstedt). The flask was washed twice with 5 ml PBS (Lonza) 
and the cell-suspension was added to the centrifuge tube. The dissociated cells 
were pelleted by centrifugation at 423 g for 3 minutes. The supernatant was 
removed and discarded and the pellet was re-suspended in 30 ml pre-warmed 
endothelial cell complete medium. 10 ml cell-suspension was added to 3x T75 
flasks pre-coated with collagen. Cells were used between passages 31 and 35. 
2.1.2.3 Cryopreserving endothelial cells 
Cells that were not immediately needed for experimentation were 
cryopreserved. When cells had reached 90 – 100 % confluency, the medium was 
removed from the flask and discarded. The method for sub-culturing was followed, 
as described in section 2.1.2.2, however, instead of re-suspending the pellet in 
endothelial cell complete medium, the pellet was re-suspended (1:1 or 1:3) in 
freezing medium DMSO:FBS (5 %/ 95 %; v/v) (Sigma) pre-warmed to 37 °C. The 
cells were stored at - 80 °C for 24 hours before being transferred to liquid nitrogen 
and stored at - 175 °C until required. 
2.1.2.4 Seeding of endothelial cells for fatty acid treatment 
Flasks that were fully confluent were sub-cultured into 6-well plates 
(Sarstedt). The method for sub-culturing was followed, as described in section 
2.1.2.2. The pellet was re-suspended in 1 ml endothelial cell complete medium 
pre-warmed to 37 °C. 20 µl of the cell-suspension was removed and added to a 
haemocytometer, as described in section 2.1.1.4. The live cells were counted in 
each of the four corner squares and averaged. Initial experiments employed a 
seeding density of 1.0 x106 cells/ well in a 6-well plate. However, after 48 hours 
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of incubation, a high proportion of the cells had died, probably because they had 
reached confluency. Therefore, it was decided to optimise the seeding density of 
these cells to allow for the relative comparison of the beta and endothelial cells. 
Endothelial cells were plated in 6-well plates and exposed to endothelial cell 
complete medium for 24, 48, 72 and 96 hours. Cell viability and the total average 
cell number (number of live and dead cells) were examined at varying seeding 
densities (0.25 x106, 0.5 x106 and 0.75 x106 cells/ ml, corresponding to 25, 50 or 
75 cells/ µl). The experimental design is shown in table 2.1, whereby endothelial 
cell complete medium was added to the cells on Day 0 and was not replaced 
during the entire duration of the experiment.  
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Figure 2.2 shows how percent viability changed over time when 
endothelial cells were seeded at increasing densities. Percent viability was 
calculated using vital dye staining whereby the average number of viable and 
non-viable cells were calculated (section 2.2). It can be seen that a seeding 
density of 0.75 x106 cells/ ml resulted in a consistent loss of viability over time. 
However, when seeded at 0.25 x106 cells/ ml and 0.5x106 cells/ ml, the 
proportions of dead cells were reduced and comparable. Based on these data, it 
was deemed appropriate to select 0.25 x106 cells/ ml as the optimal seeding 
density for the endothelial cells when these were to be incubated in 6-well plates. 
This decision was strengthened with the notion that the fewer the number of cells 
used per treatment per experiment, the more experiments could be conducted.  
Day 
0 1 2 3 4 
Growth (hours) 
0 24 48 72 96 
Table 2.1 Day versus growth of endothelial cells 
The number of days where cells are exposed to endothelial cell complete 
medium and the corresponding number of hours of growth are shown. 
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Figure 2.2 The influence of initial seeding density on endothelial cell viability 
Cells were seeded at one of three densities as shown, and their viability monitored 
over time. The data represent a single experiment conducted in triplicate. Cells 
were analysed using vital dye staining. Mean ± SEM, n=3. 
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Percent viability was also compared to the total cell number. Figure 2.3 
shows the rate of growth represented as the total cell number/ µl. It can be seen 
that, when seeded at a density of 0.75 x106 cells/ ml, the total cell number 
increased steadily over the initial 72 hours, but then decreased by 96 hours. This 
corresponded with the changes in cell viability (figure 2.2) to demonstrate that the 
number of dead cells increased as the number of live cells decreased. In addition, 
it can be seen that the growth-rate of the endothelial cells increased steadily yet 
at a slower rate when the cells were seeded at 0.25 x106 cells/ ml and 0.5 x106 
cells/ ml than when they were seeded at 0.75 x106 cells/ ml. As the growth-rate 
at 0.25 x106 cells/ ml and 0.5 x106 cells/ ml were comparable, it was decided to 
conduct experiments with endothelial cells seeded at 0.25 x106 cells/ ml in 6-well 
plates. The seeding density was halved when employing 12-well plates (0.125 
x106 cells/ well), and halved again for use in 24-well plates (0.065 x106 cells/ well).  
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Figure 2.3 Influence of seeding density on total average cell number during 
the growth of endothelial cells 
Total average cell number (number of live and dead cells) over time was measured 
at three seeding densities: 0.25 x106 cells/ ml, 0.50 x106 cells/ ml and 0.75 x106 
cells/ ml. The data represent a single experiment conducted in triplicate. Cells were 
analysed using vital dye staining. Mean ±SEM, n=3. 
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2.1.3 Preparation of fatty acid stock solutions 
The following fatty acid stock solutions were prepared at 90 mM in 90 % 
(v/v) EtOH: oleic acid (OA) (Sigma); methyl palmitate (MePA) (Sigma); methyl 
oleate (MeOA) (Sigma); ricinoleic acid (RA) (Sigma) and 2-bromopalmitic acid (2-
BrPA) (Sigma). Sodium palmitate (PA) (sodium salt derivative of palmitic acid) 
(Sigma) was prepared at 50 mM in 50 % (v/v) EtOH (table 2.2) (Welters et al. 
2004). The EtOH was prepared using absolute EtOH and autoclaved distilled 
water which was subsequently filter-sterilised. The fatty acid stock solutions were 
heated to 70 °C for 5 minutes and then stored at - 20 °C until required.  
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Sodium palmitate 
 
 
 
Oleic acid 
 
 
 
 
Methyl palmitate 
 
 
 
Methyl oleate 
 
 
 
 
2-bromopalmitic 
acid 
 
 
 
 
Ricinoleic acid  
 
 
 
 
  
O 
ONa CH3(CH2)13CH2 
O 
OH (CH2)7 
CH3(CH2)5 
O 
OCH3 CH3(CH2)13CH2 
O 
OCH3 (CH2)7 
CH3(CH2)5 
O 
OH 
CH3(CH2)12CH2 
Br 
O 
OH (CH2)7 
CH3(CH2)5 
HO 
Table 2.2 Chemical structures of fatty acids presented in this thesis 
The chemical structures of: sodium palmitate, oleic acid, methyl palmitate, 
methyl oleate, 2-bromopalmitic acid and ricinoleic acid are shown here and were 
employed in this thesis. 
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2.1.4 Treatment of beta cells with fatty acids 
Fatty acid stock solutions were bound to 10 % (w/v) fatty acid-free bovine 
serum albumin (BSA) (Sigma). The binding of fatty acids to albumin was 
performed to mimic the physiological situation in which circulating fatty acids are 
bound to plasma proteins (principally serum albumin) (Goodman 1958; van der 
Vusse 2009). The alkyl chain of fatty acids is hydrophobic and would precipitate 
out of solution if it were not bound to BSA (Oliveira et al. 2015). 10 % (w/v) BSA 
was made by dissolving the appropriate mass of BSA powder in the required 
volume of serum-free RPMI-1640 medium containing 11 mM glucose (Lonza), 
supplemented with 2 mM L-glutamine (Gibco), 100 U/ ml penicillin (Gibco), 100 
µg/ ml streptomycin (Gibco) and 50 µM β-mercaptoethanol (Fisher Chemical), 
then incubating at 37 °C for 1 hour (Dhayal & Morgan 2011). This serum-free 
medium supplemented with the above constituents will be known herein as ‘beta 
cell complete serum-free medium’ and any deviations from the composition of 
this medium will be made explicit. The 10 % (w/v) BSA solution was then filter-
sterilised. The fatty acid working solutions were made such that they contained 
final concentrations of 9 % (w/v) BSA and 5 % (v/v) EtOH. The fatty acid working 
solutions were incubated in a 95 % air and 5 % CO2 humidified atmosphere at 
37 °C for at least 1 hour (Dhayal & Morgan 2011) prior to their addition to the cells 
to ensure the free fatty acid/ fatty acid-albumin had reached equilibrium. 
The following experimental design was employed for use in 6-well plates: 
Day 0: plates were seeded with 1 ml cell suspension (0.4 x106 cells/ ml) in beta 
cell complete medium pre-warmed to 37 °C. Day 1: the beta cell complete 
medium was removed from the wells and discarded, 1.8 ml beta cell complete 
serum-free medium was added and 200 µl of the appropriate fatty acid treatment 
was added to the appropriate well to ensure a 1/10 dilution of the fatty acid stock 
solution. The serum-free medium for the beta cells contained all the 
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supplementary components as required for the complete medium, however, FBS 
was omitted. All vehicle control-treated cells (VCs) were exposed to BSA and 
EtOH. In all treatments, the final concentration of BSA was 0.9 % (w/v) and the 
final concentration of EtOH was (v/v) 0.5 %, unless otherwise stated. Day 2: the 
cells were harvested after 24 hour exposure to fatty acids, or the cells were left 
for an additional 24 hours to grow. Day 3: the cells were harvested after 48 hour 
exposure to fatty acids. Table 2.3 shows the steps taken in order to conduct a 24 
and/ or 48 hour fatty acid exposure experiment. 
 
 
2.1.5 Treatment of endothelial cells with fatty acids 
The method for treating endothelial cells with fatty acids was followed 
similarly to that for beta cells, as described in section 2.1.4. The serum-free 
medium for the endothelial cells contained no supplementary components, i.e. it 
consisted only of the medium supplied by the manufacturer. The endothelial cell 
serum-free medium, which did not contain any supplements, will be known herein 
as ‘endothelial cell serum-free medium’ and any deviations from the composition 
Day 0 1 2 3 
Action Seeding of 
cells 
Addition of 
fatty acid 
treatment and 
beta cell 
complete 
serum-free 
medium 
24 hour 
growth. Cells 
were harvested 
or left to grow 
for an 
additional 24 
hours 
48 hour 
growth. Cells 
were 
harvested 
Table 2.3 Treating INS-1 beta cells with fatty acids 
The table presents the various actions required in order to conduct a 24 and/ or 
48 hour fatty acid exposure experiment with beta cells. 
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of this medium will be made explicit. In all treatments, the final concentration of 
BSA was 0.9 % (w/v) and the final concentration of EtOH was (v/v) 0.5 %, unless 
otherwise stated 
2.1.6 Treatment of cells with etomoxir 
A 110 mM stock solution of etomoxir sodium salt hydrate (Sigma) (table 
2.4), a carnitine palmitoyltransferase 1 (CPT1) inhibitor, was made up in PBS 
(Lonza). Etomoxir was dissolved in the appropriate volume of serum-free medium 
to give a concentration of 110 μM. Cells were subsequently treated with fatty 
acids, as described previously in sections 2.1.4 or 2.1.5 depending on the cell 
type. After the addition of the appropriate volume of albumin-bound fatty acids, 
the final concentration of etomoxir became 100 μM. It should be noted that 
etomoxir was not bound to BSA as it was employed as a pharmacological enzyme 
inhibitor. 
 
Etomoxir 
 
 
 
 
 
2.2 Vital dye staining 
It is important to note that trypan blue staining was not required for the sub-
culturing of cells, however, it was required for the quantification of cell viability. 
This is because, for sub-culturing, it is not essential to know the number of dead 
•H2O 
O 
ONa 
(CH2)4CH2 
O 
O 
Table 2.4 Chemical structure of etomoxir sodium salt hydrate 
Etomoxir was employed as a chemical inhibitor of the CPT1 protein present on 
the OMM. The inhibition of this protein was used to determine whether the entry 
of FAs into the mitochondria is essential for mediating cytotoxicity. 
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cells. In addition, the live and dead/ non-viable cells can be distinguished without 
the use of trypan blue: live cells appear light in colour, and dead/ dying/ non-
viable cells appear darker in colour when visualised under a light microscope 
without the use of a stain. However, when quantifying percentage cell viability, 
the number of live and dead cells must be accurately calculated. The use of 
trypan blue ensured these cells were accurately distinguishable and counted. 
2.2.1 Quantification of cell viability 
Using the vital dye staining method, the number of live and dead cells were 
counted under the light microscope to determine cell viability as a percentage. 
See equation 2.2 below. 
Equation 2.2 Calculating percentage cell viability 
𝐶𝑒𝑙𝑙 𝑑𝑒𝑎𝑡ℎ (%)
= (
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠 +  𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
)  𝑋 100 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) = 100 − 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠 
 
Example: 
 
𝐶𝑒𝑙𝑙 𝑑𝑒𝑎𝑡ℎ (%) =  (
1 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙
1 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙 +  32 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
)  𝑋 100 = 3.03 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  100 − 3.03 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  97 
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2.2.2 Quantification of cell growth by vital dye staining 
Using the vital dye staining method, the number of live and dead cells were 
counted under the light microscope to determine the total average cell number. 
See equation 2.3 below. 
Equation 2.3 Calculating total average cell number 
𝑇𝑜𝑡𝑎𝑙 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟
= 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑜. 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠 + 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑜. 𝑜𝑓 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 
 
2.2.3 Preparation of beta cells for quantification 
At the end of each experiment, the cells were harvested from the plates. 
The medium was removed from each well and added to a 15 ml centrifuge tube 
(Sarstedt). 0.5 ml trypsin-EDTA solution (ThermoFischer Scientific) pre-warmed 
to 37 °C was added to each well and incubated for 3 minutes at 37 °C. Once 
detached from the wells, 1 ml beta cell complete medium consisting of 11 mM 
glucose (Lonza) was added to wells to neutralise the trypsin. The cell-solution 
was then removed from the wells and added to a 15 ml centrifuge tube. The cells 
were centrifuged at 188 g for 5 minutes. The supernatant was removed and 
discarded. The pellet was resuspended in 0.5 ml beta cell complete medium 
consisting of 11 mM glucose (Lonza) and 0.5 ml 0.4 % (w/v) trypan blue (Sigma) 
made up in PBS (Lonza). 
2.2.4 Preparation of endothelial cells for quantification 
At the end of each experiment, the cells were harvested from the plates. 
The same method, as described in section 2.2.3, was used, however, the cells 
were washed with PBS before and after the addition of trypsin-EDTA solution 
(Sigma). Once the cells were detached from the wells, 1 ml endothelial cell 
complete medium containing 5.55 mM glucose (PromoCell) was added to wells 
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to neutralise the trypsin. The cell-solution was then removed from the wells and 
added to a 15 ml centrifuge tube. The cells were centrifuged at 423 g for 3 minutes. 
The supernatant was removed and discarded. The pellet was resuspended in 0.5 
ml endothelial cell complete medium containing of 5.55 mM glucose (PromoCell) 
and 0.5 ml 0.4 % (w/v) trypan blue (Sigma) made up in PBS (Lonza). 
2.3 Flow cytometry 
Flow cytometry allows for the characterisation and measurement of cells 
and their intracellular constituents as they travel in a continuous stream. A beam 
of light from a laser light source (argon-ion laser) can either: (1) pass through the 
cell unobstructed, (2) bend around the outer membrane of the cell, or (3) diffract 
from components within the cell. The photons which pass through the cell 
unobstructed do not yield useful information about the status of the cell, however, 
the photons which bend around the cell can provide useful information such as 
the size of the cell. For example, a cell that is dividing and is in the G2 phase of 
the cell cycle would be larger in size than a non-dividing cell. Outgoing photons 
(photons which have come from the light source) which have bent around the cell 
are detected on the opposite side of the incoming photons. Where the outgoing 
photons are travelling in the same direction as the incoming photons, this type of 
light scattering is known as forward scatter (FSC-A). Photons which pass through 
the cell unobstructed are also detected in this way. Photons which are obstructed 
by cellular components, such as the nucleus, diffract to a much greater extent 
than those which are bent around the plasma membrane. This type of scatter, 
known as side scatter (SSC-A), can allow for the differentiation of healthy, live 
cells from dead cells. This is because a healthy cell will have its nucleus intact, 
whereas a dead cell will have a condensed nucleus and a disorganised cytoplasm, 
i.e. a dead cell will have an increased level of granularity. 
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Although cell death can be determined using the method described here, 
flow cytometry can also be coupled with fluorescent labels to yield more detailed 
information. For example, in fluorescence activated cell sorting (FACS) the 
fluorescent dye propidium iodide (PI) can be used to quantify and characterise 
functional aspects of the cell such as the extent of DNA fragmentation. PI is a 
membrane impermeant phenanthridinium dye that intercalates with DNA. PI is 
therefore only incorporated into the DNA of dying and dead cells as their plasma 
membranes are fragmented and permeable. These cells are described as ‘PI 
positive cells’. A laser beam of wavelength 488 nm passes through the DNA-PI 
complex and emits light at a longer wavelength compared to the wavelength at 
source (615 nm) which is then measured. The results can provide information 
regarding cell viability (i.e. the percentage of dead and live cells) and cell cycle 
progression (i.e. the percentage of cells at the different stages of cell division). 
As PI cannot enter live cells, FACS can only indirectly detect these cells. Such 
cells are referred to as ‘PI negative cells’. 
2.3.1 Quantification of cell viability by flow cytometry 
The quantification of cell death using flow cytometry was preferentially 
employed over trypan blue staining because flow cytometry significantly 
increases the output of data compared to vital dye staining and is considered to 
be more robust. Therefore, cell viability (‘viability %’) was determined using flow 
cytometry for the majority of experiments presented in this thesis. 
2.3.1.1 Preparation of cells for quantification of cell viability 
The appropriate methods for culturing both beta and endothelial cells 
treated with fatty acids were followed, as described in sections 2.1.4 and 2.1.2.4, 
respectively. Both live and dead cells were collected for each treatment in 12x75 
mm tubes (BD Biosciences). The pellet was re-suspended in 200 µl of the 
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appropriate complete medium containing the appropriate glucose concentration. 
A 200 µl working solution of 20 µl/ ml PI-FACS buffer (1000 µl/ ml PI stock solution 
(Sigma) made up in water diluted 1:50 with FACS buffer (PBS (Lonza), 2 % FBS 
(Sigma)) was added to each tube. The samples were kept on ice for 10 minutes 
and then analysed on the BD Accuri™ C6 Plus Flow Cytometer (BD Biosciences). 
Before the analysis of the samples was conducted, a Quality Control (QC) run 
was performed. 2x drops of QC beads (BD Biosciences) were added to 0.5 ml 
deionised H2O, vortexed, then analysed. 
2.3.1.2 Data analysis 
Both live and dead cells stained with PI were included in the analysis of cell 
viability (figure 2.4). Increasing FSC-A represents increasing cell size and 
increasing SSC-A represents increasing granularity. These two parameters, cell 
size and granularity, allow for the differentiation between the two populations of 
live and dead cells, as live cells are typically larger than dead cells and are also 
less granular. 
Annexin 5 is a protein that binds to the phospholipid phosphatidylserine. 
Phosphatidylserine is transferred from its normal localisation on the inner leaflet 
of the plasma membrane to the outer leaflet during apoptosis (Martin et al. 1995). 
The detection of this phospholipid is also utilised to quantify percent viability. 
Previous work from our group has shown that Annexin 5 positive cells correspond 
to the cells which are PI negative after flow cytometric analysis (Russell 2010).  
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Figure 2.4 Viability analysis of INS-1 and HCMec/D3 cells 
INS-1 and HCMec/D3 cells were cultured, stained with propidium iodide 
(PI) and analysed on the BD Accuri™ C6 Plus Flow Cytometer. The cells 
were pre-treated with their respective complete medium for 24 hours then 
exposed to their respective serum-free medium for a further 48 hours. The 
data presented in this figure represent untreated INS-1 cells. (a) The cells 
were gated [P1] to exclude cell debris on a FSC-A vs SSC-A plot. (b) Cells 
from P1 were gated [P2] to exclude live cells on a FSC-A vs PI/E-A plot. 
(1) PI positive cells (Q1-UL & Q1-UR) in this gate are dead. (2) PI negative 
cells (Q1-LL & Q1-LR) outside gate P2 are live. The percentage of live cells 
(21.0 %) is given based on the percentage of dead cells in P2. 
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3 Structural requirements for fatty acid-mediated 
effects on cell viability 
3.1 Introduction 
LCFAs are metabolised principally via mitochondrial beta-oxidation in a 
series of REDOX-coupled reactions. LCFAs must first be activated via the 
enzyme acetyl-CoA synthetase (ACS) which generates a thioester bond between 
the FA and cytoplasmic CoA. CoA becomes covalently bound via the carboxyl 
oxygen allowing the FA to dock onto the OMM where CoA is subsequently 
recycled, allowing: (1) the FA to enter the mitochondria via the enzyme carnitine 
palmitoyltransferase I (CPT1), and (2) for other FAs to become activated for entry 
into the mitochondria. Data show that the upregulation of CPT1 rescues 
myotubes from PA-induced cell death (Henique et al. 2010), indicating the 
potential importance of CPT1 for FA disposal and metabolism. Other data, 
however, show that PA and OA, alone, upregulate the expression of CPT1 mRNA 
in MIN6 beta cells (6.2- and 5.4-fold, respectively) (Busch et al. 2002). Since both 
FAs upregulate CPT1, but only PA induced loss of viability, the data suggest that 
increased CPT1 is not a means by which PA-induces toxicity. Interestingly, the 
inhibition of mitochondrial FAO has been shown to induce the hyperpermeability 
of endothelial-cell plasma membranes, in vitro, indicating that FAO is an 
important regulator of endothelial-cell function (Patella et al. 2015) and growth 
(Schoors et al. 2015). Patella et al. (2015) found a significant decrease in the 
viability of HUVECs upon silencing CPT1 with small interfering RNA, suggesting 
that endothelial cells undergo a basal level of FAO required for maintaining 
normal cell health. Chemical inhibition of CPT1 with etomoxir, a known inhibitor 
of CPT1, has been found to attenuate PA-induced cell death in rat islets, ex vivo 
64 
 
(Chen et al. 1994), and in BRIN-BD11 beta cells, in vitro (Diakogiannaki et al. 
2007). However, this effect was not observed by the study conducted by Patella 
et al. (2015), suggesting that the method of gene silencing may be a more robust 
method for cell-manipulation. Similarly, Staiger et al. (2006), found no effect on 
the viability of human coronary artery endothelial cells (HCAECs) during 
exposure to etomoxir. By contrast, the same group exposed HCAECs to Triacsin 
C, an ACS inhibitor, and found a decrease in cell viability in the presence of PA. 
Their work suggests that the conversion of PA to palmitoyl-CoA (PA-CoA) is 
essential for PA to mediate toxicity. These data therefore suggest that other 
processes downstream of PA-CoA production, such as protein palmitoylation or 
incorporation of PA into lipid droplets, may be responsible for the induction of PA-
induced cell death. Shimabakuro et al. (1998) also suggest that the formation of 
alkyl-CoA is the toxic metabolite which is responsible for cytotoxicity. They came 
to this conclusion by exposing rat islets, ex vivo, to alkyl-CoA synthetase in the 
presence of Triacsin C, and found alkyl-induced toxicity was prevented. 
The aims of this Chapter were to investigate the structural requirements for 
the induction of FA-induced cell death and cytoprotection in both INS-1 and 
HCMec/D3 cells. PA and OA, were employed as they are the predominant SFA 
and UFA, respectively, present in human serum. The use of INS-1 cells was 
employed as FAs have been implicated in the demise of beta cells. The effects 
of FAs were also compared to HCMec/D3 cells as many vascular complications 
arise from the development of type 2 diabetes, such as nephropathy and diabetic 
foot (Hex et al. 2012). 
I sought to determine whether the entry of PA into mitochondria was 
inhibited using structural analogues of PA. Structural analogues can be defined 
as compounds with a “similar backbone and almost the same functional groups” 
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to their parent compound (Nikolova & Jaworshka 2003, p.1007). The PA 
analogues employed here were methyl palmitate (MePA) and 2-bromopalmitate 
(2-BrPA). Cells were also exposed to etomoxir, a pharmacological inhibitor of the 
mitochondrial enzyme CPT1, in the absence and presence of PA to determine 
whether cytoprotection could be induced. 2-BrPA was employed as it is 
suggested to inhibit CPT1, like etomoxir, however, this evidence is limited as only 
Chase & Tubbs (1972) make this suggestion. 2-BrPA was therefore primarily 
used to investigate whether its ability to become activated and reduce the pool of 
CoA might influence cytotoxicity of PA. This analogue, which is structurally more 
similar to PA than etomoxir, was employed as a method to limit the secondary 
effects afforded by etomoxir. 
MePA has a methyl group covalently bound to the free carboxyl oxygen on 
the acid component of the alkyl chain. MePA was employed to determine whether 
PA-induced cytotoxicity was dependent upon this carboxyl oxygen being free. 
This was because it has previously been suggested that the formation of alkyl-
CoA may be the toxic metabolite responsible for cytotoxicity (Shimabakuro et al. 
1998). Thus, cytotoxicity observed in the studies presented in this Chapter may 
be as a result of the toxic metabolite PA-CoA. 
In addition, I sought to determine the requirements for OA-induced 
cytoprotection using structural analogues of OA. The OA analogues were methyl 
oleate (MeOA) and ricinoleic acid (RA). MeOA has a methyl group covalently 
bound to the free carboxyl oxygen on the acid component of the chain. This was 
employed to determine whether OA-induced cytoprotection was dependent upon 
this carboxyl oxygen being free. RA possesses a hydroxyl group (-OH) on the 6th 
carbon atom from the terminal end of the carbon chain. This compound was 
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employed to determine the importance of keeping the alkyl chain free from 
substituents. 
3.2 Methods 
INS-1 and HCMec/D3 cells were cultured, as described in Chapter 2. The 
cells were seeded into 6- or 12-well plates in beta cell or endothelial cell complete 
medium, respectively, for 24 hours which was subsequently removed and 
replaced with serum-free medium for either 24 or 48 hours depending on the 
duration of the experiment. The FA stock solutions: PA, OA, MePA, MeOA, 2-
BrPA and RA were dissolved in EtOH and conjugated to 10 % FA-free BSA, as 
described in sections 2.1.4 and 2.1.5. Etomoxir was not conjugated to BSA but 
dissolved in serum-free medium, as described in section 2.1.6, where the final 
concentration of etomoxir was 100 μM. Cells were harvested at the appropriate 
time point and analysed using flow cytometry and PI or vital dye staining (section 
2.2.2) for the determination of cell death (section 2.3.1.1). 
3.3 Results 
3.3.1 Effects of palmitate and oleic acid on cell viability 
Figure 3.1 shows that PA dose-dependently caused cell death after 48-
hour exposure in both INS-1 and HCMec/D3 cells. By contrast, OA did not cause 
any loss of viability at concentrations up to 0.5 mM after 48-hour exposure in 
either cell type. The cytotoxic actions of PA were time-dependent (figure 3.2) in 
HCMec/D3 cells as has been shown previously in beta cells (Chen et al. 1994; 
Diakogiannaki et al. 2007; Welters et al. 2004). 
3.3.2 Effects of etomoxir on cell viability 
Cells were exposed to etomoxir in the presence of PA to determine 
whether the inhibition of the mitochondrial enzyme CPT1 could prevent PA-
induced cytotoxicity. A final concentration of 100 µM etomoxir was chosen based 
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on previous studies where this concentration was employed (Chen et al. 1994; 
Staiger et al. 2006). Chen et al. (1994) utilised rat islets, ex vivo, to investigate 
whether the uptake of FAs via the mitochondria could be attenuated. They found 
that the enzyme CPT1 could be inhibited by at least 50 µM etomoxir. However, 
Staiger et al. (2006) found that PA-induced toxicity in HCAECs was not prevented 
with 100 µM etomoxir. 
HCMec/D3 cells were exposed to 0.25 mM PA in the absence or presence 
of 100 µM etomoxir to examine whether mitochondrial FAO is required for 
mediating cytotoxicity (figure 3.3). Etomoxir alone did not reduce cell viability. PA 
markedly reduced cell viability compared to vehicle-treated cells (p<0.001) but 
OA did not reduce cell viability. Interestingly, the combination of etomoxir with PA 
induced more cell death than PA alone (p<0.05). However, no difference in cell 
viability was observed when OA was combined with etomoxir compared to cells 
exposed to OA alone. 
A dose-response curve with increasing PA concentrations in the presence 
and absence of 100 µM etomoxir was then constructed (figure 3.4). The aim was 
to determine whether cytoprotection from etomoxir was dependent upon the dose 
of PA. HCMec/D3 cells were exposed to the combination of 100 µM etomoxir with 
increasing concentrations of PA, however, no differences were observed in 
viability between the two treatments. These data suggest that mitochondrial FAO 
does not contribute to PA-induced toxicity. 
INS-1 cells were exposed to 0.25 mM PA in the absence or presence of 
100 µM etomoxir to examine whether mitochondrial FAO is required for mediating 
cytotoxicity (figure 3.5). Unlike in the HCMec/D3 cells, etomoxir alone did worsen 
cell viability (p<0.01) in the INS-1 cells. PA markedly reduced cell viability 
compared to vehicle-treated cells (p<0.001) but OA did not reduce cell viability. 
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Contrary to the HCMec/D3 cells, the combination of etomoxir with PA had no 
effect on the INS-1 cells compared to PA alone. Interestingly, OA was able to 
improve the cell viability of cells treated with etomoxir compared to cells treated 
with etomoxir alone (p<0.001).  
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Figure 3.1 Dose-dependent effects of palmitate and oleic acid on INS-1 and 
HCMec/D3 cell viability after 48 hours 
(a) INS-1 cells were pre-treated with complete medium for 24 hours, then for 48 
hours with serum-free medium and increasing doses of palmitate (red line) and 
oleic acid (green line). The data are from two separate experiments each 
conducted in quadruplet. Cells were analysed on a BD Accuri™ C6 Plus Flow 
Cytometer. Mean values ± SEM, n=8. (b) HCMec/D3 cells were pre-treated with 
complete medium for 24 hours, then for 48 hours with serum-free medium and 
increasing doses of palmitate (red line) and oleic acid (green line). The palmitate 
data represent two experiments each conducted in triplicate. The oleic acid data 
are from a representative experiment conducted in triplicate. Cells were analysed 
using vital dye staining. Mean values ± SEM, n=6 (palmitate), n=3 (oleic acid). 
[Fatty acid] (mM)
V
ia
b
il
it
y
 (
%
)
0.
00
0.
06
25
0.
12
5
0.
18
75
0.
25
0.
31
25
0.
37
5
0.
43
75 0.
5
0
20
40
60
80
100
Green = oleic acid 
Red = palmitate 
INS-1 cells (a) 
[Fatty acid] (mM)
V
ia
b
il
it
y
 (
%
)
0.
00
0.
06
25
0.
12
5
0.
18
75
0.
25
0.
31
25
0.
37
5
0.
43
75 0.
5
0
20
40
60
80
100
(b) HCMec/D3 cells 
Green = oleic acid 
Red = palmitate 
70 
 
  
Fatty acid exposure/time  mean +/- SEM
Time (hours)
V
ia
b
il
it
y
 (
%
)
0 24 48 72 96
0
20
40
60
80
100
Control
Palmitate 0.25 mM
Oleic acid 0.25 mM
Figure 3.2 Time-dependent effects of palmitate and oleic acid 
exposure in HCMec/D3 cells 
Time-dependent experiment showing HCMec/D3-cell responses 
to treatments. HCMec/D3 cells were pre-treated with complete 
medium for 24 hours, then for 24h, 48h, 72h or 96h with serum-
free medium. Treatments: vehicle control (BSA + EtOH; blue 
line), 0.25 mM palmitate (red line) and 0.25 mM oleic acid (green 
line). The data are from a representative experiment conducted 
in triplicate. Cells were analysed using vital dye staining. Mean ± 
SEM, n=3. 
Blue = vehicle control 
Green = oleic acid 
Red = palmitate 
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Figure 3.3 Effects of fatty acids on HCMec/D3 cells in the 
presence or absence of etomoxir 
HCMec/D3 cells were pre-treated with complete medium for 24 
hours, then for 48 hours with serum-free medium. Treatments: 
vehicle control (VC; BSA + EtOH; blue bar), 0.25 mM palmitate 
(PA; red bar), 0.25 mM oleic acid (OA; green bar), 100 µM 
etomoxir (Et; purple bar), 100 µM etomoxir + 0.25 mM palmitate 
(Et + PA; orange bar) and 100 µM etomoxir + 0.25 mM oleic acid 
(Et + OA; yellow bar). The data represent three experiments each 
conducted in quadruplet. Cells were analysed on a BD Accuri™ 
C6 Plus Flow Cytometer. One-way ANOVA with Tukey’s multiple 
comparison test * (p<0.05), *** (p<0.001). Mean ± SEM, n=12. 
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Figure 3.4 Dose-dependent effects of palmitate on HCMec/D3 
cells in the presence or absence of etomoxir 
HCMec/D3 cells were pre-treated with complete medium for 24 
hours, then for 48 hours with serum-free medium and increasing 
doses of palmitate without etomoxir (green line) or with 100 µM 
etomoxir (blue line). The data represent three separate 
experiments each conducted in duplicate. Cells were analysed on 
a BD Accuri™ C6 Plus Flow Cytometer. Two-way ANOVA. Mean 
± SEM, n=6. 
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Figure 3.5 Effects of fatty acids on INS-1 cells in the 
presence or absence of etomoxir 
INS-1 cells were pre-treated with complete medium for 24 hours, 
then for 48 hours with serum-free medium. Treatments: vehicle 
control (VC; BSA + EtOH; blue bar), 0.25 mM palmitate (PA; red 
bar), 0.25 mM oleic acid (OA; green bar), 100 µM etomoxir (Et; 
purple bar), 100 µM etomoxir + 0.25 mM palmitate (Et + PA; 
orange bar) and 100 µM etomoxir + 0.25 mM oleic acid (Et + OA; 
yellow bar). The data are from two independent experiments 
each conducted in triplicate. Cells were analysed on a BD 
Accuri™ C6 Plus Flow Cytometer. One-way ANOVA with 
Tukey’s multiple comparison test ** (p<0.01), *** (p<0.001). 
Mean ± SEM, n=6. 
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3.3.3 Effects of 2-bromopalmitic acid on cell viability 
The effects of 2-BrPA on cell viability and its capability of improving PA-
induced cytotoxicity were investigated. 2-BrPA, like etomoxir, requires activation 
via ACS and may improve PA-induced cytotoxicity by reducing the pool of 
cytoplasmic CoA. Limited evidence suggests that 2-BrPA is capable of inhibiting 
the mitochondrial enzyme CPT1 (Chase & Tubbs 1972). Thus, for the purposes 
of this thesis, it was assumed that 2-BrPA does not inhibit CPT1. Based on this, 
it was hypothesised that any observed cytoprotection from the co-incubation of 
2-BrPA with PA may be, in part, due to the ability for 2-BrPA to reduce the pool 
of CoA and prevent the toxic formation of PA-CoA. 
PA and 2-BrPA each caused a dose-dependent decrease in the viability 
of INS-1 cells after 24-hour exposure (figure 3.6), whereby statistical significance 
was observed at 0.125 mM and above between both PA and 2-BrPA (p˂0.01, 
p˂0.001 and p˂0.0001). Statistical significance was observed between the VC 
treatments from both PA and 2-BrPA treatments (p˂0.001), however, this 
difference is unlikely to have any biological significance as it can be clearly seen 
that the INS-1 cells respond very similarly to both PA and 2-BrPA. Surprisingly, 
the combination of these two FAs resulted in the abrogation of the toxicity seen 
with either FA alone (p<0.001) (figure 3.7). By contrast, with its actions in INS-1 
cells, increasing concentrations of 2-BrPA caused only a less dramatic decrease 
in the viability of HCMec/D3 cells over 24 hours (figure 3.8). However, PA caused 
significant cell death in this time. When used in combination, 2-BrPA protected 
INS-1 cells against PA-induced toxicity (p<0.001) (figure 3.9). 
INS-1 cells were again treated with PA and 2-BrPA alone and in 
combination for 24 hours, however, two further treatments were added to the 
experiment (figure 3.10). I wanted to further explore the idea that when PA and 
2-BrPA were co-incubated they might compete against each other for the 
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availability of the substrate CoA. This experiment sought to determine whether 
chelation of CoA by either FA affected toxicity upon addition of the second FA. 
By reducing the pool of CoA with 0.25 mM of a FA for 4 hours, then subsequently 
co-incubating with 0.25 mM of a second FA for 20 hours, the toxicity of the second 
FA could be determined. The toxicity of both PA and 2-BrPA was significantly 
reduced by the period of pre-incubation with 2-BrPA or PA, respectively. 
(p<0.001). These data suggest that the primary FA chelated CoA and may have 
prevented the formation of the toxic metabolite, either PA-CoA or 2-
bromopalmitoyl-CoA (2-BrPA-CoA).  
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Figure 3.6 Dose-dependent effects of palmitate and 2-
bromopalmitic acid on INS-1 cells after 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, 
then for 24 hours with serum-free medium and increasing doses 
of palmitate (red line) or 2-bromopalmitic acid (pink dashed line). 
The data represent three experiments each conducted in 
triplicate. Cells were analysed on a BD Accuri™ C6 Plus Flow 
Cytometer. Two-way ANOVA with Bonferroni multiple 
comparison test ** (p˂0.01), *** (p˂0.001), **** (p˂0.0001). Mean 
± SEM, n=9. 
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Figure 3.7 Effects of palmitate and 2-bromopalmitic acid on 
INS-1 cells after 24 hours 
INS-1 cells were pre-treated with complete medium for 24 
hours, then for 24 hours with serum-free medium. Treatments: 
vehicle control (VC; BSA + EtOH; blue bar), 0.25 mM palmitate 
(PA; red bar), 0.25 mM 2-bromopalmitic acid (2-BrPA; pink bar) 
and co-incubation of 0.25 mM palmitate + 0.25 mM 2-
bromopalmitic acid (2-BrPA + PA; black bar). The data are from 
three separate experiments each conducted in triplicate. Cells 
were analysed on a BD Accuri™ C6 Plus Flow Cytometer. One-
way ANOVA with Tukey’s multiple comparison test *** 
(p<0.001). Mean ± SEM, n=9. 
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Figure 3.8 Dose-dependent effects of palmitate and 2-
bromopalmitic acid on HCMec/D3 cells after 24 hours 
HCMec/D3 cells were pre-treated with complete medium for 24 
hours, then treated for 24 hours with serum-free medium and 
increasing doses of palmitate (red line) or 2-bromopalmitic acid 
(pink dashed line). The data represent three experiments each 
conducted in triplicate. Cells were analysed on a BD Accuri™ C6 
Plus Flow Cytometer. Two-way ANOVA with Bonferroni multiple 
comparison test **** (˂p0.0001). Mean ± SEM, n=9. 
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Figure 3.9 Effects of palmitate and 2-bromopalmitic acid on 
HCMec/D3 cells after 24 hours 
HCMec/D3 cells were pre-treated with complete medium for 24 
hours, then for 24 hours with serum-free medium. Treatments: 
vehicle control (VC; BSA + EtOH; blue bar), 0.25 mM palmitate 
(PA; red bar), 0.25 mM 2-bromopalmitic acid (2-BrPA; pink bar) 
and co-incubation of 0.25 mM palmitate + 0.25 mM 2-
bromopalmitic acid (2-BrPA + PA; black bar). The data 
represent three experiments each conducted in triplicate. Cells 
were analysed on a BD Accuri™ C6 Plus Flow Cytometer. One-
way ANOVA with Tukey’s multiple comparison test *** 
(p<0.001). Mean ± SEM, n=9. 
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Figure 3.10 Effects of pre-incubation with palmitate and 2-
bromopalmitic acid prior to addition of a second fatty acid in INS-1 
cells 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Treatments: vehicle control (VC; BSA 
+ EtOH; blue bar), 0.25 mM palmitate (PA; red bar), 0.25 mM 2-
bromopalmitic acid (2-BrPA; dark pink bar), co-incubation of 0.25 mM 
palmitate + 0.25 mM 2-bromopalmitic acid (2-BrPA + PA; black bar), 4 
hours with 0.25 mM 2-bromopalmitic acid then co-incubation with 0.25 mM 
palmitate (4h 2-BrPA; light pink bar) and 4 hours with 0.25 mM palmitate 
then co-incubation with 0.25 mM 2-bromopalmitate (4h PA; light orange 
bar). The data represent three experiments each conducted in triplicate. 
Cells were analysed on a BD Accuri™ C6 Plus Flow Cytometer. One-way 
ANOVA with Tukey’s multiple comparison test *** (p<0.001). Mean ± SEM, 
n=9. 
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3.3.4 Effects of esterified fatty acids on cell viability 
INS-1 and HCMec/D3 cells were exposed to 0.25 mM of the methyl esters 
of either PA or OA for 48 hours (figures 3.11 and 3.12, respectively). Cells were 
exposed to these FAs to investigate the requirement for the carboxyl oxygen atom 
to be free to induce cytotoxicity and cytoprotection. In both cell types, MePA alone 
was not toxic and it failed to prevent the loss of viability caused by PA, indicating 
that MePA does not have cytoprotective effects. The data suggest that the free 
carboxyl group of PA is essential for inducing toxicity under these conditions. The 
data also reveal that MeOA is cytoprotective to both cell types, albeit less than 
the parent FA, OA, when provided to the cells in combination with PA, implying 
that the free carboxyl group of OA is not an absolute requirement for 
cytoprotection.  
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Figure 3.11 Effects of fatty acids and fatty acid analogues on INS-1 cell 
viability 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 48 
hours with serum-free medium and 0.25 mM fatty acid treatment: vehicle 
control (VC; BSA + EtOH; blue bar), palmitate (PA; red bar), oleic acid (OA; 
green bar), methyl palmitate (MePA; dark purple bar), methyl oleate (MeOA; 
orange bar), palmitate + oleic acid (PA + OA; yellow bar), methyl oleate + 
palmitate (MeOA + PA; light purple bar) and methyl palmitate + PA (MePA + 
PA; light brown bar). 0.9 % BSA and 0.5 % EtOH final percentages. The data 
represent three experiments each conducted in triplicate. Cells were 
analysed on a BD Accuri™ C6 Plus Flow Cytometer. One-way ANOVA with 
Tukey’s multiple comparison test *** (p<0.001). Mean ± SEM, n=6. 
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Figure 3.12 Effects of fatty acids and fatty acid analogues on HCMec/D3 
cell viability 
HCMec/D3 cells were pre-treated with complete medium for 24 hours, then 
for 48 hours with serum-free medium and 0.25 mM fatty acid treatment: 
vehicle control (VC; BSA + EtOH; blue bar), palmitate (PA; red bar), oleic 
acid (OA; green bar), methyl palmitate (MePA; dark purple bar), methyl 
oleate (MeOA; orange bar), palmitate + oleic acid (PA + OA; yellow bar), 
methyl oleate + palmitate (MeOA + PA; light purple bar) and methyl palmitate 
+ PA (MePA + PA; light brown bar). 0.9 % BSA and 0.5 % EtOH final 
percentages. The data represent three experiments each conducted in 
duplicate. Cells were analysed on a BD Accuri™ C6 Plus Flow Cytometer. 
One-way ANOVA with Tukey’s multiple comparison test *** (p<0.001). Mean 
± SEM, n=6. 
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3.3.5 Effects of ricinoleic acid on cell viability 
INS-1 and HCMec/D3 cells were exposed to 0.25 mM of RA, an analogue 
of OA with an alcohol functional group on the 6th carbon atom from the end of the 
alkyl chain, for 48 hours (figures 3.13 and 3.14, respectively). Cells were exposed 
to RA to investigate the requirement for the alkyl chain of an UFA to be free to 
induce cytoprotection. RA was toxic (p<0.001 vs VC), yet RA was much less toxic 
in HCMec/D3 cells, although still significantly toxic compared to the VC (p<0.001) 
whereby RA also failed to prevent the loss of viability caused by PA. In 
subsequent experiments, RA was also added in combination with both OA and 
PA to investigate whether it might be antagonistic, i.e. whether RA might prevent 
OA from exerting its protective effect against PA. Interestingly, RA did not prevent 
OA from inducing its cytoprotective effects, suggesting that RA is not antagonistic 
against OA. The data imply that the 6th carbon atom from the end of the alkyl 
chain must be free as a requirement for OA-induced cytoprotection.  
INS-1 cells were exposed to increasing doses of PA and RA for 48 hours to 
compare the toxicities of RA and PA to determine whether RA, an UFA, is more 
toxic than PA, a SFA. Figure 3.15 shows PA caused less cell death than RA at 
all doses tested, up to and including 0.25 mM, whereby statistical significance 
was observed at all concentrations above and including 0.0625 mM between both 
PA and RA (p˂0.0001). INS-1 cells were subsequently exposed to increasing 
concentrations of OA in the presence of either 0.25 mM PA or 0.125 mM RA for 
48 hours. The aim was to determine the extent to which OA could protect against 
PA- and RA-induced toxicity. Figure 3.16 shows that concentrations of OA greater 
than 0.0625 mM were able to prevent both PA- and RA-induced toxicity. No 
statistical difference was observed between PA and RA at any concentration.  
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Figure 3.13 Effects of fatty acids and fatty acid analogues on INS-1 cell 
viability 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 48 
hours with serum-free medium and 0.25 mM fatty acid treatment: vehicle 
control (VC; BSA + EtOH; blue bar), palmitate (PA; red bar), oleic acid (OA; 
green bar), ricinoleic acid (RA; brown bar), palmitate + oleic acid (PA + OA),  
palmitate + ricinoleic acid (PA+RA; yellow bar) and palmitate + oleic acid + 
ricinoleic acid (PA + OA + RA; purple bar). 0.85 % BSA and 0.75 % EtOH 
final percentages. The data represent three experiments each conducted in 
triplicate. Cells were analysed on a BD Accuri™ C6 Plus Flow Cytometer. 
One-way ANOVA with Tukey’s multiple comparison test *** (p<0.001). Mean 
± SEM, n=9. 
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Figure 3.14 Effects of fatty acids and fatty acid analogues on HCMec/D3 
cell viability after 48 hours 
HCMec/D3 cells were pre-treated with complete medium for 24 hours, then 
for 48 hours with serum-free medium and 0.25 mM fatty acid treatment: 
vehicle control (VC; BSA + EtOH; blue bar), palmitate (PA; red bar), oleic 
acid (OA; green bar), ricinoleic acid (RA; brown bar), palmitate + oleic acid 
(PA + OA),  palmitate + ricinoleic acid (PA+RA; yellow bar) and palmitate + 
oleic acid + ricinoleic acid (PA + OA + RA; purple bar). 0.85 % BSA and 
0.75 % EtOH final percentages. The data represent two experiments each 
conducted in quadruplet. Cells were analysed on a BD Accuri™ C6 Plus Flow 
Cytometer. One-way ANOVA with Tukey’s multiple comparison test *** 
(p<0.001). Mean ± SEM, n=8. 
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Figure 3.15 Dose-dependent effects of palmitate and 
ricinoleic acid on INS-1 cell viability after 48 hours 
INS-1 cells were pre-treated with complete medium for 24 
hours, then for 48 hours with serum-free medium and 
increasing doses of palmitate (PA; red line) or ricinoleic acid 
(RA; green line). The data represent three experiments each 
conducted in triplicate. Cells were analysed on a BD Accuri™ 
C6 Plus Flow Cytometer. Two-way ANOVA with Bonferroni 
multiple comparison test **** (p˂0.0001). Mean ± SEM, n=9. 
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Figure 3.16 Effects of palmitate and ricinoleic acid and 
increasing concentrations of oleic acid on INS-1 cell 
viability after 48 hours 
INS-1 cells were pre-treated with complete medium for 24 
hours, then for 48 hours with serum-free medium and 
increasing doses of oleic acid in the presence of 0.25 mM 
palmitate (PA; red line) or 0.125 mM ricinoleic acid (RA; green 
line). The data represent three experiments each conducted 
in singlet. Cells were analysed on a BD Accuri™ C6 Plus Flow 
Cytometer. Two-way ANOVA with Bonferroni multiple 
comparison test. No sig diff. Mean ± SEM, n=3. 
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3.4 Discussion 
3.4.1 Investigating the structural requirements for fatty acid activation 
and the role of CPT1 in mediating cytotoxicity 
INS-1 and HCMec/D3 cells were exposed to increasing concentrations of 
PA and OA, alone, over 48 hours to investigate their responses. Figure 3.1 shows 
that PA induced dose-dependent cell death in both cell types, whereas OA was 
not toxic. Further, HCMec/D3 cells were exposed to 0.25 mM PA and 0.25 mM 
OA, alone, up to 96 hours to investigate their time-dependent effects, thus 
demonstrating that PA has both dose- and time-dependent effects on cell viability, 
yet OA does not (figure 3.2). In order to study the effects of various combinations 
of FAs on cell viability, and determine whether cytotoxicity could be alleviated, a 
PA concentration of 0.25 mM was chosen. 
To investigate whether the entry of LCFAs, such as PA, into mitochondria 
is a requirement for cytotoxicity, I sought to block the entry of PA into mitochondria 
using the chemical inhibitor etomoxir. This compound is activated via ACS such 
that it can subsequently bind to CPT1; the enzyme responsible for the entry of 
LCFAs from the cytoplasm into the mitochondria via the OMM. Both HCMec/D3 
and INS-1 cells were co-incubated with etomoxir and PA for 48 hours (figures 3.3 
and 3.5, respectively). Etomoxir alone had no effect on cell viability in HCMec/D3 
cells, however, etomoxir did worsen cell viability in INS-1 cells. In HCMec/D3 cells 
the combination of etomoxir with PA worsened toxicity compared with PA alone. 
Since cell viability was not improved in HCMec/D3 cells, these data suggest that 
PA entry into the mitochondrion via CPT1 is not a requirement for cytotoxicity. In 
INS-1 cells no difference in cell viability was observed between cells treated with 
PA alone and cells treated in combination with etomoxir and PA. It can therefore 
also be suggested that PA entry into the mitochondrion via CPT1 is not a 
requirement for cytotoxicity in INS-1 cells. 
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Etomoxir has been used by many researchers to investigate the effects of 
SFAs in mammalian cells. In some cell types, etomoxir has been shown to 
improve the viability of cells treated with LCFAs, such as in rat islets (Chen et al. 
1994), however, in other studies, etomoxir has not only been unable to rescue 
cells from PA-induced toxicity (Staiger et al. 2006), but it has itself caused cell 
death (Schoors et al. 2015). The study by Staiger et al. (2006) set out to 
determine whether etomoxir would be able to rescue HCAECs from PA-induced 
apoptosis. PA-induced apoptosis was observed, yet no effect was observed when 
cells were exposed to 100 µM etomoxir. HCAECs were subsequently treated with 
both PA and etomoxir. Cells were exposed to etomoxir for 30 minutes before 1 
mM PA was added for 24 hours. The researchers concluded that since etomoxir 
did not affect PA-induced apoptosis, beta oxidation is not involved in the 
mechanism by which SFAs induce apoptosis in HCAECs. The work by Schoors 
et al. (2015) sought to determine whether etomoxir would affect angiogenesis in 
HUVECs, with the aim of utilising etomoxir as a pharmacological agent to prevent 
PA-induced cell death. However, they found that etomoxir alone reduced FAO 
and cell proliferation. Because of this effect, etomoxir was not combined with PA. 
Whether the observed differences in responses are due to species differences is 
not clear. 
Etomoxir is an analogue of SFAs, consisting of a free carboxyl oxygen, 
(allowing for activation via ACS) an epoxide and an o-linked-1,4-para-chloro-
benzene ring (table 2.4). Activation via ACS involves the covalent binding of the 
free carboxyl oxygen to CoA, irreversibly forming etomoxyl-CoA (Et-CoA). Based 
on this mechanism, the interpretation of data, whereby cells have been exposed 
to etomoxir, can be difficult and indeed misleading since the agent is not simply 
an inhibitor of CPT1. Rather, the precise mechanism by which etomoxir acts 
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within the cell is unclear. Since etomoxir requires activation (as do LCFAs), any 
observed etomoxir-induced cytoprotection may either be due to: (1) etomoxir’s 
ability to reduce the intracellular pool of CoA required for PA-activation, thus 
preventing PA-CoA-induced cytoplasmic toxicity, or (2) due to etomoxir’s ability 
to inhibit CPT1 and prevent the entry of PA into the mitochondria. If etomoxir-
induced cytoprotection were mediated by a reduction in the pool of cytoplasmic 
CoA, the mechanism of toxicity could equally be related to responses operating 
in the cytoplasm (and, for example, actions on other cellular organelles, such as 
lipid droplets), as on the mitochondria. Hence, it may be an over-interpretation of 
the data to suggest that sensitivity to etomoxir necessarily reflects a requirement 
for entry of FA into the mitochondria. 
It is important to note though that etomoxir is not cytotoxic to HCMec/D3 
cells. This is an interesting observation as compounds containing an epoxide 
group can become transformed to form diols which can result in cell death 
(Greene et al. 2000). Alternatively, etomoxir might not induce cell death as a 
result of the presence of the benzene ring acting as an electron sink, thus 
rendering the free carboxyl oxygen less nucleophilic and possibly less likely to 
react and bind covalently with CoA. Nevertheless, why etomoxir would have 
differential effects in some cell types is unclear. 
Since etomoxir has multiple effects on the cell, it was deemed important 
to investigate other compounds which might also deplete the intracellular pool of 
CoA as a means to influence cell viability. To investigate this, I made use of the 
FA analogues 2-BrPA and MePA. 2-BrPA is an analogue of PA with a bromine 
atom covalently bound to the carbon atom in the alpha (C2) position from the 
carboxyl carbon. It has been suggested that this compound can bind to CoA 
forming 2-BrPA-CoA and can inhibit CPT1 (Chase & Tubbs 1972). Even though 
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beta oxidation occurs at the third carbon atom from the carboxyl carbon, the 
presence of the bromine atom may cause steric hindrance, especially since beta 
oxidation involves the sigma (single) bond between the second and third carbon 
atoms from the carboxyl oxygen to become converted to a pi (double) bond. 
Hence, the bromine atom may prevent this process from occurring. 
2-BrPA is thought to act primarily by reducing the pool of intracellular CoA, 
however, evidence suggests that 2-BrPA inhibits protein palmitoylation, 
particularly S-palmitoylation (Webb et al. 2000). This effect may therefore have 
detrimental effects on the cell. In INS-1 cells, co-incubation of etomoxir with PA 
did not prevent PA-induced toxicity (figure 3.5), yet co-incubation of 2-BrPA with 
PA did prevent PA-induced cell death (figure 3.7). Similar responses were 
observed in HCMec/D3 cells (figures 3.3 and 3.9, respectively). 
In the INS-1 cells, 2-BrPA was found to cause cell death, as observed with 
PA (figure 3.6). This suggests that INS-1 cells are not able to tolerate a reduction 
in the pool of CoA and/ or the formation of 2-BrPA-CoA. Of course, however, 2-
BrPA may have other effects on the cell which may not be tolerated, such as 
being an inhibitor of protein S-palmitoylation (Webb et al. 2000). This may result 
in some PA which is endogenously present within the cell being unable to bind to 
cysteine residues on proteins in the Golgi apparatus, possibly preventing 
lipoproteins from being exocytosed from the cell, and possibly inducing 
cytotoxicity. This inhibition of S-palmitoylation might be why toxicity is observed 
in INS-1 cells. Interestingly, when 2-BrPA was combined with PA, the cell viability 
of INS-1 cells was found to be comparable to the VC (figure 3.7). This difference 
in response was wholly unexpected and implies that the combined actions of the 
FAs are mutually antagonistic. There is no obvious explanation, however, one 
possibility implies some kind of competition between the two FAs, possibly for 
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CoA, resulting in both FAs being diverted to a pathway where their presence does 
not elicit a toxic response. As suggested by Chase & Tubbs (1972), it may be 
possible that 2-BrPA-CoA affects the equilibrium of the formation of palmitoyl-
carnitine (the PA analogue required for the transfer of PA across the OMM via 
CPT1) from PA-CoA. In other words, 2-BrPA-CoA might be able to prevent the 
formation of palmitoyl-carnitine, suggesting that palmitoyl-carnitine might be 
responsible for cytotoxicity. This may be the case in the HCMec/D3 cells. 
However, this hypothesis would not be able to justify the observation in INS-1 
cells because the presence of 2-BrPA-CoA would likely cause some toxicity, as 
observed when INS-1 cells were treated with 2-BrPA alone (figure 3.6). The 
method for detecting palmitoyl-carnitine, presented by Hulme et al. (2017), might 
be utilised to further investigate this hypothesis. 
In contrast, 2-BrPA, unlike PA, was found to be non-toxic to HCMec/D3 
cells (figure 3.8), whereby statistical significance was observed at 0.125 mM and 
above between both PA and 2-BrPA (p˂0.0001). This suggests that HCMec/D3 
cells are able to tolerate a reduction in the pool of CoA, possibly because these 
cells have greater levels of cytoplasmic CoA. The results also suggest that 
HCMec/D3 cells are able to tolerate the formation of 2-BrPA-CoA. Further, the 
formation of 2-BrPA-CoA might not have any biological effects on these cells and 
may be inert. Interestingly, when 2-BrPA was combined with PA, toxicity was 
comparable to the VC (figure 3.9). This may be due to 2-BrPA’s ability to reduce 
the pool of CoA, thus preventing the formation of toxic PA-CoA. However, why 
INS-1 and HCMec/D3 cells would respond differentially is unclear since the 
activation of LCFAs via CoA is essential for their entry into mitochondria. The 
data presented here were obtained after exposure to FAs for 24 hours. It is 
possible that the observed heightened sensitivity of INS-1 cells to 2-BrPA and the 
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lessened sensitivity of HCMec/D3 cells to 2-BrPA might be a temporal effect. In 
other words, toxicity in HCMec/D3 cells might be observed above 24 hours of 
exposure. Over time, the accumulation of 2-BrPA might have physical effects on 
the cell possibly affecting cytoplasmic processes and leading to cell death, such 
as: (1) the accumulation of diacylglycerol (Hagve & Christophersen 1987) or (2) 
the insertion into membranes, disrupting membrane integrity (McMahon & 
Boucrot 2015) 
To further investigate the requirements for FA activation for the induction 
of cell death, INS-1 cells were pre-treated with either 2-BrPA or PA for 4 hours 
and then with 2-BrPA or PA for a further 20 hours (figure 3.10). This experiment 
sought to determine whether the direct reduction of the pool of CoA might improve 
cellular viability. Interestingly, when PA was added to INS-1 cells for 4 hours and 
the cells were subsequently exposed to 2-BrPA for 20 hours, cell viability 
improved compared to cells exposed to PA alone for 24 hours. Since 2-BrPA can 
undergo activation via CoA, it may be possible that 2-BrPA is able to bind to CPT1 
and prevent the entry of PA into the mitochondria, as suggested by Chase & 
Tubbs (1972). It is possible that PA may also prevent 2-BrPA-induced cytotoxicity 
via a similar mechanism. The data show that incubating cells with either PA or 2-
BrPA for 4 hours is not as effective at preventing cytotoxicity versus their co-
incubation. Once the second FA is added, however, toxicity improves versus 
exposure to PA or 2-BrPA for 24 hours. From this we can conclude that 
cytotoxicity can be prevented, possibly via the prevention of FA activation, 
however, this mechanism is unclear. It can be suggested, however, that some 
kind of competition may be occurring within the cell which prevents both PA and 
2-BrPA from inducing cell death. 
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MePA was employed to further investigate the importance of a FA 
consisting of a free carboxyl oxygen atom on cell viability. It is chemically 
impossible for MePA to bind with CoA, due to the carboxyl oxygen atom being 
covalently esterified to a methyl group. Thus, since MePA cannot reduce the pool 
of cytoplasmic CoA, it was hypothesised that this compound, when combined 
with PA, would not improve PA-induced cell death. In support of this, viability data 
revealed no improvement following the addition of MePA compared to PA alone, 
in both cell types (figures 3.11 and 3.12). Interestingly, unlike its parent FA, PA, 
MePA alone was non-toxic. This observation shows that neither INS-1 nor 
HCMec/D3 cells de-esterify MePA, otherwise toxicity would be observed. From 
these data we can conclude that a free carboxyl oxygen atom is required 
(possibly for cytotoxicity for the formation of the toxic metabolite PA-CoA). Thus, 
it can be suggested that the activation of PA is a requirement for cytotoxicity. 
When MePA was combined with PA, cell viability was lost to the same extent as 
seen with PA alone. Interestingly, this was not observed when PA was combined 
with 2-BrPA, suggesting that cytoprotection might be a result of the chelation of 
CoA via the presence of a free carboxyl oxygen atom on the alkyl chain of the FA. 
Overall, the data suggest that entry of PA into the mitochondria or the availability 
of the pool of CoA could be responsible for the ability of PA to cause cell death. 
3.4.2 Investigating the structural requirements for unsaturated fatty acids 
to mediate cytoprotection 
The ability for OA to protect against PA-induced cytotoxicity was further 
investigated using its methyl ester analogue MeOA. In both INS-1 and HCMec/D3 
cells, the viability of MeOA was found to be comparable to the VC (figures 3.11 
and 3.12, respectively). Interestingly when MeOA was combined with PA, MeOA 
was shown to be cytoprotective, but to a lesser extent that its parent FA, OA. 
Since, by contrast with OA, MeOA is cytoprotective in cells exposed to PA, these 
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data suggest that: (1) the mechanisms of protection do not require a free carboxyl 
oxygen, (2) the unsaturation of the carbon chain may be responsible for 
cytoprotection, and that (3) the mechanism of PA-induced toxicity might be due 
to the presence of a free carboxyl oxygen. However, other studies introduce 
caveats to these arguments. For example, a study by Harvey et al. (2009) sought 
to investigate the effects of SFAs and UFAs on Human aortic endothelial cell 
(HAECs). They showed that myristic acid, a SFA consisting of 14 carbon atoms 
in the alkyl chain, is not toxic to HAECs. Additionally, the study by Welters et al. 
(2004) shows that myristate (C14) (sodium salt of myristic acid) is not cytotoxic 
to BRIN-BD11 beta cells. Further, work has shown that phytanic acid, a branched 
chain UFA, consisting of 16 carbon atoms in the alkyl chain, is not toxic to BRIN-
BD11 beta cells up to 100 µM after 17 hour incubation (Dhayal, unpublished work). 
These observations suggest that the length of the alkyl chain might be an 
irrelevant aspect when considering the mechanism of toxicity of PA, and also 
show that the presence of a free carboxyl oxygen atom is not the sole requirement 
for cytotoxicity. 
In addition to understanding the importance of keeping the carboxyl 
oxygen free from substituents to mediate cytoprotection, the importance of 
keeping the alkyl chain free from substituents was studied. Previous experiments 
have shown that elaidic acid (an analogue of OA containing a trans carbon-
carbon double bond between the 9th and 10th carbon atoms of the alkyl chain) is 
not toxic to BRIN-BD11 beta cells and that it is protective when combined with 
PA (Dhayal et al. 2008). Additional studies have shown that the precise position 
of the carbon-carbon double bond within the FA chain is not an absolute 
determinant of cytoprotective activity since petroselinic acid, a mono-UFA with 
97 
 
the carbon-carbon double bond between the 12th and 13th carbon atoms, prevents 
PA-induced death in BRIN-BD11 cells (Dhayal & Morgan 2011). 
Interestingly, unlike a whole raft of other UFA derivatives, RA induced 
significant cell death in both the INS-1 and HCMec/D3 cells (figures 3.13 and 3.14, 
respectively). This was unexpected and the mechanism by which RA induces cell 
death is unclear. However, it may be possible for hydroxyl-FAs to react with one 
another via their hydroxyl groups on the alkyl chain to form polyesters via the 
carboxyl oxygen; yielding either large polymer structures or ring-like structures, 
as described by Slivniak & Domb (2005) and Hayes et al. (2012). The formation 
of these higher order compounds may, perhaps, cause the cell death reported in 
this Chapter. However, evidence suggests that other hydroxyl-FAs can be non-
toxic or even cytoprotective since Kunda et al. (2018) noted that hydroxyl-PA is 
not toxic in murine models, unlike its parent FA, PA, and may even ameliorate 
insulin sensitivity. 
The data illustrating the effects of RA on INS-1 and HCMec/D3 cells add 
weight to the argument advocating that a change in the chemical composition of 
the alkyl chain, such as the addition of an -OH group, and the structure of the 
chain in space, affects the ability of OA not only to regulate toxicity but also to 
mediate cytoprotection when combined with a SFA. These data highlight the 
importance of maintaining the structure and composition of the UFA carbon chain 
for exerting its non-toxic and/ or cytoprotective effect(s). 
To conclude, the work presented in this Chapter has shown the differential 
responses which INS-1 and HCMec/D3 cells have towards PA and analogues of 
PA. Whether the entry of PA into the mitochondrion is a requirement for PA-
induced toxicity is yet unclear. In addition, the methods which are employed to 
study FA-entry into the mitochondrion require careful consideration and 
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interpretation. This work has also shown how small chemical changes to the 
structure of UFAs can affect cell viability, yet the mechanism by which these 
effects occur is yet unclear.  
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4 Evaluation of the effects of fatty acids on the 
cell cycle 
Data presented in Chapter 3 showed that PA was cytotoxic in both INS-1 beta 
cells and HCMec/D3 microvascular endothelial cells. In addition, OA was found 
to not only be non-toxic in both cell types but was also shown to prevent PA-
induced cell death. The literature suggests that these FAs might be able to effect 
the cell cycle. The purpose of this Chapter therefore sought to further investigate 
whether the mechanism of PA-induced cytotoxicity and OA-induced 
cytoprotection was as a result of their ability to affect cell cycle progression. 
4.1 Introduction 
Many types of eukaryotic cells can replicate for the purposes of regeneration, 
repair and restoration, as well as for growth and asexual reproduction. Beta cells 
of the pancreas are strongly proliferative in young children (up to the age of 2 
years) but the rate of proliferation then declines dramatically and is almost absent 
in adults (Tschen et al. 2009). However, this situation can change in response to 
physiological circumstances including during pregnancy and, possibly in obesity 
(Bonner-Weir et al. 2010; Nir et al. 2007; Wang et al. 2015b). Mature beta cells 
are therefore known to be relatively stable, poorly-proliferative cells as they will 
only replicate in response to very specific stimuli. Similarly, microvascular 
endothelial cells have very low basal rates of turnover, and only replicate when 
they are stimulated after damage (Tannock & Hayashi 1972). 
Cell division occurs by mitosis in all somatic cells and is sub-divided into 
four distinct phases which, collectively, comprise the cell cycle. The stages are 
as follows: G0+G1, S, G2 and M. The G0+G1 phase is considered to be the cell’s 
resting state, a state where the cell is prepared for DNA synthesis, when required 
101 
 
(Voet et al. 2000). The G0+G1 phase is followed by the S phase, the only period 
in the cell cycle where DNA is synthesised. The S phase leads into the G2 phase 
where the cell prepares for cell division by doubling all other cellular components. 
The final phase, M, involves the physical processes of cell division and the 
formation of daughter cells (Voet et al. 2000). 
Each phase of the cell cycle is preceded by a checkpoint to ensure that the 
cell is adequately prepared for cell division and that mistakes in the DNA 
replication process are corrected before the next phase is embarked upon. These 
checkpoints, regulated by cyclin-dependent kinases, are essential because they 
ensure that only cells with correctly copied DNA divide (Voet et al. 2000). 
Incorrectly copied DNA or uncontrolled replication can be dangerous and may 
lead to the formation of tumours (Voet et al. 2000). It is therefore important to 
determine whether exogenous or endogenous molecules can inhibit or enhance 
the efficiency of the checkpoint control mechanisms during the cell cycle. 
In the context of diabetes, it is important to learn whether relevant 
exogenous compounds can stimulate beta cell growth to maintain beta cell mass 
and glucose homeostasis as this might be of therapeutic value. For example, 
work conducted by Wang et al. (2015a) show, using three different mouse and 
human islet in vivo-based models, that harmine, a small molecule, is capable of 
inducing beta cell proliferation. Therefore, understanding how otherwise 
quiescent cells may be induced to replicate in adult life could improve the lives of 
those living with diabetes. 
Various methods exist to monitor cell proliferation in vitro or ex vivo, and, in 
many of these, cells are treated with agents which become incorporated into 
newly formed DNA such that they can be detected immunologically. Examples 
include BrdU and EdU, two nucleotide analogues which are incorporated into 
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replicating DNA. In addition, proteins, e.g. Ki-67 (Kim & Sederstrom 2015), and 
mcm-2 (Yousef et al. 2017) can also be used as these are synthesised only at 
specific points during the cell cycle. The rate of DNA replication is assessed as 
the extent of incorporation of the surrogate molecules which are then quantified 
and compared to untreated cells. These studies can inform us as to whether 
certain compounds are pro-proliferative or even able to inhibit proliferation. 
The aims of this Chapter were to determine whether SFAs or UFAs 
influence progression through the cell cycle of INS-1 beta cells and HCMec/D3 
microvascular endothelial cells using an intercalating dye, PI, and flow cytometry. 
Particularly, I sought to determine whether: (1) PA was able to inhibit cell 
proliferation as a contributory factor to its mechanism of cell death, (2) OA was 
able to induce a pro-proliferative response alone, and (3) OA was able to prevent 
PA-induced cell death by inducing a pro-proliferative response as a 
compensatory mechanism for PA-induced cell death. 
Although neither beta cells nor endothelial cells normally proliferate in vivo, 
the use of cell lines were employed here as a model to investigate the effects of 
FAs on the cell cycle. The use of cell lines, although not directly translatable to 
cells in vivo, may help to further our understanding of beta cell and endothelial 
cell biology and slowly bridge the gap between the effects of FAs observed in 
vitro and in vivo. 
4.2 Methods 
INS-1 and HCMec/D3 cells were cultured, as described in Chapter 2. Cells 
were prepared for cell cycle quantification using flow cytometry. 
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4.2.1 Preparation of cells for quantification of cell cycle progression 
Live and dead cells were harvested after 24-hour pre-treatment with 
complete medium and then after exposure for 48 hours to complete serum-free 
medium and FAs complexed to albumin, as described in Chapter 2. 
A group of positive control HCMec/D3 cells were also employed. These 
cells were treated with endothelial cell complete medium for 72 hours (complete 
medium control: CMC). 
All the cells were collected after each treatment in 12x75 mm tubes (BD 
Biosciences) and centrifuged. The cell pellet was resuspended in 250 µl cold 
saline GM and 750 µl cold 95 % (v/v) EtOH for 30 minutes to achieve plasma 
membrane permeabilisation and simultaneous fixation (table 4.1).  
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Saline GM/ fixative solution 
Stock solutions were made up in double distilled water (ddH2O) and stored at 
5 °C (table 4.1). 
 
500 μl of the stock solutions (table 4.1) were added to the following solution: 
25 ml ddH2O consisting of 0.4 g NaCl (Sigma) + 50 μl 0.5 M EDTA (Sigma). This 
solution (now ~ 27 ml) was made up to 50 ml with ddH2O. This final solution is 
known as saline GM. 
Cells that were not immediately analysed on the flow cytometer were 
stored at - 20 °C for up to 2 weeks (in falcon tubes suitable for freezing). Frozen 
cells were defrosted then centrifuged at 188 g for 5 minutes or 423 g for 3 minutes 
for INS-1 or HCMec/D3 cells, respectively. Each pellet was resuspended in 1 ml 
staining solution consisting of PI:RNase A, (50 μg/ ml PI (Sigma), 100 μg/ ml 
RNase A (ThermoFischer Scientific) in PBS) for 1.5 hours and then analysed on 
the BD Accuri™ C6 Plus Flow Cytometer (BD Biosciences). 
4.2.2 Data analysis 
Live and dead cells were harvested after the appropriate time point, the cell 
membranes permeabilised then fixed and the DNA subsequently stained with PI. 
The live cell population was gated on a FSC-A vs SSC-A plot, as shown in figure 
G-(+)-glucose (Sigma) 110 mg/ ml (0.61 M) 
KCl (Sigma) 40 mg/ ml (0.54 M) 
Na2HPO4 (Sigma) 39 mg/ ml (0.28 M) 
KH2PO4 (Sigma) 15 mg/ ml (0.11 M) 
Table 4.1 Stock solutions of components for saline GM/ fixative solution 
Stock solutions of the components in this table were made up in double distilled 
water. These solutions were added to other components to make saline GM. 
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4.1. While in a viability assay the PI stain binds DNA of non-viable cells (as their 
plasma membranes are no longer intact) in the cell cycle assay the plasma 
membranes of viable cells are deliberately permeabilised. Since only viable cells 
are able to proliferate, it was imperative that only live cells were included in the 
analysis. The FSC-A-axis depicts cells of increasing size and the SSC-A-axis 
depicts cells with increasing granularity. The live cell population was selected 
(gated) for analysis, whereas cellular debris and swollen cells were excluded. The 
live cell population was subsequently gated for single cells on a PI-Height vs PI-
Area plot, whereby cellular aggregates, e.g. doublets (two cells joined together), 
were excluded to ensure accurate determination of the percentage of single cells 
in each phase of the cell cycle, as shown in figure 4.1. The final stage of the 
analysis involved the separation of the desired cell population into each stage of 
the cell cycle: G0+G1, S and G2+M. All single cells which had their plasma 
membranes permeabilised were plotted on a Count vs PI-Area plot where the 
cells in the different phases of the cell cycle were quantified, as shown in figure 
4.1. Although the gating process aims to exclude any non-viable cells (those with 
disrupted plasma membranes and doublets), some cells with fragmented DNA 
are present in the viable cell population as these cells have intact plasma 
membranes. These cells, the M6 population, therefore represent cells which have 
fragmented DNA yet have intact plasma membranes. Thus, the cells in the 
G0+G1, S and G2+M phases have both intact plasma membranes and intact 
DNA. The cells which have an intact plasma membrane and fragmented DNA will 
be known herein as ‘non-viable’.  
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Figure 4.1 Cell cycle analysis using flow cytometry 
INS-1 cells were cultured, stained with PI and analysed on the BD 
Accuri™ C6 Plus Flow Cytometer. (a) Cells were pre-treated with 
complete medium for 24 hours, then with serum-free medium, fatty 
acid-albumin complex and vehicle (BSA + EtOH) for 48 hours. The cells 
were gated [P1] to exclude cell debris and swollen cells on a FSC-A vs 
SSC-A plot. (b) Cells from P1 were gated [P2] to exclude for 
doublets/aggregates on a PI-A (area) vs PI-H (height) plot. (c) A PI 
histogram of cells (gated on single cells from P2 gate) distinguishes the 
percentage of cells at the G0+G1, S and G2+M cycle phases. M6 
indicates the percentage of cells which are non-viable. 
(a) (b) 
(c) 
Cellular debris 
Swollen cells 
Doublets/ 
Aggregates 
Single cells 
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4.3 Results 
4.3.1 Percentage calculations 
To investigate whether FAs influence proliferation in INS-1 and HCMec/D3 
cells, cells were analysed using flow cytometry after staining with PI. The 
percentage of cells in the different phases of the cell cycle were calculated and 
expressed in the following categories: non-viable, G0+G1 phase, S phase and 
G2+M phase (figures 4.2 and 4.4). Since only dividing cells are considered to be 
proliferating, cells in the S and G2+M phases were combined (figures 4.2 and 
4.4). The INS-1 cells treated with the VC were exposed to BSA and EtOH. The 
HCMec/D3 control cells were treated with either: (1) complete medium, without 
BSA or EtOH (CMC: positive control), or (2) serum-free medium, with BSA and 
EtOH (VC: vehicle control). 
4.3.2 Data normalisation 
In order to eliminate the possibility of the non-viable cell population 
influencing the relative percentages of viable cells, each viable cell population 
was normalised against the non-viable cell population and the values were re-
plotted (figures 4.3 and 4.5). The coefficient was calculated for each sample and 
the percentage of diving cells recalculated. See equation 4.1 and subsequent 
calculations below. 
Equation 4.1 Calculation of coefficient for data normalisation 
𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 =  
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑎𝑙𝑙 𝑙𝑖𝑣𝑒 +  𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑎𝑙𝑙 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
 
 
Example: 
 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑎𝑙𝑙 𝑙𝑖𝑣𝑒 + 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠 = (𝐺0 + 𝐺1 + 𝑆 + 𝐺2 + 𝑀 + 𝑛𝑜𝑛 − 𝑣𝑖𝑎𝑏𝑙𝑒)
= 98.93 % 
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𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑎𝑙𝑙 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 = (𝐺0 + 𝐺1 + 𝑆 + 𝐺2 + 𝑀) = 78.85 % 
 
Calculation of coefficient: 
 
𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 =  
98.93
78.85
= 1.26 
 
Calculation of percentage of cells in G0+G1 phase with coefficient: 
 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝐺0 + 𝐺1 𝑝ℎ𝑎𝑠𝑒 = 54.28 % 
𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑋 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝐺0 + 𝐺1 𝑝ℎ𝑎𝑠𝑒 
1.26 𝑋 54.28 = 68.4 % 
 
4.3.3 Effects of fatty acids on INS-1 and HCMec/D3 cells 
Figures 4.2 and 4.4 show the effects of FAs on cell cycle progression in 
INS-1 and HCMec/D3 cells. Exposure of INS-1 cells to the VC resulted in 
approximately 19 % non-viable cells, 67 % of cells in the G0+G1 phase, 8 % of 
cells in the S phase and 6 % of cells in the G2+M phase. Exposure of HCMec/D3 
cells to the VC resulted in approximately 15 % non-viable cells, 56 % of cells in 
the G0+G1 phase, 11 % of cells in the S phase and 18 % of cells in the G2+M 
phase. The percentage of non-viable cells is consistent with the data presented 
in Chapter 3. Some HCMec/D3 cells were also exposed to complete medium for 
72 hours. This positive control (CMC) shows that a pro-proliferative response can 
be elicited in these cells. On average, fewer non-viable cells (9 %) were observed 
and a greater proportion of cells in the G0+G1 (60 %) phase was detected in the 
CMC compared to the VC (non-viable: 15 %; G0+G1: 56 %). 
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In both cell types, exposure to 0.25 mM PA for 48 hours resulted in an 
absolute increase in the percentage of non-viable cells and a decrease in the 
proportion of cells in the G0+G1 phase (figures 4.2 and 4.4). However, the 
exposure of these cells to MePA, the esterified analogue of PA, was comparable 
to the VC, indicating the requirement of the free carboxyl group for PA to induce 
cell death. When MePA was combined with PA, the percentage of non-viable 
cells was comparable to that of PA alone indicating that MePA is not able to 
protect against PA-induced toxicity. Exposure of both cell types to 0.25 mM OA 
resulted in the percentage of cells in each phase of the cell cycle comparable to 
the VC. Interestingly, OA in combination with PA was comparable to OA on its 
own, indicating the ability of OA to protect against PA-induced toxicity, as also 
shown in the viability data in figures 3.11 and 3.12. 
Figures 4.2 and 4.4 show the percentage of cells in the S and G2+M 
phases of the cell cycle combined. The data show that 0.25 mM PA on its own 
(or in combination with MePA) caused a significant decrease in the percentage 
of cells in the S and G2+M phases (p<0.001). 0.25 mM OA in combination with 
0.25 mM PA was able to prevent the cell death caused by PA alone. When used 
in combination with PA, OA did not cause an increase in the percentage of cells 
in the S and G2+M phases. These data suggest that OA does not induce a strong 
pro-proliferative response as part of its mechanism of cytoprotection. 
Figures 4.3 and 4.5 show the percentage of cells in the G0+G1, S and 
G2+M phases after normalisation to account for the non-viable cell population. 
The percentage of cells in each phase of the cell cycle was comparable to 
untreated cells, whereby the majority of cells were in the G0+G1 phase and the 
remaining cells were divided relatively equally between the S and G2+M phases. 
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Figures 4.3 and 4.5 show the normalised percentages of cells in the S and 
G2+M phases of the cell cycle combined. These two phases were combined 
because they represent the dividing cell populations. The data show no significant 
difference between the VC and any FA-treated cells, alone or in combination. The 
data suggest that neither SFAs nor UFAs induce a pro-proliferative response or 
inhibit proliferation in INS-1 and HCMec/D3 cells. 
Since both INS-1 and HCMec/D3 cells responded in the same way using 
the method presented in this Chapter, the evidence from the literature to discuss 
the effects of different techniques on beta cells and endothelial cells will be 
combined in the discussion section of this Chapter.  
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Figure 4.2 Effects of fatty acids and fatty acid analogues on INS-1 cell 
cycle progression after 48 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 48 
hours with serum-free medium and 0.25 mM fatty acid treatment: vehicle 
control (VC) (BSA + EtOH), palmitate (PA), oleate (OA), methyl palmitate 
(MePA), palmitate + oleate (PA + OA) and methyl palmitate + palmitate 
(MePA + PA). The data represent four experiments each conducted in 
triplicate. Cells analysed on BD Accuri™ C6 Plus Flow Cytometer. (a) 
Percentage of: non-viable cells (red bar); cells in G0+G1 phase (green bar); 
cells in S phase (blue); cells in G2+M phase (orange). (b) S and G2+M phase 
data from graph 1 combined. One-way ANOVA with Tukey’s multiple 
comparison test *** (p<0.001) n=12. Mean ± SEM. 
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Figure 4.3 Effects of fatty acids and fatty acid analogues on INS-1 cell 
cycle progression after 48 hours post-normalisation 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 48 
hours with serum-free medium and 0.25 mM fatty acid treatment: vehicle 
control (VC) (BSA + EtOH), palmitate (PA), oleate (OA), methyl palmitate 
(MePA), palmitate + oleate (PA + OA) and methyl palmitate + palmitate 
(MePA + PA). The data represent four experiments each conducted in 
triplicate. Cells analysed on BD Accuri™ C6 Plus Flow Cytometer. (a) 
Percentage of: cells in G0+G1 phase (green bar); cells in S phase (blue); 
cells in G2+M phase (orange) normalised against the percentage of non-
viable cells. (b) S and G2+M phase data from graph 1 combined. One-way 
ANOVA with Tukey’s multiple comparison test. No sig. diff. n=12. Mean ± 
SEM. 
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Figure 4.4 Effects of fatty acids and fatty acid analogues on HCMec/D3 
cell cycle progression after 48 hours 
HCMec/D3 cells were pre-treated with complete medium for 24 hours, then 
for 48 hours with serum-free medium and 0.25 mM fatty acid treatment: 
vehicle control (VC) (BSA + EtOH), palmitate (PA), oleate (OA), methyl 
palmitate (MePA), palmitate + oleate (PA + OA) and methyl palmitate + 
palmitate (MePA + PA). Cells in the CMC group were exposed to complete 
medium for 72 hours. The data represent three experiments each conducted 
in duplicate. Cells analysed on BD Accuri™ C6 Plus Flow Cytometer. (a) 
Percentage of: non-viable cells (red bar); cells in G0+G1 phase (green bar); 
cells in S phase (blue); cells in G2+M phase (orange). (b) S and G2+M 
phase data from graph 1 combined. One-way ANOVA with Tukey’s multiple 
comparison test *** (p<0.001) n=6. Mean ± SEM. 
114 
 
Treatment
C
e
lls
 (
%
)
CMC VC PA OA MePA PA+OAMePA+PA
0
10
20
30
40
(b) 
Figure 4.5 Effects of fatty acids and fatty acid analogues on HCMec/D3 
cell cycle progression after 48 hours post-normalisation 
HCMec/D3 cells were pre-treated with complete medium for 24 hours, then 
for 48 hours with serum-free medium and 0.25 mM fatty acid treatment: 
vehicle control (VC) (BSA + EtOH), palmitate (PA), oleate (OA), methyl 
palmitate (MePA), palmitate + oleate (PA + OA) and methyl palmitate + 
palmitate (MePA + PA). Cells in the CMC group were exposed to complete 
medium for 72 hours. The data represent three experiments each conducted 
in duplicate. Cells analysed on BD Accuri™ C6 Plus Flow Cytometer. (a) 
Percentage of: non-viable cells (red bar); cells in G0+G1 phase (green bar); 
cells in S phase (blue); cells in G2+M phase (orange) normalised against 
the percentage of non-viable cells. (b) S and G2+M phase data from graph 
1 combined. One-way ANOVA with Tukey’s multiple comparison test. No 
sig. diff. n=6. Mean ± SEM. 
Treatment
C
e
ll
s
/p
h
a
s
e
 (
%
)
CMC VC PA OA MePA PA+OAMePA+PA
0
20
40
60
80
100
G0+G1 phase
S phase
G2+Mitosis phase
(a) 
115 
 
4.4 Discussion 
Although BrdU is often considered as the gold standard for measuring cell 
proliferation (Mead & Lefebvre 2014), there are technical and temporal limitations 
to this technique. For example, the moment in time which the BrdU nucleotide is 
added to the cells, and the length of time which the cells are exposed to the 
nucleotide can affect the final results. BrdU may be added at the beginning, 
middle or end of the experiment which can result in more or less of the compound 
being incorporated onto DNA. For example, Pascoe et al. (2012) exposed mouse 
islets, cultured ex vivo, to BrdU to the final 24 hours of a 72 hour incubation and 
did not observe pro-proliferation upon exposure to OA. However, Brelje et al. 
(2017) exposed rat islets, also cultured ex vivo, to BrdU during the last 12 hours 
of cell culture and did observe OA-induced pro-proliferation. These technical 
differences could have resulted in differential BrdU incorporation into the DNA of 
cells upon exposure to OA. 
Based on the limitations attributed to the BrdU assay, it was decided to 
utilise an alternative method. I consider that the method presented in this Chapter 
is superior to that of other cell proliferation methods for the following reasons: (1) 
it removes from the analysis cells with both intact plasma membranes and 
fragmented DNA, and cellular aggregates, (2) it separates the proportion of cells 
into the different phases of the cycle (non-viable, G0+G1, S and G2+M), (3) the 
nucleotide stain, PI, was added at the end of the experiment so as not to affect 
normal cellular functions, and (4) it normalises the viable cell population against 
the non-viable cell population. 
A casual consideration of the cell cycle data presented in this Chapter might 
lead to the conclusion that PA inhibits cell proliferative because there was a large 
decrease in the percentage of cells in the S and G2+M phases following exposure 
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to this FA in both INS-1 and HCMec/D3 cells. However, this conclusion is 
challenged when the data are normalised such that viable cells are compared 
against the population of non-viable cells. The normalisation process removes 
any ambiguity that the non-viable cell population might have on the data. This is 
because the non-viable cells, although having intact plasma membranes, do not 
have intact DNA, which skews the percentage values obtained for the viable cell 
population. The non-viable cell population must therefore be removed for the 
analysis to be valid. Rather than simply removing these data and re-plotting the 
values, the process of normalisation allows the data to be restructured and 
prevents confounding factors from affecting the interpretation of the data. In this 
case, normalising the viable cell population to account for the non-viable cell 
population improves the integrity of the data. 
The post-normalised data for all FAs in both cell types show no differences 
in proliferation compared to the VC. In the case of PA, since the data show no 
difference in the percentage of cells in the combined S and G2+M phases, these 
data suggest that the mechanism of cytotoxicity of PA observed here is probably 
not due to PA inhibiting cell proliferation. The cytotoxicity observed is therefore 
likely to be via a different mechanism. In addition, there is no statistically 
significant increase in the percentage of cells in the S and G2+M phases exposed 
to OA in combination with PA. These data suggest that OA does not protect 
against PA-induced toxicity via a pro-proliferative mechanism. 
4.4.1 Effects of unsaturated fatty acids on cell proliferation 
A study by Ben-Harosh et al. (2017) measured relative cell proliferation 
(cell number) of pancreatic stellate cells after exposure to pathophysiological (0.5 
mM) levels of OA and PA. The aim of that study was to determine whether these 
two most frequently consumed dietary FAs could lead to cell stress. By measuring 
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cell proliferation, they sought to determine whether the FAs could affect cellular 
activation and migration. The researchers were interested in understanding 
whether the cells could undergo compensatory pro-proliferation upon exposure 
to stimuli inducing stress. Since PA has been shown in various models to induce 
cell stress, this FA was compared against OA, its non-toxic counterpart. They 
found that OA was not able to induce cell proliferation in these cells, since the 
rate of cell proliferation was comparable to the untreated pancreatic stellate cells. 
The researchers chose to count the cells under a haemocytometer, however, they 
failed to state whether they included both the viable and non-viable cell 
populations in the proliferation analysis. In addition, the steps taken to calculate 
cell proliferation are not described. Since OA failed to provoke a pro-proliferative 
response, the researchers took this response to be expected as OA does not 
induce cell stress. The idea that toxic stimuli might induce a pro-proliferative 
response is very interesting as it highlights the different perspectives when 
considering whether compounds can or cannot induce pro-proliferation. The 
researchers suggest that compounds which induce cell stress should provoke 
pro-proliferation, however, using the method I have presented in this Chapter, a 
pro-proliferative response was not observed in either the beta or the endothelial 
cells upon exposure to PA. However, one would not expect to observe a pro-
proliferative response in vitro because the cells do not have the internal milieu of 
an organ. 
Likewise, it has been shown that OA alone is not pro-proliferative in beta 
cells of mice (Pascoe et al. 2012). In that study, mice were infused with saline, 
Liposyn II (a fat emulsion), glucose or both Liposyn II and glucose for four days. 
The aim of the study was to determine whether the presence of elevated free FAs 
in the circulation would affect beta cell proliferation. Primary beta cells were 
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isolated and their rate of proliferation compared to that of INS-1 cells using a 
BrdU-based assay. The authors found that lipid infusion did not alter basal beta 
cell proliferation in either cell type, nor was significant cell death observed. The 
incorporation of BrdU into OA-treated cells was comparable to untreated beta 
cells. 
Artwohl et al. (2003) employed a more detailed approach to study the cell 
cycle whereby the proportion of HUVECs in each phase of the cycle were 
analysed. Similar to the method presented in this Chapter, cells were fixed in ice 
cold ethanol (75 %), exposed to a solution of RNase A and PI, then subsequently 
analysed using flow cytometry. They showed that OA marginally, yet statistically 
significantly, decreased the percentage of cells in the S phase and increased the 
percentage of cells in the resting, G0+G1 phase. These data suggest that OA 
does not induce a pro-proliferative response in the cells, possibly because, as 
suggested by Ben-Harosh et al. (2017), OA is not toxic and therefore a 
compensatory response is not required. 
Contrastingly, OA has been shown to induce cell proliferation in rat islets 
ex vivo (Brelje et al. 2017), in BRIN-BD11 rat beta cells in vitro (Diakogiannaki et 
al. 2007) and in HVSMCs (Lamers et al. 2011) using the BrdU assay. It is 
interesting that some studies find that OA does not affect cell proliferation, 
whereas others show OA to be pro-proliferative. OA may in fact be pro-
proliferative and the different effects seen may be due to differences in cell lines 
from different species, for example, from the studies conducted by Pascoe et al. 
(2012) and Brelje et al. (2017), whereby mice and rats were used, respectively. 
In addition, the use of cells ex vivo, as employed by Pascoe et al. (2012) and 
Brelje et al. (2017), does not provide a robust representation of the effects of FAs 
on beta cells. This is because islets consist of various other cells, including alpha 
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cells, which may respond differentially to beta cells and may therefore affect the 
metabolism of FAs and therefore the interpretation of the data. 
4.4.2 Effects of saturated fatty acids on cell proliferation 
Artwohl et al. (2003), Ben-Harosh et al. (2017), Diakogiannaki et al. (2007), 
Lamers et al. (2011) and Pascoe et al. (2012) found that PA is toxic to beta cells 
and endothelial cells, and also concluded that PA has no effect on cell 
proliferation. 
Work by Ben-Harosh et al. (2017) found that PA halted cell proliferation in 
pancreatic stellate cells. However, what was not clear was whether PA halted cell 
proliferation or whether the non-viable cell population masked proliferation. What 
the researchers failed to state was whether they normalised the viable cell 
population against the non-viable cell population. 
Pascoe et al. (2012) showed that PA caused a significant decrease in the 
incorporation of BrdU into the DNA of viable INS-1 cells and hence concluded 
that PA is able to inhibit proliferation. The researchers concluded that this effect 
was caused by PA inhibiting cell proliferation, however, this effect is likely to be 
due to cell death induced by PA. The researchers also wanted to determine 
whether certain cyclin-dependent kinase inhibitors were affected as a further 
measure of cell-cycle progression ex vivo and in vitro. The aim of this analysis 
was to determine whether expression levels of these cell-cycle regulators were 
affected by FAs. By studying these regulators, they sought to determine whether 
FAs would target components upstream of cell proliferation, such as the 
localisation of proteins responsible for gene regulation. They found that PA did 
not block the nuclear localisation of cyclin D2, suggesting that if a reduction in 
proliferation were to be observed, it would most likely be due to an effect 
downstream of cyclin D2. Cyclin-dependent kinases, such as cyclin-dependent 
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kinase 4, are responsible for blocking the progression of the cell cycle past the 
G1 phase. Interestingly, upon exposure of INS-1 cells to PA, an increase in the 
expression of p16 and p18 inhibitors of cyclin dependent kinase 4 was observed, 
thus preventing cell proliferation. 
Similarly, Artwohl et al. (2003) showed that the SFA stearic acid (C18:0), 
dose-dependently increased apoptosis in HUVECs. The researchers came to this 
conclusion after they normalised the viable cell population against the non-viable 
cell population. They observed stearic acid-induced G0+G1 cell cycle arrest, a 
decrease in the percentage of cells in the S phase, and no change in the 
percentage of cells in the G2+M phase. A concomitant up-regulation of the cyclin 
dependent kinase inhibitor p21, a negative regulator of the G0 phase of the cell 
cycle, was also observed. This is an interesting observation as they suggest that 
the stearic acid-induced G0+G1-arrest could be interpreted as being responsible 
for inducing apoptosis. 
4.4.3 Limitations to studying cell proliferation 
Su & O’Farrell (1998) suggest that when studying cell growth, attention 
should turn to studying the dysregulation of size (hypertrophy) rather than cell 
proliferation (hyperplasia). This is because it is worth noting that, although a 
compound might not affect the cell cycle, cells can grow without dividing; they 
can undergo hypertrophy, a process by which cells grow in size and where the 
cell cycle is not altered. In the context of diabetes, it might be worth: (1) 
considering the use of assays such as cellular hyperplasia, or the duplication of 
cellular components to study whether cells can compensate for cell death caused 
by toxic stimuli, or (2) determining whether compounds can affect specific 
processes associated with cell division, such as the localisation of cell cycle 
regulators, e.g. cyclin D3, which can lead to the dysregulation of growth. Although 
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some diabetes research does focus on identifying therapeutic compounds to 
induce hyperplasia, the focus might require shifting to study hypertrophy and cell-
cycle deregulation. This is because cell proliferation is not directly proportional to 
growth – a reduction in beta cell mass does not necessarily require the induction 
of cell proliferation because cells can divide without getting larger. Indeed, 
diabetes research is shifting slightly such that the connections between cell mass 
and cell proliferation are being investigated. For example, the notion that 
pancreatic ductal and/ or acinar cells can transdifferentiate into insulin-producing 
beta cells, without resulting in a hyperplastic response is emerging (Kim & Lee 
2016). Hence, the fact that beta cells do not proliferative during adolescence and 
adulthood is proving irrelevant in identifying therapeutic treatments for diabetes. 
In conclusion, the data presented in this Chapter show that OA is not pro-
proliferative in either INS-1 beta cells or the HCMec/D3 cells, adding to the 
existing body of evidence (Artwohl et al. 2003; Ben-Harosh et al. 2017; Pascoe 
et al. 2012) arguing that the mechanism of OA-induced cytoprotection is not via 
a pro-proliferative mechanism. The data presented in this Chapter therefore 
suggest that the mechanism of OA-induced cytoprotection occurs via a different 
mechanism. 
Although the literature is divided as to whether OA is pro-proliferative in 
both INS-1 and HCMec/D3 cells, the literature states that PA does not inhibit cell 
proliferation. The data presented in this Chapter add to this body of evidence 
(Artwohl et al. 2003; Ben-Harosh et al. 2017; Diakogiannaki et al. 2007; Lamers 
et al. 2011; Pascoe et al. 2012) showing that PA does not inhibit cell proliferation. 
These data therefore suggest that the mechanism of PA-induced cytotoxicity is 
not via the inhibition of cell proliferation.  
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Lastly, further work, involving the study of the duplication of cellular 
components to determine whether PA stunts the growth of cells, and 
subsequently causes cell death, might be worth conducting.  
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5 Development of a methodology using Raman 
microspectroscopy to study intracellular lipid 
disposition 
5.1 Introduction 
5.1.1 Spectroscopy 
Spectroscopy is an analytical technique used to analyse the electromagnetic 
radiation emitted, absorbed or scattered by molecules and/ or the atoms they 
comprise. The information obtained aids the understanding of the electronic 
configuration of atoms and their vibrational states. 
5.1.1.1 Vibrational states 
As very little energy is needed to change the rotation of a molecule, the 
electromagnetic radiation emitted or absorbed lies in the microwave region. 
However, the vibrational energy of a molecule changes greatly when exposed to 
radiation since the change in energy is dependent upon the bond lengths, their 
strengths and atomic weight. Raman microspectroscopy, for example, cannot 
measure microwaves, yet molecular changes in vibrational energy can be 
measured. 
5.1.1.2 Raman scattering 
Raman microspectroscopy enables the understanding of molecular energy 
levels by analysing the frequencies present in the radiation scattered by 
molecules and their constitutive atoms. A laser beam from a monochromatic light 
source (ω
p
) is passed through a sample and the scattered radiation is measured. 
There are three different forms of outgoing radiation. This is because how the 
outgoing radiation is emitted is dependent upon whether the incoming radiation 
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comes into contact with the electronic field of the sample. Some of the radiation 
that passes through the sample is not scattered and is emitted at the same energy 
as the incoming radiation. This is termed Rayleigh scattering (ω
p
). However, most 
radiation that passes through a sample is scattered, i.e. incoming photons collide 
with atoms of the molecule and change their energy states (Toporski, Dieing & 
Hollricher 2018, p. 50). This is because if the incoming radiation does come into 
contact with the sample, this radiation will affect the electrical charge distribution 
of the molecules within the sample (Toporski, Dieing & Hollricher 2018, p. 48). 
Thus, the outgoing radiation will be representative of the chemical composition of 
sample and the frequency of the incoming radiation. Since in Raman 
microspectroscopy the incoming radiation is in the visible spectrum, any Rayleigh 
scattering will be in the visible spectrum. Photons that lose some of their energy 
and emerge with a lower energy (and thus a lower frequency) are termed Stokes 
radiation (ω
s
). Photons that gain energy and emerge with a higher energy, and 
thus a higher frequency, are termed anti-Stokes radiation (ω
as
) (figure 5.1).  
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Figure 5.1 Schematic of a Raman scattering experiment 
How incoming radiation is scattered is dependent upon whether it comes 
into contact with the electronic system of the sample: ω
as 
anti-Stokes 
scatter (scattering of wavelength is higher in energy than incoming 
radiation), ω
p 
Rayleigh scatter (scattering of wavelength is the same as 
incoming radiation), and ω
s 
Stokes scatter (scattering of wavelength is 
lower in energy than incoming radiation). Scattered light is detected using 
a CCD detector. 
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5.1.1.3 Raman microspectroscopy 
Raman microspectroscopy is a label-free technique which is used to study the 
composition of materials, primarily those which consist of small numbers of 
substances; such as the pigments within paints or graphene structures. Recently, 
however, this technique has also been utilised to study changes in the chemical 
nature of components within cells such as nuclear material (Krafft et al. 2006), 
proteins (Bazylewski, Divigalpitiya & Fanchini  2017) and lipids (Bradley et al. 
2016; Cao et al. 2016; Chen et al. 2015; Chien et al. 2012; Kochan et al. 2013a; 
Kochan et al. 2013b; Kochan et al. 2015; Majzner et al. 2014; Majzner, Chlopicki 
& Baranska 2016; Majzner et al. 2018; Mansfield & Winlove 2017; Schie et al. 
2013; Slipchenko et al. 2009;Stiebing et al. 2014; Stiebing et al. 2017; van Manen 
et al. 2005; Yue et al. 2012). 
In the study conducted by Krafft et al. (2006), human embryonic stem cells 
were exposed to a stress-inducing stimulus for 24 hours which is known to block 
DNA synthesis. The aim was to determine whether spontaneous Raman 
microspectroscopy could detect changes in nuclear composition upon cell stress. 
Cluster analysis identified the nuclear material in the spectral range from 980 cm-
1 to 1600 cm-1. The spectra were normalised against the phenylalanine peak at 
1003 cm-1. Upon exposure to the stress-inducing stimulus the cell nucleus was 
found to decrease in size, coupled with a decrease in the intensity of the nuclear 
material, indicating degradation of DNA and RNA: cellular changes which occur 
during the early stages of apoptosis (Krafft et al. 2006). 
Despite the conclusions that are drawn from the study conducted by Krafft et 
al. (2006), it should firstly be noted that the cells imaged were not analysed 
individually. This means that some spectra were in fact representing cellular 
material from two cells that were imaged side by side. This would normally be 
acceptable if the spectra from the two cells had been collected separately, then 
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subsequently averaged. However, this was not the case. Based on this 
observation, I was determined to analyse all the INS-1 beta cells, in this thesis, 
individually even if two cells were imaged side by side, then subsequently 
average the spectra taken from each individual cell. This would ensure that the 
numbers of cells imaged per treatment were accurately depicted. Secondly, the 
conclusions drawn from the study conducted by Krafft et al. (2006) were based 
on six cells only. This did not seem adequate, in my opinion, in terms of statistical 
significance. I was therefore determined to image and analyse as many INS-1 
cells per treatment as possible to ensure that the data could be confidently relied 
upon. 
The aim of the study conducted by Bazylewski, Divigalpitiya & Fanchini (2017) 
was to determine whether spontaneous Raman microspectroscopy could 
distinguish between modifications to L-cysteine amino acids in proteins and 
enzymes. In this case, they wanted to monitor the reversible formation and 
cleavage of disulphide bonds. Cysteine-based samples were dissolved in 
deionised water and spectra were obtained. The researchers were able to identify 
the products obtained from chemical reactions using Raman microspectroscopy 
and claim that their methodology can be applied to the study of enzyme activity 
of sulphur containing groups. 
The study conducted by Bradley et al. (2016) employed the use of coherent 
anti-Stokes Raman scattering microscopy (CARS). This technique, a Raman 
spectroscopy technique, involves selecting a single vibrational frequency/ 
wavenumber to generate uni-variate data in the form of Raman maps. This 
technique cannot, therefore, generate multi-variate data in the form of spectra. 
The aim of the study conducted by Bradley et al. (2016) was to measure lipid 
distribution in mouse oocytes and embryos. In order to visualise C-H bonds in 
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LDs, they used the 2850 cm-1 vibrational frequency as this wavenumber has been 
suggested to correspond to C-H bond within R-CH2/ R-CH3 groups within lipids, 
as described by Baeten et al. (1998) (table 5.1). Bradley et al. (2016) found that 
CARS was able to discern the degree of aggregation of LDs and observed that 
the aggregation of LDs changed significantly during oocyte maturation and during 
embryo development. 
Chien et al. (2012) also employed CARS to measure intracellular lipids. The 
researchers overexpressed two lipid regulatory proteins (one to increase TAG 
content and another to decrease TAG content) in live Drosophila larvae under fed 
and starved conditions. The aim was to determine whether CARS could be used 
to determine changes in the size of LDs. The researchers chose to use the 2845 
cm-1 vibrational frequency to visualise C-H bonds present in lipids and obtained 
uni-variate data. They found that CARS was able to identify significant differences 
in lipid content in oenocytes (which are analogous to hepatocytes in mammals) 
and body fat, and were able to conclude that the two cell types metabolise and 
utilise lipids differentially. 
The study conducted by Schie et al. (2013) aimed to compare lipid 
composition and lipid ratios within HepG2 hepatocytes using a home-built CARS 
system coupled with a spontaneous Raman system. HepG2 cells were exposed 
to 0.25 mM OA and 0.25 mM palmitic acid, alone and in combination, for 24 hours, 
to determine whether the composition of LDs reflected which exogenous FAs the 
cells were exposed to - a similar aim to one presented in this thesis, although not 
executed in the same way. The research conducted by Schie et al. (2013) also 
aimed to either support or counter the research conducted by Listenberger et al. 
(2003), which suggests that OA might be able to protect cells from PA-induced 
cytotoxicity by shuttling PA into LDs. Schie et al. (2013) also coupled CARS with 
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gas chromatography to determine whether the results from CARS could be 
replicated and validated using an alternative method. These experiments 
involved removing the lipid from the cells and converting them to methyl ester 
FAs and quantifying their composition. 
The HepG2 cells were exposed to up to 0.5 mM OA and up to 0.5 mM palmitic 
acid, alone and in combination, for 24 hours. From their data, they concluded that 
the FA composition was, on average, similar in all the LDs in the samples they 
studied. However, only three LDs were studied from one cell per treatment group, 
using the CARS system, which in terms of statistical analysis does not instil 
confidence in the data. Unfortunately, the researchers do not state which 
statistical analysis they used to analyse their data, and the Raman maps of the 
HepG2 cells are questionable as the nuclei are not clearly visible. In addition to 
this, the researchers noticed that many cells exposed to 0.25 mM palmitic acid 
had detached from their substrate after their 24 hour exposure (most likely due 
to them undergoing apoptosis). Although they obtained Raman maps of cells still 
adherent to their substrate, it is likely that the lipid within those adherent cells 
were not representative of healthy cells. Despite these shortcomings, Schie et al. 
(2013) concluded that when HepG2 cells were exposed to equimolar 
concentrations of OA and palmitic acid, the level of palmitic acid increased, 
suggesting that their data do support the hypothesis presented by Listenberger 
et al. (2003). However, they failed to realise that this effect was also observed 
when the HepG2 cells were exposed to palmitic acid alone. If OA had shuttled 
palmitic acid into LDs, a far greater increase in the percentage of palmitic acid 
would have been observed in the HepG2 cells versus those exposed to palmitic 
acid alone. Thus, it cannot be concluded that OA shuttles palmitic acid into LDs 
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meaning that the data presented by Schie et al. (2013) do not support the 
hypothesis presented by Listenberger et al. (2003). 
The aim of the study conducted by Chen et al. (2015) was to investigate the 
function of human sweat glands in humans. The researchers did this by applying 
olive oil onto a sweat gland and imaging the ejection of sweat droplets from the 
sweat gland. Since sweat is composed of water and some electrolytes, it does 
not mix with the olive oil. Thus, any movement of the sweat through the gland 
would be detected via the movement of olive oil on the surface of the gland. The 
researchers employed the 2845 cm-1 wavenumber to image the ejection of sweat 
droplets from the sweat glands as this wavenumber has been suggested to 
correspond to C-H bond within R-CH2/ R-CH3 groups within lipids. Using the 
CARS system, Chen et al. (2015) were able to visualise the movement of sweat. 
They observed that during sweat discharge the olive oil was flushed out from the 
sweat pore allowing them to visualise and determine the temporal sequence of 
sweat discharge from the glands. 
Yue et al. (2012) employed the use of CARS and spontaneous Raman 
microspectroscopy to study the cell membranes of non-neoplastic human 
mammary epithelial HMT-3522S1 cells. The researchers treated the cells with 
ethylene glycol tetraacetic acid, a disruptor of the formation of acini-cell (secretory 
cells of mammary glands) apical polarity. They explained that these cells must 
maintain both apical and basal polarity in order to prevent the disruption of 
mammary tissue architecture and to prevent cancer development. Thus, the aim 
of their research was to determine whether, using CARS, they could detect 
changes in lipid ordering in apical and basal membranes and subsequently 
characterise apical polarity in live mammary acini. Forty cells per treatment were 
analysed which gave confidence in the statistical analysis. The Raman spectra in 
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the R-CH2/ R-CH3 region between 2700 cm-1 and 3500 cm-1 underwent peak 
fitting analysis whereby the peaks within this region were separated to avoid 
overlapping peaks. In this case, the peaks in the spectral region described above, 
were fitted into seven Lorentzian bands. The area under the Curve (AUC) for 
each of the seven bands were calculated and compared between one another 
and between different treatments. From this, the researchers observed 
differential lipid composition between lipids in the apical and basal membranes of 
acini cells, suggesting differences in lipid packaging. 
Cao et al. (2016) employed the use of stimulated Raman microspectroscopy 
coupled with a high-throughput microfluidics system to quantify the formation and 
distribution of LDs in live, adherent HeLa cells. HeLa cells are human cervical 
cancer cells and are used extensively in cell biology. Stimulated Raman 
microspectroscopy is similar to CARS, whereby it generates uni-variate data. 
HeLa cells were cultured directly onto the microfluidics system and were exposed 
to increasing concentrations of OA for 3 hours then imaged the cells using the 
2850 cm-1 wavenumber to detect C-H bonds in CH2 groups within lipids. Cao et 
al. (2016) stated that they used OA to induce lipid accumulation in the HeLa cells. 
However, they do not state why they specifically used OA, nor do they cite 
previous literature that have shown or suggested that OA induces the formation 
of LDs. The researchers conducted one experiment in triplicate and 3466 cells 
were imaged in total. The researchers found that the size of the LDs was 
consistent when the HeLa cells were exposed to different concentrations of OA. 
They also found that the intensity of the LDs did not show significant variation 
between the treatments. Interestingly, they found that the number of LDs in the 
HeLa cells increased as the concentration of exogenous OA increased, and from 
this they concluded that the HeLa cells store excessive lipids by increasing the 
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number of LDs. However, intercellular heterogeneity was observed, whereby 
some cells exposed to very low concentrations of OA had large amounts of LDs, 
whereas at high concentrations of OA, some cells had very few LDs. Cao et al. 
(2016) note the importance of detecting, measuring and characterising sub-
populations of cells in order to improve our understanding of basic cell biology 
and how cells might respond to medications, for example. 
Slipchenko et al. (2009) employed the use of spontaneous Raman 
microspectroscopy, CARS and stimulated Raman spectroscopy to investigate the 
formation of LDs in live cells in vivo and in vitro upon exposure to deuterated and 
non-deuterated FAs. Investigations were conducted in live differentiated and 
undifferentiated murine fibroblast-like 3T3-L1 cells, CHO cells, and subcutaneous 
adipocytes and sebaceous glands from an ear of a living BALB/c mouse. In order 
to determine whether certain FAs were present in the LDs of these cells, the 
Raman spectra of pure FAs were obtained to enable their comparison with 
spectra obtained from cells. In order to do this, the researchers obtained the 
spectra from methyl ester FAs: MePA, MeOA and methyl linoleic acid (C18:2). 
The researchers wanted to observe how much of the exogenously supplied 
deuterated palmitic acid had been incorporated into endogenous LDs. Using 
spontaneous Raman microspectroscopy and CARS, 3T3-L1 cells were exposed 
to 50 µM deuterated palmitic acid for four days to study de novo lipid synthesis. 
The Raman spectra were normalised against the 1445 cm-1 peak as this peak 
corresponds to C-H bonds in CH2 groups in lipids. They were then able to 
compare the relative peak heights of the band at 1654 cm-1 which corresponds 
to C=C bonds in unsaturated lipids. The 1654/ 1445 cm-1 ratio for FAs produced 
via de novo synthesis was 0.32 ± 0.04 (mean ± standard deviation), whereas for 
cells exposed to oleic acid, the ratio was 0.58 (standard deviation not provided). 
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From this, the researchers concluded that the LDs in untreated 3T3-L1 cells 
contained a significant portion of SFAs. 
The researchers also compared the ratio of the peaks at 2100 cm-1, as this 
corresponds to C-D bonds found in deuterated compounds and is used as a proxy 
to detect exogenous FAs, and at 2850 cm-1, as this corresponds to C-H bonds 
found in CH2 groups in lipids and is used as a proxy to detect endogenous FAs. 
Differentiated 3T3-L1 cells were exposed to deuterated palmitic acid and non-
deuterated oleic acid in a 1:9 molar ratio. Based on the ratios of the peaks 
corresponding to C-D and C-H bonds, the researchers concluded that the 
exogenous FAs constituted 19 % of the total lipids studied. From this, they then 
concluded that LDs accumulate in differentiated 3T3-L1 cells in the presence of 
exogenous FAs due to free FA uptake as well as de novo lipid synthesis. 
Unusually, the researchers did not study the effects of non-deuterated palmitic 
acid and non-deuterated oleic acid separately on LD formation in this cell type. 
Therefore, it would be inaccurate to conclude that deuterated palmitic acid is 
taken up in such low quantities as instead, the presence of non-deuterated oleic 
acid may have altered the uptake of deuterated palmitic acid and its incorporation 
into LDs. A subsequent experiment involved the exposure of undifferentiated 
3T3-L1 cells to 50 µM deuterated palmitic acid for four days. As undifferentiated 
3T3-L1 cells do not synthesise LDs de novo, the aim of the experiment was to 
determine whether this FA would accumulate within the cell. Interestingly, the 
researchers observed that LDs were composed of 70 % C-D bonds, inferring that 
the LDs were 70 % composed of deuterated palmitic acid. 
3T3-L1 cells were then analysed via the coupling of spontaneous and 
stimulated Raman microspectroscopy. Like with CARS, a Raman map was 
generated for each vibrational frequency selected. Contrast of the LDs, 
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cytoplasm and the nucleus were compared at 2600 cm-1, 2850 cm-1 and 2935 
cm-1. At 2850 cm-1 a bright contrast was observed from LDs, a low contrast from 
the cytoplasm, and no contrast from the nucleus. At 2935 cm-1 a higher contrast 
was observed from the cytoplasm and nucleus compared to 2850 cm-1. Contrast 
nearly disappeared at 2600 cm-1. This was expected as only deuterated bonds 
appear at this vibrational frequency, as described by van Manen et al. (2005) and 
Stiebing et al. (2017). 
Slipchenko et al. (2009) then investigated the effects of exposing CHO cells 
to 500 µM oleic acid for 6 hours using spontaneous Raman microspectroscopy 
and CARS. Three LDs from one CHO cell were analysed using single point 
spectra and compared to the spectrum of pure MeOA. Untreated cells were found 
to contain no LDs. However, upon exposure to oleic acid, an increase in the 
number of LDs was observed, compared to the untreated cells, suggesting that 
the presence of oleic acid induces the formation of LDs in CHO cells. The three 
cell spectra were also found to be identical. In addition, upon comparison of the 
averaged cell spectra with the spectrum of MeOA, the researchers stated that the 
cell spectrum resembled the spectrum of MeOA. A higher intensity of the peak at 
1265 cm-1, corresponding to =C–H bonds, as described by Weng et al. (2003) 
Weng, and at 1654 cm-1 were observed in the cell spectrum compared to the 
spectrum of pure MeOA. From this, it could be suggested that oleic acid: (1) 
induces the formation of LDs, (2) induces endogenous LDs to become more 
unsaturated, and/ or (3) itself becomes incorporated into LDs. 
Next, the researchers then determined the 1654/ 1445 cm-1 ratio for FAs in 
LDs present in subcutaneous adipocytes and sebaceous glands using CARS and 
second-harmonic generation, a technique which generates contrast and allows 
for the visualisation of intracellular structures. Similar to the study conducted by 
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Yue et al. (2012), Slipchenko and co-workers conducted peak fitting analysis of 
the Raman spectra between 2500 cm-1 and 3500 cm-1. This spectral region was 
fitted into six Lorentzian bands and the AUC for each of the six bands were 
calculated and compared between the two cell types. For subcutaneous 
adipocytes the ratio was 0.82 ± 0.04, and for sebaceous glands the ratio was 0.29 
± 0.03, suggesting a higher level of saturated lipids in the glands. The 2850/ 2935 
cm-1 ratio was also compared for the two cell types. A 2.1-fold increase in SFAs 
in the sebaceous glands was observed compared to the subcutaneous 
adipocytes, suggesting that lipid packing in sebaceous glands is more ordered 
than in the subcutaneous adipocytes. 
Finally, the researchers conclude that in vivo fat contains more UFA than the 
fat formed via de novo synthesis in 3T3-L1 cells. This conclusion was based on 
the observation that the 1654/ 1445 cm-1 ratio for FAs in LDs in the subcutaneous 
adipocytes was much higher (0.82 ± 0.04) than in the 3T3-L1 cells (0.32 ± 0.04). 
The study conducted by van Manen et al. (2005) involved using spontaneous 
Raman microspectroscopy to determine whether it could identify the composition 
of LDs in human-derived PLB-985 cells, differentiated into neutrophil cells, 
exposed to deuterated arachidonic acid. It has been suggested that LDs consist 
of a monolayer of phospholipids (Ohsaki, Suzuki & Fujimoto 2014). Arachidonic 
acid, an omega-6 polyunsaturated FA consisting of four carbon-carbon double 
bonds, is thought to be a component of phospholipids within LDs. It has been 
suggested that these LDs could act as a source of arachidonic acid for the 
synthesis of eicosanoids. Eicosanoids are signalling molecules made by the 
oxidation of arachidonic acid or other polyunsaturated FAs. The researchers 
exposed differentiated PLB-985 cells to deuterated arachidonic acid for 1 hour 
and obtained uni- and multi-variate data. The =C-H bond within the RHC=CHR 
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group at approximately 3014 cm-1 (Sadeghi-Jorabchi et al. 1970; van Manen et 
al. 2005) shifts to the silent region of the spectrum, between 1800 – 2800 cm-1, 
due to the presence of C-D bonds, as described by van Manen et al. (2005), 
Slipchenko et al. (2009) and Stiebing et al. (2017). This occurs because 
deuterium, a heavier isotope of hydrogen, affects the vibrational tendencies of 
the sigma bond. van Manen et al. (2005) observed peaks in the 2220 cm-1 and 
2249 cm-1 regions of the Raman spectrum which they concluded had 
corresponded to the presence of deuterated arachidonic acid within the cells. The 
researchers were then able to visualise the deuterated arachidonic acid and 
determine that it localised closely with LDs using the 1658 cm-1 wavenumber 
corresponding to C=C bonds within UFAs present within LDs, as suggested by 
Sadeghi-Jorabchi et al. (1970) (table 5.1). van Manen et al. (2005) then exposed 
neutrophil cells to latex beads, which were phagocytosed (engulfed) by the cells, 
and observed where they localised within the cells. It was observed that the 
membranes of the phagosomes were in close proximity of the LDs consisting of 
arachidonic acid. Based on this observation, the researchers suggested that 
arachidonic acid is released from LDs and may be important in the maturation of 
phagosomes. 
Interestingly, van Manen et al. (2005) observed that the neutrophils which 
were inactivated did not take-up FAs or behave in the same way as those that 
were activated. Inactivated/ quiescent neutrophils contained little or no LDs, 
whereas the number of LDs appeared to increase upon exposure to deuterated 
arachidonic acid. Unfortunately, however, the researchers did not state how 
many cells were utilised per treatment group within the study, nor did the 
researchers quantify these observations and employ statistical analysis to justify 
the observations. 
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Stiebing et al. (2014) also exposed cells to deuterated FAs to determine 
whether spontaneous Raman microspectroscopy would determine whether they 
were incorporated into LDs. THP-1 monocytes were differentiated into 
macrophages then exposed to 400 µM deuterated arachidonic acid and 
deuterated palmitic acid, alone and in combination, for various lengths of time (3, 
6, 8, 24 and 32 hours). The study of lipid uptake and storage behaviour in 
macrophages is important because these cells play a key role in the development 
of atherosclerotic lesions within the walls of blood vessels. The overexposure of 
these cells to FAs causes the formation of LDs and gives these cells a foamy 
appearance. Thus, Stiebing et al. (2014) aimed to determine whether these two 
deuterated FAs localised within LDs in macrophage cells by obtaining uni- and 
multi-variate data using spontaneous Raman microspectroscopy. Gas 
chromatography was also employed, similar to the study conducted by Schie et 
al. (2013), to validate the Raman data. 
Spontaneous Raman microspectroscopy was able to visualise the lipid 
content within untreated macrophage cells, however, the vibrational frequency 
which was utilised to observe the lipid is not mentioned in the research paper. Of 
the four untreated cells presented in the paper, lipid heterogeneity was observed. 
The researchers suggest that this heterogeneity was due to the different stages 
of the cell cycle which the cells were in. 
Stiebing and co-workers observed that deuterated arachidonic acid was 
present in macrophage cells, an observation similar to that reported by van 
Manen et al. (2005), whereby neutrophil cells were exposed to deuterated 
arachidonic acid. In the macrophage cells a rapid increase of deuterated 
arachidonic acid in LDs was observed within 3 hours, but levels plateaued at 8 
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hours. In addition, the area which the LDs occupied did not increase after 8 hours 
of exposure to deuterated arachidonic acid. 
Interestingly, the formation of foam cells was not observed. This could have 
been because foam cells may not form upon exposure to polyunsaturated FAs. 
Foam cells may only form upon exposure to SFAs. 
Unfortunately, Stiebing et al. (2014) did not present the data for the 
macrophage cells exposed to deuterated palmitic acid alone. They did, however, 
describe the data obtained. The researchers detected deuterated palmitic acid in 
almost all LDs within the macrophage cells at all of the time points studied. The 
biological significance of this observation is not considered. 
Upon co-incubation with deuterated arachidonic acid and deuterated palmitic 
acid, Stiebing et al. (2014) observed heterogeneous storage of these two FAs 
within LDs. It cannot be inferred from these data whether these results support 
the hypothesis presented by Listenberger et al. (2003) that UFAs or 
polyunsaturated FAs protect cells from the cytotoxic effects of palmitic acid or PA 
by shuttling them into LDs. 
The results from the gas chromatography studies were similar to the Raman 
results whereby the amount of arachidonic plateaued after 24 hours. The 
combined Raman and gas chromatography data suggest that arachidonic acid is 
first stored in LDs where saturation within LDs in reached after 8 hours. For longer 
incubation times, arachidonic acid is likely to be metabolised into adrenic acid (a 
FA consisting of two additional carbon atoms in the alkyl chain compared to 
adrenic acid), and/ or incorporated into phospholipids of cell membranes and 
organelle membranes. The researchers suggest that the conversion of 
arachidonic acid to adrenic acid might be more energetically favourable for the 
storage of arachidonic acid within cells. 
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The study conducted by Stiebing et al. (2014), where THP-1 monocyte cells 
were differentiated into macrophage cells, was followed up in a study published 
by Stiebing et al. (2017). The same cell type was studied using spontaneous 
Raman microspectroscopy, stimulated Raman microspectroscopy and CARS. 
The aim of the study was to expose the macrophage cells to deuterated palmitic 
acid and track the intracellular mobility of deuterated palmitic acid and the growth 
of LDs. Using spontaneous Raman microspectroscopy and the 2101 cm-1 
wavenumber, the C-D bond present within the deuterated palmitic acid was 
visualised within LDs in the macrophage cells. Raman maps were obtained every 
30 minutes for 5 hours. The researchers found that the intensity of deuterated 
palmitic acid increased over time. Although the trend of the data suggests that 
FA uptake plateaued after 4 hours of exposure of deuterated palmitic acid, the 
range of time points was not extensive enough to determine this conclusively. 
The distribution of the LDs observed in the Raman maps were also seen to 
change, whereby LDs appeared to arrange themselves in the perinuclear region.  
By using the 1650 cm-1 wavenumber, the researchers wanted to determine 
whether C=C bonds, present within UFAs were localised within LDs, and hence 
gain a better insight into the composition of FAs within the LDs. A C=C signal was 
detected within LDs indicating the presence of UFAs within the LDs. However, it 
cannot be determined whether the presence of C=C bonds were attributed to: (1) 
the unsaturation of palmitic acid to palmitoleic acid, or (2) the bonds present in 
endogenous UFAs (before the cells were exposed to deuterated palmitic acid). 
In addition, the researchers observed that the macrophage cells they imaged 
were able to take up the FAs because they were viable. However, the cells may 
have been: (1) pre-apoptotic, or (2) able to tolerate the presence of the elevated 
levels of deuterated palmitic acid if the cells contained sufficient desaturase 
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enzymes to convert palmitic acid into palmitoleic acid, as suggested by Eynard 
(1997). 
In order to visualise the uptake of deuterated palmitic acid in real-time, the 
stokes lasers in the stimulated Raman microspectroscopy and CARS systems 
which the researchers employed were fixed at 2125 cm-1. The researchers 
observed that the LDs were highly abundant around the nucleus. Interestingly, 
two populations of cells were observed. Some cells contained a high 
concentration of deuterated palmitic acid, whereas some cells contained very low 
concentrations of deuterated palmitic acid. Stiebing et al. (2017) suggest that this 
lipid heterogeneity might have been due to some cells exhausting their lipid 
storage capacity faster than other cells, particularly if some cells already had 
large numbers of LDs to begin with. The researchers suggest that this observed 
effect could be considered to be a mechanism which protects cells from 
lipotoxicity. However, why some cells would contain more LDs than others before 
they had been exposed to any FAs (i.e. why this heterogeneity exists and what 
its biological significance is) is unclear. 
In addition, Stiebing et al. (2017) observed was that foam cells did not form 
when macrophage cells were exposed to deuterated palmitic acid. Similarly, the 
observation was made in the study by Stiebing et al. (2014) that foam cells were 
not formed upon exposure to deuterated arachidonic acid. It may be the case that 
foam cells only form under certain conditions, such as upon exposure to SFAs. 
However, since the formation of foam cells was not observed upon the exposure 
of macrophage cells to deuterated palmitic acid in the study conducted by 
Stiebing et al. (2017), it could be suggested that foam cells form under more 
biologically and/ or physically complex conditions. Unfortunately, Stiebing et al. 
(2017) did not clearly state whether the cells visualised in the spontaneous 
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Raman microspectroscopy studies were the same cells employed in the coherent 
Raman studies. In addition, it would appear that only four cells were imaged in 
the coherent Raman studies, which in terms of statistical analysis does not instil 
confidence in the data. 
The aims of the study by Mansfield & Winlove (2017) were to: (1) study the 
distribution and composition of endogenous LDs, and (2) study the localisation of 
exogenous FAs in two zones of chondrocyte cells (cells which secrete the matrix 
of cartilage) in bovine cartilage: the deep and superficial zones. Lipids within 
cartilage were studied because evidence had suggested that changes in lipid 
content are associated with osteoarthritic degradation in humans and animal 
models. More specifically, it had been suggested that SFAs may increase the 
progression of osteoarthritis. 
Spontaneous Raman microspectroscopy was employed to investigate the 
composition of endogenous LDs in the 2840 – 2850 cm-1 spectral range. In total, 
cartilage joints from 19 animals were used for the study. The joints were collected 
from a local abattoir. Multiple samples from 11 cartilage joints were analysed for 
Raman analysis. Confocal microscopy was employed to investigate the 
localisation of exogenous LDs using 1 µM of the fluorescent marker BODIPY-
palmitic acid (493/503) (BODIPY-PA), a labelled version of palmitic acid 
employed as a proxy for unlabelled palmitic acid, for various time points. Multiple 
samples from eight cartilage joints were analysed for the analysis of FA uptake. 
From the Raman and confocal studies, Mansfield & Winlove (2017) found that 
endogenous lipid in the deep zone of the bovine cartilage were more numerous 
in number and were larger than in the superficial zone. In addition, the 
endogenous lipid was predominantly unsaturated. Interestingly, the researchers 
observed that the quantity of lipid within the chondrocytes increased with depth 
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into the tissue. Lastly, the researchers believe they were the first to have obtained 
Raman spectra from chondrocyte cells embedded within intact tissue. 
The work published by Kochan et al. (2013a), Kochan et al. (2013b), Kochan 
et al. (2015), Majzner et al. (2014), and Majzner, Chlopicki and Baranska (2016), 
Majzner et al. (2018), generated from a collaborative approach to research, 
describe research which aimed to study the distribution and composition of LDs 
in liver tissue ex vivo, HAECs in vitro and HMEC-1 cells in vitro. The main findings 
of these studies are presented below. 
The study by Kochan et al. (2013a) involved comparing the LD content of 
livers of 16 week-old diabetic (db/db) and 24 week-old atherosclerotic 
(ApoE/LDLR-/-) mice to the livers of control mice using histochemical staining and 
spontaneous Raman microspectroscopy. Sections of liver were stained with Oil 
Red O, a lipophilic dye used to visualise lipid. More lipid was observed in the 
livers from atherosclerotic (ApoE/LDLR-/-) mice compared to the control mice. 
However, the numbers of mice in the control group was not disclosed in the 
research paper, and the extent of lipid distribution in the tissues were not 
quantified. Next, Raman maps were generated of the livers in the 2800 – 3020 
cm-1 spectral range. The researchers observed that in contrast to the 
histochemical staining, lipid content was the highest in the livers of the diabetic 
mice compared to the control mice. The researchers then compared the lipid 
content of the liver tissues from the diabetic mice with their protein content by 
generating Raman maps in the 1215 – 1275 cm-1 spectral range to identify the 
amide III region in proteins. From this, they observed signals from proteins in 
areas close to the edge of the LDs. This is an interesting observation as it has 
been suggested that LDs contain proteins either on the outer surface (Welte 2007; 
Wilfling et al. 2014) or inside (Ohsaki, Suzuki & Fujimoto 2014). Next, the 
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researchers compared Raman maps at the 1656 cm-1 and 1445 cm-1 bands 
corresponding to C-H bonds within saturated FAs in present within LDs to 
determine the degree of unsaturation of the LDs. This was done by dividing the 
average peak area of the band at 1656 cm-1 by the average peak area of the 
band at 1445 cm-1. The researchers found no change in the degree of 
unsaturation of the LDs within livers from any of the groups of mice. 
A similar study was published by Kochan et al. (2013b) where liver tissue from 
six month-old atherosclerotic (ApoE/LDLR-/-) mice, who were fed a control diet, 
were examined via spontaneous Raman microspectroscopy, infrared 
spectroscopy and histochemical staining. Unfortunately, few conclusions were 
made regarding the lipid state of the tissue from the mice. For example, ratios of 
the band intensities 1656 cm-1 and 1444 cm-1 were supposedly calculated from 
the LDs from within the tissue, however, the results were not shown. From the 
infrared measurements, the presence of cholesterol was observed in small 
quantities in some areas, yet this was not observed in the Raman maps. Lastly, 
the researchers stated that the lipid-rich tissue from the livers of the 
atherosclerotic mice had low protein content. This is an interesting observation 
as the opposite phenomenon was observed in the livers of the diabetic mice in 
the study by Kochan et al. (2013a), as described previously. 
A follow-up study by Kochan et al. (2015) involved characterising lipids in the 
livers of mice. Similar to the previous studies conducted by Kochan and co-
workers, the aim of this study was to determine whether spontaneous Raman 
microspectroscopy could determine the chemical composition of lipids in the 
livers of mice with non-alcoholic fatty liver disease. Two mice models which 
exhibited macrovesicular and microvesicular steatosis were employed. Within 
these groups, some mice were fed a high fat diet and others were fed a low 
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carbohydrate, high protein diet. The researchers observed LDs in both groups of 
mice. The livers of mice model exhibiting macrovesicular steatosis developed 
large LDs, however, the mice models developed small LDs. The degree of 
saturation of the LDs was then investigated by comparing the ratios of the Raman 
bands at 1659 cm-1 and 1446 cm-1. Interestingly, in both groups of mice, a 
significant decrease in the unsaturation of the LDs was observed compared to 
the LDs in the control cells. 
The study by Majzner et al. (2014) involved exposing liver tissue ex vivo and 
endothelial cells in vitro to arachidonic acid, then characterising the composition 
of the LDs using spontaneous Raman microspectroscopy. Spectral 
characterisation was achieved by comparing cell spectra with reference lipid 
spectra. Three male C57BL/6J mice were fed a high fat diet (consisting of 60 % 
of calories from saturated fat) for six weeks, and three control mice were fed a 
standard diet for six weeks. In addition, primary HAECs were exposed to 25 µM 
arachidonic acid for 24 hours. The researchers do not state what vehicle this FA 
was dissolved in, however, it can be assumed it was dissolved in sterile water 
because they say that the control cells were exposed to sterile water in place of 
the FA. Many studies previous to this study state that FAs must be dissolved in 
BSA in order to best-replicate physiological conditions. Thus, unfortunately, the 
results from the study conducted by Majzner et al. (2014) cannot be directly 
compared with other studies. 
Further, in order to obtain a more accurate representation of the degree of 
saturation of LDs in the endothelial cells, 3D Raman maps of LDs were acquired. 
This involved ‘depth profiling’ the cells, a process whereby the cells are measured 
in 2D layers and then combined to form a 3D image. In this case, there were nine 
layers in a stack for every 1.0 µM in the z-direction. From the data, the 
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researchers observed the formation of LDs as a result of the uptake of 
arachidonic acid, and the cell spectra of the LDs indicated that their main 
component was arachidonic acid. The HAECs were subsequently stained with 
Nile Red, a lipophilic dye, and were studied under confocal microscopy. Although 
changes in LD content within the cells were not quantified, and the numbers of 
cells studied per study was not disclosed in the journal paper, the researchers 
concluded that the cells treated with arachidonic acid contained more LDs than 
in the control cells, and inferred that this observation concurred with the 
observations from the Raman results. 
Lastly, to determine the degree of LD unsaturation in liver tissue, Majzner et 
al. (2014) compared the ratios of the 1656 cm-1 and the 1444 cm-1 Raman bands 
from the spectra corresponding to LDs. This analysis was conducted despite the 
observation by Rygula et al. (2013) that the 1656 cm-1 wavenumber also 
corresponds to the Amide I stretching vibration mode, C=O which is present 
within proteins. From their analysis, Majzner et al. (2014) concluded that the 
distribution of saturated versus unsaturated lipids in liver LDs was homogenous. 
Similar to the study conducted by Majzner et al. (2014), the study by Majzner, 
Chlopicki and Baranska (2016) involved exposing HAECs to 10 µM or 25 µM 
arachidonic acid or eicosapentaenoic acid (an omega-3 polyunsaturated FA) for 
24 hours and employing spontaneous Raman microspectroscopy to investigate 
the uptake, distribution and size of LDs formed in these cells. In addition, the cells 
were exposed to various concentrations of 1-methylnicotinamide hydrochloride, 
a metabolite of nicotinamide, which has been implicated in inducing certain 
effects in the endothelium, such as anti-inflammatory effects. Previous work by 
Majzner et al. (2014) had suggested (using spontaneous Raman 
microspectroscopy) that exposing HAECs to arachidonic acid and 
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eicosapentaenoic acid, separately, resulted in the spectra of LDs containing 
Raman bands similar to those found in the Raman spectra of those FAs. Thus, 
Majzner, Chlopicki and Baranska (2016) sought to determine whether the 
formation and composition of endothelial cells exposed to those two FAs in the 
presence of 1-methylnicotinamide hydrochloride affected the formation and 
composition of LDs. To determine the degree of unsaturation of the LDs within 
the cells, the ratio of the Raman bands at 1659 cm-1 and 1446 cm-1 were 
compared. For each experimental condition, at least three biological replicates 
were seeded and at least five cells were analysed by spontaneous Raman 
microspectroscopy. 
Firstly, in order to determine the extent to which these two FAs were 
incorporated into the LDs of the HAECs, 3D Raman maps at the 3000 – 3030 cm-
1 band were generated. Analysis of the Raman maps indicated the incorporation 
of these two FAs in the LDs of HAECs exposed to them. In addition, it was 
observed that cells exposed to 10 µM arachidonic acid/ eicosapentaenoic acid 
formed smaller LDs relative to the cells exposed to 25 µM arachidonic acid/ 
eicosapentaenoic acid, suggesting that the size of LDs is dependent upon the 
[FA]. The spectra corresponding to the LDs within these cells identified spectral 
features typically exhibited in the pure spectrum of these two FAs. 
Next, the researchers studied the effect of exposing HAECs to 100 µM 1-
methylnicotinamide hydrochloride in the absence and presence of arachidonic 
acid/ eicosapentaenoic acid. In the absence of either of these two FAs, 1-
methylnicotinamide hydrochloride did not induce the formation of LDs. However, 
in the presence of arachidonic acid/ eicosapentaenoic acid, 1-methylnicotinamide 
hydrochloride seemed to potentiate the formation of LDs, suggesting that 1-
methylnicotinamide hydrochloride was able to facilitate the uptake of arachidonic 
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acid/ eicosapentaenoic acid into LDs. This was observed despite there not being 
any Raman evidence indicating that 1-methylnicotinamide hydrochloride had 
been taken up by the cells. Therefore, the mechanism by which LD formation was 
potentiated remains unclear. 
The researchers also employed the histochemical stain Nile Red to visualise 
lipids under fluorescence microscopy. For each experimental condition, three 
biological replicates were prepared and at least 35 images from each replicate 
were analysed and the standard deviation calculated. The results were quantified 
whereby the number of intracellular LDs were counted per treatment group. It 
was observed that the largest number of LDs within cells, on average, were those 
exposed to 25 µM arachidonic acid and 25 µM 1-methylnicotinamide 
hydrochloride. 
Similar to the previous studies published by Majzner and co-workers in 2014 
and 2016, the study by Majzner et al. (2018) involved employing spontaneous 
Raman microspectroscopy to determine the chemical composition of LDs within 
endothelial cells exposed to polyunsaturated FAs. Contact atomic force 
microscopy was also employed to investigate whether the exposure of the 
endothelial cells affected the stiffness of the plasma membrane. 
HMEC-1 microvascular endothelial cells were exposed to 10 µM or 25 µM 
arachidonic acid, deuterated arachidonic acid, eicosapentaenoic acid and 
docosahexaenoic acid (an omega-3 polyunsaturated FA) for 24 hours. At least 
three biological replicates were prepared for each experiment with at least five to 
eight technical replicates within each biological replicate. Interestingly, the 
researchers observed the formation of LDs upon exposure to arachidonic acid 
and eicosapentaenoic acid, separately, however, no accumulation of LDs was 
observed upon exposure to docosahexaenoic acid. This suggests that 
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docosahexaenoic acid was degraded or possibly converted to a different FA 
which was not incorporated into LDs. Unfortunately, however, the researchers 
failed to quantify the changes observed which does not add confidence to their 
final conclusions. 
The results from the atomic force microscopy experiments, which were 
performed on randomly selected cells, demonstrated that the presence of LDs in 
the endothelial cells increased the stiffness of the plasma membranes. However, 
whether the increased stiffness of the plasma membrane of cells was caused by: 
(1) a change in the chemical composition of the plasma membrane, or (2) an 
increase in cytoplasmic surface tension caused by an increase in the presence 
of cytoplasmic LDs. To be able to determine the cause of the increased stiffness 
of the plasma membrane of cells, I would advise researchers to measure the 
permeability of plasma membranes. If the permeability of the plasma membrane 
decreases after cellular exposure to polyunsaturated FAs, this would suggest that 
the composition of the plasma membrane had been altered, and could justify the 
observed stiffness in the plasma membranes. However, if no change in the 
permeability of plasma membranes is observed, then the observed stiffness of 
the plasma membranes could be as a result of the increase in cytoplasmic 
surface tension. This could make it seem like the cell is stiffer. 
5.1.1.4 Measuring cellular molecules 
The ability to measure the composition of intracellular FA stores in beta cells 
is of interest to researchers studying diabetes because some FAs are associated 
with the destruction of beta cells. Therefore, understanding how FAs are 
metabolised and distributed within cells is important. Various techniques, 
involving labelled and label-free FAs have attempted to address this question. 
Studies have shown that Raman microspectroscopy can detect not only the 
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composition of fatty stores but also their size, number and spatial distribution 
(Bradley et al. 2016; Chien et al. 2012). Although work has shown that 
fluorescently-labelled palmitic acid accumulates in the Golgi apparatus (Corcoran, 
unpublished work), it has been difficult to determine the spatial distribution of 
fluorescent UFAs since these are not commercially available. Raman 
microspectroscopy might allow us to determine the differences in the spatial 
distribution of SFAs and UFAs in INS-1 beta cells, thus furthering our 
understanding of FA-induced toxicity. It is important to note that this technique, 
however, cannot distinguish between changes in diacylglycerol and TAG 
formation as these are structurally too similar. In addition, it is not possible for this 
technique to distinguish between glycerol-bound FAs, the bilayer lipid structure 
which cell membranes are composed of, and the monolayer of lipid membranes 
which organelles are composed of. This could mean that the lipid structures 
observed in the Raman maps presented in this thesis are composed of a 
combination of LDs and membrane structures. However, it is unlikely that lipid 
structures within membranes were detected because if they were, the plasma 
membrane of the cells analysed would be clearly demarcated with a more intense 
yellow colour compared to the cytoplasm. 
Using radiolabelled FAs, the study by Akoumi et al. (2017) showed that 
exposure to OA induced the formation of lipid droplets in H9C2 cardiomyocytes, 
whereas PA was found to poorly induce the formation of lipid droplets. This was 
also observed when Listenberger et al. (2003) exposed CHO cells to 
radiolabelled OA and PA. This phenomenon was also observed when Cao et al 
(2016) exposed HeLa cells to 1.2 mM non-radiolabelled OA, when Slipchenko et 
al. (2009) exposed CHO cells to 500 µM non-radiolabelled oleic acid, and when 
Plötz et al. (2016) exposed INS-1 beta cells to 100 µM non-radiolabelled oleic 
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acid. Further, Listenberger et al. (2003) suggest that OA might shuttle PA into 
TAG, acting as the principal mechanism by which cell death is evaded 
(Listenberger et al. 2003). 
Techniques, such as Gas Chromatography – Mass Spectrometry, have 
shown that the exposure of BRIN-BD11 insulin-producing beta cells to SFAs and 
UFAs, alone and combination, results in the total lipid content changing to reflect 
the FA they have been exposed to (Diakogiannaki et al. 2007). This suggests that 
changes in lipid droplet-content might be dependent upon the species of FA that 
the cells are exposed to. In an attempt to visualise changes to lipid droplets in 
situ, studies using markers, such as Oil Red O, Nile Red and BODIPY-PA, have 
proven useful, yet inconclusive. In a study by Plötz et al. (2016) INS-1 cells were 
exposed to SFAs and UFAs, then subsequently stained with Oil Red O to study 
changes in lipid distribution. The researchers found that UFAs strongly induced 
the formation of lipid droplets compared to the untreated cells, whereas SFAs 
only induced minor lipid droplet formation. No correlation between cytoprotection 
and the ability of LDs to form, upon FA co-incubation, was observed. In addition, 
not only can it be argued that fluorescent dyes can detrimentally affect the 
physical processes of NLD formation, but the results from experiments emploing 
the use of fluorescent dyes can be misleading. This is because changes in 
saturation and chain length of the carbon chain of Fas cannot be inferred from 
the distribution and localisation of the emitted flourescence from fluorescent dyes. 
Since cells consist of a plethora of different chemical entities, our ability to 
measure changes in chemical composition is extremely challenging. Raman 
microspectroscopy can quantify the disposition of lipid within cells, thus it can be 
considered to be superior to other techniques which aim to measure these cellular 
changes. Raman microspectroscopy was therefore employed in this thesis to 
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study lipid disposition within cells. In this Chapter, I describe a comprehensive 
methodology to quantitatively study changes in the distribution and composition 
of NLDs in INS-1 cells exposed to non-esterified and esterified FAs. This method 
can be adapted for use in any adherent cell type. 
5.2 Instrument set-up and data acquisition 
Raman maps were acquired on a WiTec alpha 300r Raman 
microspectrometer with a 532 nm (green) laser with 16 mW power at the sample 
and a 63x INA water immersion objective (Zeiss WPlan Apochromat). A few drops 
of water were placed on the coverslip for the water immersion objective, and 
maps were collected at room temperature. The maps covered the entire spectral 
range from 0 cm-1 to 3800 cm-1 with 4 cm-1 spectral resolution. An integration time 
of 0.1 s and a 600 g/ mm grating was found to provide a satisfactory compromise 
between the spatial resolution and mapping time. 
5.2.1 Rationale choosing the 2845 ± 10 cm-1 band for analysis 
In order to study global changes in the lipid disposition within INS-1 cells, 
it was important to select a wavenumber which could identify the presence of 
lipids, preferably in the form of LDs. Table 5.1 consists of the Raman band 
assignments of FAs within intracellular LDs. Specifically, it includes only the 
assignments for the alkyl chain, i.e. carbon-carbon and carbon-hydrogen bonds, 
and does not include carboxyl group assignments. This section highlights some 
concerns researchers may have when deciding which wavenumber to choose in 
order to best-represent the lipid content within eukaryotic cells. 
The bands at 1444 cm-1 and 1310 cm-1 correspond to the scissoring 
(Sadeghi-Jorabchi et al. 1970) and twisting vibrations (Baeten et al. 1998) of the 
C-H bond within the CH2 group, respectively (table 5.1). It was decided not to use 
these wavenumbers to measure changes in lipid disposition for this study since 
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it would not be possible to distinguish between the incorporation of SFAs or UFAs 
into LDs. 
The band at the 1050 – 1150 cm-1 spectral range corresponds to the C-C 
stretching vibration mode within alkyl chains of lipids and FAs, as described by 
Chan et al. (2005) (table 5.1). This region can therefore be measured to 
determine changes in the saturation of the alkyl chain. However, this region was 
not chosen for the study presented in this thesis because the peaks in this region 
are very low in absolute intensity. It would, therefore, be difficult to be sure if a 
change in intensity were true, as a large change in intensity would need to occur 
to indicate a change in alkyl saturation. 
The band at the 2800 – 2970 cm-1 spectral range corresponds to the 
stretching vibration mode of the C-H bond within both CH2 and CH3 groups. This 
region can be used to indicate changes in the saturation of alkyl chains as the 
saturation/ unsaturation of the carbon chain affects the stretching vibration mode 
of the C-H bond. The study of this region would serve as a proxy for measuring 
change in the saturation of the carbon chain, and thus would be informative. 
However, currently, no Raman spectroscopic system is able to differentiate 
between two FAs which have the same saturation content but have small 
changes in the length of the carbon chain. 
Based on the Raman regions of lipid described above, and the observation 
that others (Chen et al. 2015; Chien et al. 2012; Mansfield & Winlove 2017; Nan, 
Potma & Xie, 2006) have used the 2845 cm-1 region (either alone or including an 
extended band width of ± 10 cm-1), or the 2850 cm-1 region (Bradley et al. 2016; 
Cao et al. 2016; Slipchenko et al. 2009) for studying changes in lipid distribution 
and/ or disposition within biological material, the 2845 ± 10 cm-1 spectral range 
was chosen to determine whether exposing INS-1 cells to differential FAs affects 
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the disposition of intracellular lipid. This spectral range was utilised to collect uni-
variate data for determining changes in lipid distribution and concentration, the 
method for which is further described in section 5.6.1. 
Challenges were faced when determining the most suitable method to 
measure changes in the composition of lipid. A method was required to be able 
to determine whether there had been an increase or decrease in the saturation 
content of lipid within cells. This type of analysis is known as multi-variate analysis 
and is further described in section 5.6.2.1. 
It should be noted that Raman microspectroscopy is particularly suited for the 
analysis of lipids compared to other techniques, such as infrared spectroscopy. 
This is because water and aqueous environments have a strong infrared 
scattering cross-section, whereas water has a very weak Raman scattering 
cross-section (Tipping et al. (2016). This, therefore, makes it difficult to study 
molecules in aqueous environments using infrared spectroscopy. In addition, the 
Raman band for water is above 3014 cm-1 (Sun 2009) which is outside the 2800 
– 2970 cm-1 region which corresponds to C-H bonds within R-CH2/ R-CH3 groups. 
Furthermore, lipids exhibit a large Raman scattering cross-section (Stiebing et al. 
2017). Thus, researchers can study lipids using Raman microspectroscopy: (1) 
without having to be concerned about the band for water obscuring the band for 
lipid, and (2) because this method is particularly suited for visualising the 
distribution and composition of lipids.  
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Table of assignments of the main Raman bands of lipids 
Raman shift 
(approx. cm-1) 
Group (bond), 
vibration-type 
Reference 
1050 – 1150 R-(CH2)n-R (C-C), 
stretch 
Chan et al. 
(2005) 
1250 – 1300 RHC=CHR (=C–H), 
in-plane bend 
Weng et al. 
(2003) 
1310 R-CH2 (C-H), 
twisting out-of-plane bend 
Baeten et al. 
(1998) 
1444 R-CH2 (C-H), 
scissoring in-plane bend 
Sadeghi-Jorabchi et al. 
(1970) 
1661 RHC=CHR (C=C), 
cis stretch 
Sadeghi-Jorabchi et al. 
(1970) 
1670 RHC=CHR (C=C), 
trans stretch 
Bailey & Horvat 
(1972) 
2800 – 2970 R-CH2/ R-CH3 (C-H), 
symmetric stretch 
Baeten et al. 
(1998) 
3014 RHC=CHR (=C-H), 
asymmetric stretch 
Sadeghi-Jorabchi et al. 
(1970) 
Table 5.1 Table of assignments of the main Raman bands of the alkyl chain 
within lipids/ FAs 
The assignments of the main Raman bands of lipids/ FAs are shown in this table. 
The Raman shifts listed include those that are only associated with the alkyl chain 
within lipids and FAs, i.e. carbon-carbon (C-C/ C=C) and carbon-hydrogen (=C-H/ 
C-H) bonds. The table does not include carboxyl group assignments. The Raman 
shifts are presented as approximate cm-1 values. The types of vibration shown are 
either stretch vibrations or bending vibrations (also known as deformations). 
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5.3 Cell culture 
Although Raman mapping of live cells has been described in the literature 
by Draux et al. (2008), Klein et al. (2012), Slipchenko et al. (2009), Smith, Wright 
& Ashton (2016), I chose to fix the INS-1 cells instead of mapping them live. This 
was to avoid complications arising from physical movement and structural or 
metabolic changes occurring in the cell during the inevitably long mapping time 
and increased sensitivity to radiation damage. 
5.3.1 Seeding of beta cells 
INS-1 cells were cultured and subcultured, as described in sections 2.1.1.1 
and 2.1.1.2. 1x borosilicate glass, round coverslip (Ø 13 mm, Scientific 
Laboratory Supplies) was added per well in a 24-well plate (Sarstedt). Coverslips 
were prepared as follows: wash for 1 hour in 1 M HCl, rinse with ddH2O, rinse 
with 70 % (v/v) EtOH, and store in 100 % EtOH. Cells were seeded at 1 x 105 
cells per well in complete medium and were incubated for 24 hours. The FA-BSA 
working solutions were made, as described in section 2.1.4, and incubated at 
37 °C for at least 1 hour, as described by Dhayal & Morgan (2011), prior to the 
addition to the cells. The complete medium was removed, 450 μl serum-free 
medium was added per well, and 50 μl treatment was added to the appropriate 
well to give a final volume of 500 μl. VC–treated cells were exposed to BSA and 
EtOH only, with the final percentages at 0.9 % (w/v) and 0.5 % (v/v), respectively. 
After 24-hour exposure to the treatment the cells were fixed. 4 % (w/v) 400 
μl cold paraformaldehyde (PFA) made up in PBS was added to each well (without 
the removal of the medium from the wells) and the cells were incubated at 37 °C 
for 10 minutes. All liquid was subsequently removed from the wells before the 
further addition of 400 μl PFA. The wells were incubated for 15 minutes at room 
temperature. The PFA was removed from the wells before the cells were 
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subsequently washed once with 500 μl sterile PBS for 1 minute. The PBS was 
removed from the wells before a further 500 μl PBS was added. The coverslips 
were stored in PBS for up to 1 hour before being transferred onto Superfrost Plus 
glass slides (25 x 75 x 1.0 mm, Thermo Fischer Scientific). 
5.3.2 Fixing and preparing the beta cells for Raman microspectroscopy 
The coverslips were removed from the wells carefully with tweezers and a 
needle. The coverslip was dipped in PBS to wash residual medium or treatment 
from the surface of the cells. The coverslip was placed, cells facing down, onto 
the surface of a Superfrost Plus glass slide. Excess PBS was dried and 
nitrocellulose was immediately added to the rim of the coverslip and glass slide 
to create a seal, as described by Mansfield & Winlove (2017). The cells were 
analysed on the microspectrometer within nine days of sealing with nitrocellulose. 
Before the cells were analysed, the upward facing side of the coverslip was 
cleaned using a cotton bud with 70 % (v/v) EtOH to remove any adherent cells 
and debris. 
Immunocytochemical analysis of cells grown on coverslips involves fixing 
coverslips onto Superfrost Plus glass slides using fluorescence mounting 
medium (Dako). An issue for Raman mapping was potential contributions to the 
spectra or to the background from the mounting medium. A comparison was 
therefore undertaken of mounted and unmounted cells. Borosilicate glass does 
not show a signal on the spectrum between 2800 cm-1 and 3100 cm-1, thus a 
signal should not be observed in this region of the spectrum. Only a signal should 
be observed from the cell itself. The mounting medium coated both the substrate 
and the cell. A spectrum of the substrate was measured. It was found that the 
mounting medium generated a signal where there should not be one (figure 5.2). 
A spectrum of the cell was also measured. The spectrum was found to be the 
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same as that obtained from the substrate. The mounting medium therefore 
interfered with the spectral region of interest for the study of intracellular lipids: 
the C-H stretching vibration mode between 2800 cm-1 and 3100 cm-1 (compare 
figures 5.2 and 5.3), thereby obscuring any signal arising from the cell. This trial 
revealed the sensitivity of the Raman technique and highlighted the importance 
of optimising the method for fixed cells.  
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(b) 
Figure 5.2 Intra- and extra-cellular spectra of a beta cell fixed with 
mounting medium 
INS-1 beta cells were treated with complete medium for 72 hours. The 
cells were fixed onto a Superfrost Plus glass slide with mounting 
medium. The coverslip and glass slide were sealed with nitrocellulose. 
(a) White light image of beta cell, red box drawn around single cell 
(yellow dotted line). (b) Raman map using the band at 2845 ± 10 cm-1 
with a 0.5 s integration time. Spectrum (c) corresponds to the area 
outside the cell (1) (the substrate coated in mounting medium). 
Spectrum (d) corresponds to regions within the cell (2), also coated in 
mounting medium. No differences were seen within the spectral region 
of interest (2800 – 3100 cm-1) between spectra (c) and (d). 
(1) 
(2) 
(d) 
(c) (a) 
160 
 
  
(c) 
(d) 
(1) 
(2) 
(b) 
Figure 5.3 Intra- and extra-cellular spectra of a beta cell fixed 
without mounting medium 
INS-1 beta cells were treated with complete medium for 72 hours. 
Mounting medium was not used to fix the coverslip onto the glass slide. 
The coverslip was sealed onto the glass slide using nitrocellulose. (a) 
White light image of beta cell, blue box drawn around single cell (yellow 
dotted line). (b) Raman map, using the band at 2845 ± 10 cm-1 with a 
0.5 s integration time. Spectrum (c) corresponds to the area outside the 
cell (1) (the substrate). Spectrum (d) corresponds to regions within the 
cell (2). The spectrum corresponding to the outside of the cell (c) shows 
minimal intensity versus the spectrum corresponding to the inside of the 
cell (d) within the region of interest (2800 – 3100 cm-1). The white star 
shows the location of the nucleus. The white arrow points to yellow 
pixels, all of which correspond to lipid. 
(a) 
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5.3.3 Spectra of pure fatty acids 
To assist in peak attribution, spectra were obtained for pure PA and pure 
OA and compared with cell spectra averaged per treatment. This method had 
been described and employed by Chan et al. (2005), Kochan et al. (2015), 
Majzner et al. (2014), Majzner et al. (2018), Slipchenko et al. (2009) and Stiebing 
et al. (2014). 
In the study presented in this thesis, the pure FAs were deposited onto a 
Superfrost Plus glass slide and three single point spectra of different points of the 
sample, using the 20x dry lens with a 0.5 s integration time with 20 accumulations, 
were acquired. Figure 5.4 shows the full spectrum of pure PA after averaging 
three single point spectra. The three single point spectra were averaged and 
background subtracted. The spectra were not normalised. 
Section 5.5.3 outlines the process for conducting background subtraction of 
a Raman map. In figure 5.4 the C-H stretching vibration mode is expanded to 
show the two peaks of highest intensity at 2852 cm-1 and 2882 cm-1. This method 
was also employed for measuring single point spectra of pure OA.  
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Figure 5.4 Raman spectrum of pure sodium palmitate 
(a) White light image of pure sodium palmitate. Yellow cross-hairs represent the 
positions where 3 single point spectra were taken on the sample. (b) Spectrum of 
averaged single point spectra of sodium palmitate. (c) Spectral range between 2800 
cm-1 and 3000 cm-1 of graph (b) showing prominent peaks at 2852 cm-1 and 2882 cm-1. 
(b) 
(c) 
C-H stretching vibration 
mode 
(a) 
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5.4 Beta cell selection for mapping 
In preliminary experiments, it was established that it was preferable to 
conduct the analysis on single cells rather than over a whole field due to 
limitations in the analysis software. Individual cells were selected for analysis on 
the following criteria: the cell must: 
(1) Be anchored to the substrate via at least one protrusion, indicating the cell is 
healthy. Since dead cells detach from their substrate and remain floating in 
the medium they could be excluded from the analysis, 
(2) Not be exhibiting signs of exocytosis. The cell in figure 5.5 shows a “bleb” on 
the side of the cell (as shown by the white arrow) and is probably undergoing 
exocytosis and does not have an intact nucleus. Therefore, it is likely that this 
cell is undergoing apoptosis. This cell was excluded from the analysis, 
(3) Be in the G0+G1 phase of the cell cycle. This was determined by the intensity 
of the nuclear space of the Raman map relative to the background intensity: 
a. The Raman map at 2845 ± 10 cm-1 of a healthy cell was required to 
show a round nucleus with a continuous boundary and uniform 
intensity. This indicated that the nuclear DNA was intact. Figure 5.3 
depicts a healthy cell. The white star shows the location of the nucleus 
which is clearly defined as a round, black space. The white arrow points 
to yellow pixels, all of which correspond to lipid, 
b. Examples of cells that might have been dividing (in the S or G2+M 
phases) or undergoing cell death (pre-apoptosis, apoptosis, or 
necrosis) are shown in figure 5.5. For example, the cell in figure 5.5 
appears to be dividing as two nuclei are visible (as shown by the two 
white stars). None of the cells presented in figure 5.5 have clearly 
defined nuclei and were, therefore, excluded from the analysis.  
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Figure 5.5 Raman maps of INS-1 beta cells excluded from analysis 
Raman maps of INS-1 beta cells using the band at 2845 ± 10 cm-1. The lipid 
distribution within these cells was not measured as their nuclei were not 
clearly visible, either because the cells were dividing or because the cells 
were undergoing cell death. (a) The cell does not have a clearly defined 
nucleus. (b) The cell is dividing, as shown by the two white stars which show 
the location of the two nuclei. (c) The cell does not have a clearly defined 
nucleus. (d) The cell does not have a clearly defined nucleus, and the white 
arrow shows the location of a bleb indicating that this cell is likely to be 
undergoing apoptosis. (e) The cell does not have a clearly defined nucleus. 
(f) The cell does not have a clearly defined nucleus. 
(a) 
(e) (d) 
(c) (b) 
(f) 
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5.5 Data pre-processing 
5.5.1 Cosmic ray removal 
All maps were pre-processed using the WiTec Project FOUR+ software. 
Cosmic rays were removed using the ‘CRR & Smooth’ function. The Filter Size 
was set at 2 and the Dynamic Factor was set between 1 and 100 for every cell 
analysed in this thesis. Figure 5.6 shows the colour of the cosmic ray changing 
from blue to red. This change of colour indicated that the ray had been removed 
from the data-set. It is essential to remove cosmic rays because their high 
intensities can skew the true data obtained from the cell. The process of cosmic 
ray removal did not change the highest intensity value within the cell shown in 
figure 5.6. This was expected since no rays were present in the 2845 ± 10 cm-1 
spectral range of any pixel in the Raman map. 
5.5.2 Intensity values 
Intensity values are measures of photons which, when they hit a detector, 
known as a charge-coupled device (CCD), are converted into electrons. The 
device then measures the electric charge of the corresponding pixel and converts 
this energy into a visual output. The visual output of the interaction between the 
electron and detector corresponds to a unit of measurement, known as a CCD 
count, which is given to each pixel. The result is a false colour image/ map of 
intensity of the material/ substance being imaged/ mapped.  
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Figure 5.6 Identification and removal of cosmic rays from Raman map of INS-1 
beta cell 
(a) Raman map of INS-1 cell before cosmic ray removal. 2845 ± 10 cm-1 band chosen 
to visualise lipid within the cell. The map was scanned manually for cosmic rays. (b) 
Spectrum of a single pixel shows a single, blue, sharp peak at ~ 700 cm-1 (see pink 
arrow). This is a cosmic ray which required removal from the spectrum. The Filter Size 
was set at 2 and the Dynamic Factor was set between 1 and 100. (c) After cosmic ray 
removal the blue peak turned red in colour. (d) Raman map of INS-1 cell before cosmic 
ray removal using the band at 2845 ± 10 cm-1. (e) Raman map of INS-1 cell after cosmic 
ray removal using the band at 2845 ± 10 cm-1. The chosen Filter Size and Dynamic 
Factor values were applied globally within the Raman maps. No change in intensity 
value (CCD counts) was observed. 
(a) (b) 
(c) 
(d) (e) 
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5.5.3 Background subtraction 
Fluorescent background was removed using the ‘Shape’ function within the 
‘Background Subtraction’ function in the WiTec Project FOUR+ software. The 
Shape function was employed as it is considered to be the most effective for 
subtracting fluorescent areas. The ‘Shape Size’ parameter was always set at 100 
and the ‘Noise Factor’ parameter was always set at 2 for every cell analysed in 
this thesis. The process for background subtraction involves selecting regions of 
the spectrum which contain peaks to fit the baseline. The same regions were 
selected manually for every spectrum from every cell, thus ensuring consistent 
and replicable removal of the fluorescent background from every cell. 
Conducting background subtraction in the pre-analysis of data is vital. The 
process of background subtraction decreased the highest intensity value from 
213 to 136.9 CCD counts within the cell shown in figure 5.7. If this step is not 
conducted, data can be misinterpreted and conclusions drawn can be misleading.  
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Figure 5.7 Background subtraction of Raman map of INS-1 beta cell 
(a) Raman map of INS-1 cell after cosmic ray removal from figure 5.6. 2845 ± 10 cm-1 
band chosen to visualise lipid within the cell. The spectrum of a single pixel corresponding 
to lipid within the cell was selected for background subtraction. (b) Shape Size was set at 
100 and the Noise Factor was set at 2. (c) Sections highlighted in white were applied 
globally to all pixels within the Raman map, whereby the sections were baselined. (d) 
Spectrum of a single pixel corresponding to lipid after background subtraction. (e) Raman 
map of INS-1 cell before background subtraction using the band at 2845 ± 10 cm-1. (f) 
Raman map of INS-1 cell after background subtraction using the band at 2845 ± 10 cm-
1. The intensity bar (CCD counts) shows the difference in intensity between the Raman 
map before and after background subtraction. The highest intensity value decreased from 
213 to 136.9 CCD counts after background subtraction. 
(a) (b) 
(c) (d) 
(e) (f) 
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5.6 Data processing and analysis 
5.6.1 Quantifying lipid distribution and concentration 
The measured intensity of a Raman spectral line depends on the 
scattering cross-section of the bond in its particular chemical environment, 
spectrophotometer performance and pre-processing procedures such as 
background subtraction. All of these factors introduce uncertainties that must be 
borne in mind in relating spectral intensity to the actual concentration of a 
molecule of interest. 
Uni-variate analysis involves quantifying the pixels of interest observed 
from a Raman map by selecting a specific wavenumber from the spectrum. It is 
important to note that Raman maps are 2D images and represent a cross-section 
in the middle of the cell (Toporski, Dieing & Hollricher 2018, p. 101). Thus, the 
quantification of molecules cannot be extrapolated to 3D images of cells. This is 
a limitation of the technique, however, as long as the same plane is selected for 
each cell, the cells can be compared. The middle of the cell was selected 
manually using the laser as a guide to select the plane of the cell with the highest 
area of intensity. 
Figure 5.8 schematically outlines the process for generating a Raman map. 
Simply, a plane within the cell is selected, then a map is generated at the 2845 ± 
10 cm-1 spectral range. The map undergoes pre-processing using WiTec Project 
FOUR+ software, then undergoes processing. For the purposes of this thesis, the 
total cell area, the percentage of lipid, and the intensity of lipid within each map 
was analysed using ImageJ software.  
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Figure 5.8 Uni-variate analysis used to measure lipid distribution and 
intensity 
To generate a 2D Raman map, a plane within the cell must be selected. To quantify 
lipid distribution the 2845 ± 10 cm-1 band was selected. The Raman map is then: 
(1) pre-processed using WiTec Project FOUR+ software, then (2) imported into 
ImageJ to be processed. The maps are analysed to quantify all the pixels 
corresponding to each map, the pixels of interest within each cell and their intensity 
values. All of these pixels have x and y coordinates. 
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The Raman map in figure 5.9 shows a clear nucleus within the cell (dark 
brown in colouring) and a clear outline of the cell with three protrusions indicating 
that the cell is attached to the substrate and is healthy. The yellow pixels are 
indicative of the C-H bonds of interest. I sought to quantify these yellow pixels 
and calculate their percentage within the 2D plane/ cross-section of the cell. 
ImageJ analysis of each cell was used to map and quantify the lipid 
distribution using the spectral band at 2845 ± 10 cm-1 (corresponding to the CH2 
symmetric stretching vibration mode). Before the lipid distribution could be 
quantified each Raman map underwent a process of thresholding. The process 
of thresholding is used to create binary images from greyscale images. This is 
because these components cannot be calculated using the coloured Raman 
maps. A binary image only contains pixels which are black and white. Figure 5.9 
shows how a Raman map is converted from an image with orange and yellow 
colouring to a black and white image. An algorithm is used to threshold images. 
Many algorithms exist, and each one will calculate whether a pixel should become 
a binary unit (i.e. white or black pixel) depending on what the intensity value of 
the original Raman pixel is. Each algorithm choses a different intensity value to 
threshold against. By ensuring the instrument set-up is the same each time an 
image of a cell is taken, and by ensuring that the same algorithm is used to 
analyse each cell, a group of cells can be compared against one another.  
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Figure 5.9 Thresholding one INS-1 beta cell 
(a) Raman map of a single INS-1 cell taken using the spectral band at 2845 ± 10 cm-
1. The cell is healthy. It consists of: a clear nucleus which is dark brown in colour, 
three protrusions (indicating that the cell is attached to the substrate and is healthy), 
and yellow pixels which are indicative of the C-H bonds of interest (pixels which 
correspond to C-H bonds within lipids). (b) The same Raman map as (a) but each 
pixel is converted into a binary unit. The MinError threshold algorithm has been 
applied. 67.7 % of the cell contains the pixels of interest. (c) The same Raman map 
as (a) but each pixel is converted into a binary unit. The Otsu threshold algorithm 
has been applied. 38.8 % of the cell contains the pixels of interest. (d) The same 
Raman map as (a) but each pixel is converted into a binary unit. The MaxEntropy 
threshold algorithm has been applied. 21.3 % of the cell contains the pixels of 
interest. 
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An algorithm for the analysis of all the INS-1 cells was chosen based on 
whether it could best represent the number of yellow pixels shown on a Raman 
map. Figure 5.9 shows the differences in threshold values between three 
algorithms (MinError, MaxEntropy and Otsu). The percentage of black pixels 
which correspond to the yellow pixels in the original Raman map are shown for 
each of the three algorithms. Figure 5.9 shows that the MinError algorithm 
calculated that the cell contained 67.7. % of the pixels of interest, and hence the 
bond of interest. However, it can be seen that this algorithm has converted too 
many pixels black, i.e. the number of black pixels does not match the number 
yellow pixels on the original Raman map. The Otsu algorithm was also 
considered to be unsuitable. The coverage of black pixels from the MaxEntropy 
algorithm (21.3 %) best-matches the yellow pixels from the Raman map. Of the 
16 algorithms trailed on the ImageJ software the MaxEntropy algorithm was 
deemed to be the most appropriate algorithm to use as it best represented the 
percentage of pixels corresponding to the yellow pixels on the original Raman 
map. 
Using ImageJ software, the following steps were taken to calculate the 
number of pixels corresponding to the bond of interest within the 2D image of the 
INS-1 cell, and their corresponding intensity values: (1) select the pre-processed 
Raman map using the spectral band at 2845 ± 10 cm-1 and convert the image 
into an ASCII file, (2) import the image into the ImageJ software. The image will 
appear in greyscale, (3) draw a line around the cell, (4) threshold the image using 
the MaxEntropy algorithm with the cell boundary selected. This process converts 
the greyscale image into a binary image. The pixels of interest corresponding to 
lipid appear black, and all other pixels appear white. In order for the ImageJ 
software to quantify the intensity values of the pixels of interest, these pixels must 
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be black in colour. Thus, the colouring of the pixels is reversed, (5) reverse the 
colour of the background pixels with the pixels of interest so that the background 
pixels and pixels which are not of interest appear black and the pixels of interest 
appear white. This process is outlined schematically in figure 5.10. 
The ImageJ software can go one step further and can quantify the intensity 
values of each of the pixels which have been selected for thresholding. The 
intensity value of the black pixels become zero and the intensity values of the 
pixels of interest become greater than zero. For each map/ cell the ImageJ 
software averages the intensity values of all the pixels within the cell boundary. 
The intensity values for cells within treatment groups can be averaged and then 
compared between treatment groups to quantify changes in the concentration of 
the molecules of interest.  
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Figure 5.10 ImageJ analysis of Raman map depicting one INS-1 
beta cell 
(a) Raman map of INS-1 cell using the band at 2845 ± 10 cm-1. (b) 
Greyscale image of Raman map imported into ImageJ. (c) Yellow line 
drawn around cell to define the cell boundary. (d) Thresholding of 
image using MaxEntropy algorithm with cell boundary selected. This 
process converts the greyscale image into a binary image. The pixels 
of interest corresponding to lipid, are black, and all other pixels are 
white. (e) The colours of the pixels have been reversed, whereby the 
pixels of interest are now white and all other pixels are black. 
(e) 
(a) 
(c) 
(b) 
(d) 
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5.6.2 Quantifying lipid droplet composition 
As previously described, uni-variate analysis allows for the quantification 
of a certain bond by selecting a specific wavenumber from the Raman spectrum. 
This analysis can be taken further. Much of the existing research using 
spontaneous Raman microspectroscopy focuses on identifying the chemical 
composition of cellular material, known as multi-variate analysis. 
Multi-variate analysis was employed here to determine whether changes 
in the composition of lipid within the INS-1 cell could be detected after their 
exposure to exogenous FAs. This was done using the ‘Cluster Analysis’ function 
within the WiTec Project FOUR+ software. Cluster analysis collates and averages 
all of the spectra which correspond to the pixels of interest within a single Raman 
map. The spectra from cells within the same treatment group are averaged and 
normalised to obtain a better representation of the spectra selected, especially if 
the data being selected have similarities (Toporski, Dieing & Hollricher 2018, p. 
109 - 113). Lastly, the spectra from different treatment groups can then be 
compared and further analyses on the spectra, such as peak fitting, can be 
carried out. Figure 5.11 shows how this process involves collating the spectra 
from a single Raman map.  
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Figure 5.11 Multi-variate analysis used to measure lipid composition 
Cluster analysis collates and averages all the spectra of the pixels 
corresponding to the molecules of interest within a single Raman map (in this 
case, the pixels which are coloured yellow). The black cross-hairs correspond 
to pixels of interest. The pixels have x and y coordinates, yet the spectra are in 
the z-axis. The spectra corresponding to the pixels of interest within a single 
Raman map are averaged. The spectra from multiple single cells within the 
same treatment group are averaged and normalised. The spectra from different 
treatment groups can then compared. 
y 
x 
z 
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The following steps were taken to select and average the spectra of pixels 
corresponding to intracellular lipid using the cluster analysis function: (1) select 
the pre-processed Raman map using the spectral band at 2845 ± 10 cm-1 to 
visualise the pixels corresponding to lipid, (2) using the K-means cluster analysis 
function, select three clusters. Each cluster will highlight a separate part of the 
Raman map depending on the similarity of the intensity of the pixels. Pixels with 
very similar intensity values are collated and a false colour map of those pixels 
are visualised. Figure 5.12 shows a cell where every single pixel has been falsely 
coloured. The substrate (borosilicate glass) is coloured green, the plasma 
membrane is coloured blue, and the intracellular space is coloured red. The red 
component of the cell contains the pixels of interest which correspond to lipid, (3) 
a manual process of ‘de-selection’ involves identifying the pixels of interest within 
these three clusters which correspond to the pixels in the original Raman map, 
(4) the spectra of these pixels are then averaged. In this case, the pixels which 
correspond to intracellular lipid are averaged. This involves collating and 
averaging all of the spectra of the pixels which correspond to the population of 
yellow pixels, (5) each averaged spectrum from each cell within a treatment group 
is then collated and averaged to generate a single spectrum. Lastly, the spectra 
from each treatment group are then normalised against the phenylalanine peak 
at 1008.3 cm-1, as described by Krafft et al. (2006). This peak was chosen as the 
position of this peak does not change in absolute terms on the x-axis of spectra 
following alterations to the intracellular environment. This entire process is 
outlined schematically in figure 5.12.  
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Figure 5.12 Cluster analysis of Raman map of INS-1 beta cell 
(a) Raman map of INS-1 cell using the spectral band at 2845 ± 
10 cm-1. (b) False colouring of pixels within the cell, whereby the 
pixels corresponding to the: substrate are green; plasma 
membrane are blue; intracellular space are red. (c) The pixels 
corresponding to the pixels of interest have been identified. (d) 
All of the pixels of interest have been collated and averaged 
which has generated a single spectrum (e). 
(a) (b) 
(c) (d) 
(e) 
180 
 
5.6.2.1 Overlaying spectra of pure fatty acids with cell spectra 
In order to determine the degree of unsaturation of intracellular LDs, and 
determine whether changes in the unsaturation-content of lipids within cells had 
occurred upon exposure to exogenously supplied FAs, Kochan et al. (2013a), 
Kochan et al. (2013b), Kochan et al. (2015), Majzner et al. (2014), Majzner, 
Chlopicki & Baranska (2016) and Slipchenko et al. (2009) chose to compare the 
relative ratios of Raman peaks of lipid within cell spectra at approximately 1656 
cm-1 and 1444 cm-1. Although the study by Li-Chan et al. (1994) would argue that 
3010 cm-1 is a good indicator for the identification of UFAs. This method of 
comparing the relative ratio of peak heights was also employed by Slipchenko et 
al. (2009). However, in addition to comparing the relative peaks corresponding to 
C=C bonds and C-H, Slipchenko et al. (2009) also compared the relative ratios 
of the peaks at 2100 cm-1 (corresponding to C-D bonds) and 2850 cm-1 
(corresponding to C-H bonds in CH2 groups). 
The 1656 cm-1 peak is thought to correspond to the C=C cis bond in UFAs 
and the 1444 cm-1 peak is thought to correspond to C-H bonds of the R-CH2 
group in both UFAs and SFAs. Thus, if the ratio of these two spectral peaks are 
calculated and a higher relative peak height of 1656 cm-1 is observed versus the 
relative peak height of 1444 cm-1, this might indicate that the sample is more 
unsaturated than saturated. The comparison of these two specific wavenumbers 
was first described by Sadeghi-Jorabchi et al. (1970) where the unsaturation 
content of various commercial oils, such as sunflower oil, were investigated using 
fourier transform Raman spectroscopy. However, Sadeghi-Jorabchi et al. (1970) 
employed the 1661 cm-1 peak, not the 1656 cm-1 peak, to determine the 
unsaturation content of oils. The primary aims of these Raman studies were to 
identify whether oils had been subject to adulteration (Li-Chan et al. 1994) and to 
determine their quality (Li-Chan et al. 1996). It was not until the 1990s where 
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Raman microspectroscopy was applied to clinical situations, such as the study 
by Frank et al. (1994) which sought to identify irregularities in healthy breast 
tissue biopsied from healthy individuals versus healthy breast tissue biopsied 
from tissue adjacent to cancerous tissue. The identification of specific FAs within 
single cells began much later as a result of the advancement of technology and 
as a result of improved software to analyse both uni- and multi-variate data. 
Additionally, the study of nuclear material using Raman microspectroscopy, as 
previously mentioned, has also recently begun. However, other methods to study 
nuclear damage exist that are less time-consuming than Raman 
microspectroscopy, and will continue to be used until: (1) the acquisition time of 
Raman maps can be accelerated without compromising resolution, (2) the 
through-put capabilities of the technology are improved, and (3) data pre-
processing and processing (uni- and multi-variate analysis) can be automated 
without compromising quality. Nonetheless, the application of Raman 
microspectroscopy to study cellular changes at a single-cell level has slowly 
become an important endeavour as it can allow researchers to better understand 
the cellular mechanisms which affect human health and the mechanisms which 
may lead to the onset of disease. 
For the purposes of the analysis presented in this thesis, the relative peak 
ratios of the 1656 cm-1 and 1444 cm-1 spectral regions were not compared. The 
reasons for this were two-fold: (1) proteins, like lipids, also contain CH2 bonds, 
bonds which feature in the 1400 – 1500 cm-1 spectral range (Rygula et al. 2013). 
Thus, any changes in absolute or relative peak intensity would not enable us to 
differentiate between the presence of protein and lipid within the cell, and (2) the 
spectrum of pure OA has a peak at approximately 1656 cm-1, which is where 
proteins also have a peak corresponding to the Amide I stretching vibration mode, 
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C=O, as described by Rygula et al. (2013). Therefore, any changes in absolute 
or relative peak intensity would not allow for the differentiation between changes 
in carbon chain saturation in lipids and the presence of protein. 
Contrary to the method described above, the method of overlaying the 
spectrum of pure PA and OA with averaged cell spectra was contemplated in 
order to identify the presence of PA or OA (esterified or non-esterified) within the 
LDs of intracellular LDs. Considerations were made to determine whether this 
approach could detect the presence of certain FAs (e.g. the difference between 
SFAs and UFAs), and whether certain peaks corresponding to pure FAs could be 
compared with peaks found in the spectra of cells. If peaks appear in the same 
position on the x-axis of spectra corresponding to a pure FA and that of a cell, 
this could indicate the presence of that particular FA within the cell. This method 
could also identify changes in the relative peak heights from the cell spectra to 
indicate at what concentration the FA has been incorporated into the lipid 
structures. 
It could be argued that this method of overlaying the spectra of pure FAs with 
cell spectra is not robust enough as the binding of FAs to glycerol may shift the 
position of the 2845 cm-1 peak on the x-axis. This could occur as a result of a 
change in the chemical composition of the molecule inducing a change in the 
stretching vibration mode of the C-H bonds within the FAs. This effect might 
render the use of this wavenumber obsolete as it would not be possible to detect 
whether PA, for example, is incorporated into lipid. However, this argument can 
be countered by noting that the C-H bond stretching vibration mode within FAs 
should not be significantly affected upon their incorporation into TAGs. This is 
because glycerol binds via the carboxyl group, and not via the alkyl chain. This 
argument is strengthened further as evidence from Czamara et al. (2014) shows 
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very similar peak positions between the 2800 – 3100 cm-1 region of the spectrum 
of PA and its corresponding TAG: tripalmitin. This suggests that the binding of 
PA with glycerol does not affect the vibrational stretching mode of C-H bonds in 
the PA. This is likely to be the case for other FAs too. 
Based on the limitations and arguments presented in this Chapter, I decided 
that the method of overlaying the spectra of pure FAs with normalised cell spectra 
was the most robust method for measuring changes in the incorporation of PA 
and OA into lipid within INS-1 cells. This method was therefore employed for 
determining the composition of lipid within these cells. 
5.6.2.2 Peak fitting of cell spectra 
Further considerations were made to determine whether the degree of 
unsaturation of LDs within FA-treated cells versus untreated cells could be 
measured. A method of calculating the AUC of peaks corresponding to peaks in 
the spectra of pure PA and pure OA was considered. This approach involved 
conducting a process known as ‘peak fitting’, employed by Slipchenko et al. (2009) 
and Yue et al. (2012). 
The peak fitting process involves conducting spectral decomposition followed 
by second derivative analysis of spectra. The averaged and normalised cell 
spectra underwent peak fitting using WiRE 2.0 software. Background subtraction 
was conducted for the spectrum of each cell corresponding to each treatment. 
The curve fitting extended over the C-H region of all the spectra analysed. Even 
though the individual spectra were noisy, they were not smoothed before being 
fitted to avoid removing data. The baseline for background subtraction was a 
cubic spline fitted at 2600 cm-1, 2700 cm-1, 2800 cm-1, 3250 cm-1 and 3740 cm-1. 
Cubic spline interpolation was employed preferentially over polynomial 
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interpolation because polynomial interpolation can delete data where the 
baseline points exceed the original spectrum. 
Second derivative analysis identified six peaks which were fitted using the 
WiRE 2.0 software on each averaged spectrum between 2700 cm-1 and 3050 cm-
1 (figure 5.13). The peak centres were allowed to drift during the analysis, 
however, no significant difference was observed between individual spectra 
within treatments or between treatments. Note that the cross-hairs on figure 5.13, 
and any other similar figures, do not represent anything, they are automatically 
present on the last curve during the fitting process. 
Although more curves provide better fitting, I aimed to fit each spectrum with 
the minimum number of curves to account for the true peaks within the spectrum. 
Although five curves were trialled, these gave a false fitting at the 2720 cm-1 peak, 
thus six peaks were employed. The software then calculated the peak centre, 
peak width, peak height, gaussian % and the AUC for each peak of each 
spectrum analysed. The same parameters were employed for each curve fitted. 
To determine whether there had been a change in the FA composition of cells 
exposed to exogenously exposed FAs, the AUC of the peaks of interest were 
compared with the AUC of the peaks of interest of the cells exposed to the 
corresponding VC. See equation 5.1 below. 
Equation 5.1 Identifying the presence of a particular fatty acid within a Raman 
cell spectrum and calculating fold change of this peak 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑓𝑎𝑡𝑡𝑦 𝑎𝑐𝑖𝑑
=  
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑝𝑒𝑎𝑘 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 𝑓𝑟𝑜𝑚 𝑐𝑒𝑙𝑙𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑒𝑥𝑜𝑔𝑒𝑛𝑜𝑢𝑠 𝐹𝐴𝑠
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑝𝑒𝑎𝑘 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 𝑓𝑟𝑜𝑚 𝑐𝑒𝑙𝑙𝑠 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑡𝑜 𝑡ℎ𝑒 𝑉𝐶
 
 
The workings for this calculation are shown in the following example for 0.125 
mM PA versus the VC: 
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(1) Identify the appropriate AUC values by identifying the appropriate peaks to 
interrogate: 
(a) The peak for identifying PA presence in the lipid spectrum of cells 
exposed to PA was 2882.28 cm-1. The AUC for this peak was 4378.84 ± 
342 cm-1, 
(b) The peak for identifying PA presence in the lipid spectrum of cells 
exposed to VC was 2885.99 cm-1. The AUC for this peak was 4214.09 ± 
314 cm-1. 
(2) Calculate fold change: 
 
4378.84
4214.09
= 1.04 
 
(3) Calculate error as a percentage: 
 
(100𝑥
342
4378.84
) + (100𝑥
314
4214.09
) = 15.26 % 
 
(4) Calculate absolute error: 
 
1.04𝑥 (
15.26
100
) = 0.158704 = 0.16 
 
Fold change = 1.04 ± 0.16 
 
Note that any conclusions or suggestions drawn from the peak fitting values 
have been done with only the fold change values, whereby the error values have 
not been taken into consideration. This is because the error values are required 
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to represent the statistical significance of the data. The error values do not, upon 
publication of this thesis, hold any biological significance.  
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Figure 5.13 Peak fitting of spectrum corresponding to untreated INS-1 beta 
cells 
The spectra from 16 vehicle control-treated cells from the non-esterified fatty acid 
data-set were averaged and normalised against the phenylalanine peak at 1008.3 
cm-1 (red line). Baseline subtraction was conducted within the 2600 – 3740 cm-1 
region of the spectrum, followed by peak fitting (blue line), whereby 6 curves were 
fitted. From each of the 6 curves (green lines) (only 5 curves shown), the peak 
centre and the AUC were calculated with WiRE 2.0 software. 
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In conclusion, I have developed a robust methodology to measure the 
distribution, intensity and composition of lipid within fixed INS-1 beta cells. This 
method has been applied to INS-1 cells exposed to exogenous FAs. The results 
from this work are presented in Chapter 6.  
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Chapter 6 
 
Use of Raman microspectroscopy to 
study the distribution and composition 
of lipid in beta cells 
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6 Use of Raman microspectroscopy to study the 
distribution and composition of lipid in beta 
cells 
6.1 Introduction 
The Raman microspectroscopy methodology presented in Chapter 5 was 
employed to investigate the hypothesis that differential deposition of SFAs and 
UFAs into LDs occurs in beta cells in vitro. Since each FA molecule has its own 
vibrational signature, determined by the atoms in the molecule, the 
characteristics of the individual bonds and their polarisability, these frequencies 
can be measured. As a result, labels are not required in this technique. 
The aims of the work presented in this Chapter were three-fold: to investigate 
whether: (1) exposing beta cells to PA causes a change in LD disposition 
(distribution and composition) in beta cells, whether (2) OA would be able to 
mitigate the effects caused by PA, by shuttling PA into LDs, and whether (3) 
esterified FAs affect LD disposition. 
6.2 Methods 
6.2.1 Seeding of beta cells and treatment with fatty acids 
INS-1 cells were seeded, as described in section 5.3.1, treated with FAs, 
as described in section 2.1.4, and fixed, as described in section 5.3.2. The 
following FA stock solutions were prepared: 90 mM OA (Sigma) in 90 % (v/v) 
EtOH, 50 mM PA (Sigma) in 50 % (v/v), 90 mM MePA (Sigma) in 90 % (v/v) EtOH; 
and 90 % MeOA (Sigma) in 90 % (v/v) EtOH. 10 % FA-free BSA (Sigma) was 
prepared in RPMI-1640 serum-free medium. Cells were treated with 0.125 mM 
or 0.5 mM FAs for 24 hours before being fixed and imaged using a WiTec alpha 
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300r Raman microspectrometer, as described in section 5.2. Cells treated with 
the VC were exposed to serum-free medium, BSA and EtOH only. The final 
percentages of BSA and EtOH at 0.9 % (w/v) and 0.5 % (v/v), respectively for all 
treatments. Cells treated with the VC will also be known herein as ‘untreated cells’. 
6.2.2 Pre-processing of Raman maps 
Three data-sets of Raman maps were collected, each from differential FA 
treatments. They are: (1) non-methyl ester 0.125 mM FA, (2) non-methyl ester 
0.5 mM FA, and (3) methyl-ester 0.125 mM FA. Within each data-set cells were 
pre-processed, then processed. However, some cells which were pre-processed 
were not included in any further analysis. These cells and the reasons for not 
including them in any further analysis are described here: (1) one VC-treated cell 
within the ‘methyl-ester 0.125 mM FA’ data-set did not undergo uni- and multi-
variate analysis as I deemed its percentage lipid value abnormally low compared 
to other data points within the data-set. Thus, this cell was considered to be an 
anomalous result. It must be noted that although ten VC-treated cells were 
imaged and pre-processed, only nine cells underwent further analysis, and (2) 
one methyl palmitate-treated cell within the ‘methyl-ester 0.125 mM FA’ data-set 
did not undergo uni- and multi-variate analysis as I deemed its percentage lipid 
value abnormally high compared to other data points within the data-set. Thus, 
this cell was considered to be an anomalous result. It must be noted that although 
nine methyl palmitate-treated cells were imaged and pre-processed, only eight 
cells underwent further analysis. These abnormal values could be due to one of 
the following reasons: (1) an incomplete removal of all cosmic rays during the 
pre-processing stage, or (2) a cell-specific biological anomaly concerning the size 
of the cell(s) and/ or the percentage of lipid within the cell(s). 
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6.2.3 Analysis of intracellular lipid distribution and concentration (uni-
variate analysis) 
The distribution of lipid was determined by mapping and quantifying the 
total intensity of the 2845 ± 10 cm-1 spectral band within individual cells. One 
image was taken/ cell/ treatment over a plane approximately at mid-depth through 
the cell. The Raman maps were pre-processed and analysed, as described in 
sections 5.5 and 5.6, respectively. ImageJ analysis allowed the total area fraction 
of each cell and the distribution of lipid within each cell, in which the peak intensity 
was above background, to be quantified. In all cases, the MaxEntropy algorithm 
was deemed most suitable for thresholding the images because the number of 
pixels corresponding to lipid matched most closely to the original Raman map, as 
described in section 5.6.1. 
6.2.4 Analysis of lipid composition (multi-variate analysis) and peak 
fitting 
Cluster analysis was applied to the pixels corresponding to lipid, as 
described in section 5.6.2, to quantify the contributions of individual lipid species 
within the INS-1 cells. From each FA treatment studied, the spectra from the INS-
1 cells were averaged. Subsequently, the peaks in the C-H region of the cell 
spectrum between 2800 cm-1 and 3100 cm-1 were decomposed to identify peaks 
that were hidden by stronger signals, as described in section 5.1.6.1. In many 
cases, large peaks are made up of smaller peaks. The positions of these smaller 
peaks on the x-axis can distort the shape and size of the larger peaks, thus 
allowing for misinterpretation of the data. After peaks have been decomposed, 
the AUC of each peak can be compared between differential treatments. 
However, it can be difficult to identify which peaks to compare with one another. 
As discussed in Chapter 5, I decided to overlay cell spectra with spectra of pure 
FAs to determine whether the lipid within cells was composed of a particular FA. 
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By identifying the peaks which overlay on the x-axis, it could as to whether that 
particular FA was present within the lipid. 
An alternative approach could have been to compare the relative peak 
heights of two peaks within a spectrum of one treatment and compare it with 
another treatment. However, this would not have been appropriate. This is 
because important information, such as the shape and height of the peak, would 
not have been taken into consideration and may have biased the data, which is 
why calculating the AUC is considered a more robust approach. In addition, 
choosing two peaks to compare would have been difficult as the process of 
assigning peaks to chemical bonds is already a difficult process. The 
interpretation and conclusions made from these data would have proven 
extremely complex and possibly misleading. 
In order to choose the peaks which corresponded to chemical components 
in the spectra of both the pure FA and the intracellular lipid, both the pure FA 
spectra and cell spectra were overlaid. In the case of PA, the best-fitting peak 
was present at ~ 2882 cm-1 (figure 6.9). In the case of OA, the best-fitting peak 
was present at ~ 2853 cm-1 (figure 6.18). These peaks were identified within the 
decomposed peaks within cell spectra and compared between treatments. 
Each decomposed peak from each FA treatment was compared with their 
respective VC. The calculation for determining whether a FA was present within 
the Raman maps corresponding to lipid within cells exposed to a particular FA 
was conducted as shown in equation 5.1. This equation can be explained in more 
detail as follows: (1) determine which peak of the pure FA spectrum to quantify 
and ensure this peak corresponds to one of the decomposed peaks within the 
cell spectrum, (2) identify the curve centre of the peak from the spectrum 
corresponding to the FA-treated cell spectrum (3) identify the curve centre of the 
194 
 
peak from the spectrum corresponding to the VC, (4) divide the AUC of the peak 
identified in step (2) with the peak identified in step (3), then calculate the error 
values (in this case the standard error of the mean (SEM)). The final value 
obtained indicates the fold change in the area of the peak of the FA-treated cell 
versus the VC-treated cell. A value of ~ 1 indicates that there is no change in the 
areas of both cell spectra, thus indicating no change in the composition of the 
lipid within the FA-treated cell spectrum. It should be noted, however, that other 
cellular components contain C-H bonds, including other FAs and protein, thus the 
values obtained from the multi-variate analysis presented here can merely 
indicate whether a change in the composition of the cell spectrum is due to the 
presence of the two FAs of interest here: PA or OA. 
6.3 Results 
6.3.1 Vehicle control-treated cells versus 0.125 mM palmitate-treated 
cells 
6.3.1.1 Lipid distribution and concentration 
The cells exposed to the VC showed a consistent distribution of lipid 
(bonds corresponding to the CH2 stretch vibration) throughout the cell (figure 6.1). 
The Raman maps of untreated cells showed a clear distribution of yellow pixels 
within the cells. Lipid within beta cells had not been visualised before using 
Raman microspectroscopy, so it was interesting to see such vast amounts within 
the untreated cells. However, according to Krafft et al. (2006), it should not be a 
surprise to see so much lipid within untreated cells, as normal, healthy, cells 
should, apparently, be lipid-rich. 
Of the 15 cells exposed to 0.125 mM PA, seven cells showed comparable 
lipid distribution to the untreated cells, however, in eight cells lipid accumulated 
in circular structures. The size and number of these circular structures have not 
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been quantified, they are merely visual observations. Instead, the number of 
pixels of interest and their intensity values have been quantified (figure 6.2). 
Note that the figures representing total cell area, percentage intracellular 
lipid, and lipid intensity depict the data in two graphs. A bar chart shows the mean 
value of all the data points ± SEM. A scatter plot shows the absolute values used 
to calculate the mean values presented in the bar chart. The lowest (min) and 
highest (max) values are presented with error bars. 
There was no significant change in the total area of the PA-treated cells 
indicating that under these incubation conditions the treated cells were not 
undergoing apoptosis. Furthermore, changes in lipid distribution were not a 
consequence of a change in the physical size of the cell (figure 6.3). 
There was a significant reduction in the area of lipid within PA-treated beta 
cells (p<0.05) (figure 6.4). Interestingly, the scatterplot shows different 
populations of lipid. Nine cells were comparable to the VC-treated cells, which 
had lipid areas between 10 and 30 %, whereas six cells had lipid areas between 
0 and 10 %. 
There was a significant increase in the intensity of lipid within PA-treated 
cells (p<0.01) (figure 6.5). These data correlate with the data presented in figure 
6.4 which showed that the concentration of lipid within the cell increased, 
probably due to the lipid occupying less space within the cells.  
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Figure 6.1 Raman maps showing distribution of lipid within 
untreated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with BSA and EtOH in serum-free medium for 24 hours. (a – o) The data 
represent cells imaged from six experiments. Sixteen cells were imaged 
and pre-processed using a WiTec 300r Raman microspectrometer. The 
yellow pixels correspond to lipid at the CH2 symmetric stretch vibration 
mode: 2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) (e) 
(f) 
(g) 
(h) 
(i) 
(j) 
(k) 
(l) (m) 
(n) 
(o) 
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Figure 6.2 Raman maps showing distribution of lipid within 
palmitate-treated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with 0.125 mM palmitate for 24 hours. (a – l) The data represent cells 
imaged from six experiments. Fifteen cells were imaged and pre-
processed using a WiTec 300r Raman microspectrometer. The yellow 
pixels correspond to lipid at the CH2 symmetric stretch vibration mode: 
2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) 
(e) 
(f) 
(g) 
(h) 
(i) 
(j) 
(k) 
(l) 
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Figure 6.3 Total area of beta cells treated with palmitate for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate (PA; red). The number of pixels corresponding to each entire cell 
was calculated on ImageJ after the MaxEntropy algorithm was employed. 
The data represent six experiments conducted where a total of 16 VC-
treated cells and 15 PA-treated cells were acquired for ImageJ analysis. 
One-way ANOVA with Tukey’s multiple comparison test. (a) Total cell area 
versus treatment. Mean ± SEM. (b) Total cell area versus treatment. 
Minimum to maximum values ± error. 
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Figure 6.4 Percentage of intracellular lipid in beta cells treated with 
palmitate for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate (PA; red). The number of pixels corresponding to each entire cell 
and the lipid within each cell was calculated on ImageJ after the MaxEntropy 
algorithm was employed. The percentage of lipid in each cell was 
subsequently calculated. The data represent six experiments conducted 
where a total of 16 VC-treated cells and 15 PA-treated cells were acquired 
for ImageJ analysis. One-way ANOVA with Tukey’s multiple comparison 
test * (p<0.05). (a) Lipid area versus treatment. Mean ± SEM. (b) Lipid area 
versus treatment. Minimum to maximum values ± error. 
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Figure 6.5 Intensity of intracellular lipid in beta cells treated with 
palmitate for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate (PA; red). The intensity of the pixels corresponding to lipid within 
each cell was calculated on ImageJ after the MaxEntropy algorithm was 
employed. The data represent six experiments conducted where a total of 
16 VC-treated cells and 15 PA-treated cells were acquired for ImageJ 
analysis. One-way ANOVA with Tukey’s multiple comparison test ** 
(p<0.01). Note that the removal of data point [A] from the scatterplot does 
not change statistical significance. (a) Lipid intensity versus treatment. 
Mean ± SEM. (b) Lipid intensity versus treatment. Minimum to maximum 
values ± error. 
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6.3.1.2 Lipid composition 
6.3.1.2.1 Peak fitting 
In the case for cells treated with 0.125 mM PA, equation 5.1 was employed 
to calculate the fold change in the AUC of the peak of interest (compare figures 
6.6 and 6.7): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑃𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑃𝐴 (2882.28 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(1)(2885.99 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
4378.84
4214.09
= 1.04 
(100𝑥
342
4378.84
) + (100𝑥
314
4214.09
) = 15.26 % 
1.04𝑥 (
15.26
100
) = 0.158704 = 0.16 
0.125 𝑚𝑀 𝑃𝐴 ÷ 𝑉𝐶(1) = 1.04 ± 0.16 
 
6.3.1.2.2 Overlay of pure fatty acid spectra and cell spectra 
The full spectrum of pure PA was overlaid with the INS-1 cell spectrum 
after treatment with 0.125 mM PA (figure 6.8). It can be seen that some areas of 
both spectra overlap, such as at ~ 1150 cm-1, between 1400 cm-1 and 1500 cm-
1, and between 2800 cm-1 and 2900 cm-1. 
The C-H region of the cell spectrum between 2800 cm-1 and 3050 cm-1 is 
visible in figure 6.9. The peak at ~ 2880 cm-1 in the spectrum of pure PA is present 
in the cell spectrum, hence why this region was chosen for determining the 
composition of the lipid within the cells treated with PA. 
In conclusion, the uni-variate analysis suggests that PA is incorporated 
into NLDs because the area of lipid decreases and the intensity of this lipid 
increases. However, the multi-variate analysis suggests that PA is not 
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incorporated into NLDs as the fold change of the AUC from the treatment 
spectrum and the VC at ~ 2880 cm-1 is close to 1.  
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Figure 6.6 Peak fitting of spectrum representing INS-1 cells treated with 
the vehicle control (1) 
The spectra of 16 INS-1 cells treated with the vehicle control were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3050 cm-1. 
Peak-VC (1) for PA presence 
2885.99 cm-1 
Peak-VC (1) for OA presence 
2852.13 cm-1 
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Figure 6.7 Peak fitting of spectrum representing INS-1 cells treated with 
0.125 mM palmitate 
The spectra of 15 INS-1 cells treated with 0.125 mM palmitate were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3050 cm-1. 
Peak-0.125 mM PA 
2882.28 cm-1 
Raman shift (cm-1) 
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Figure 6.8 Full spectrum of pure palmitate overlaid with INS-1 cell 
spectrum after treatment with 0.125 mM palmitate 
Black spectrum represents pure palmitate. Red spectrum represents 
averaged spectrum of INS-1 cells treated with 0.125 mM palmitate. Spectral 
range 0 – 3800 cm-1. 
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Figure 6.9 Spectrum of pure palmitate overlaid with INS-1 cell spectrum 
after treatment with 0.125 mM palmitate 
Red spectrum represents pure palmitate. Blue spectrum represents averaged 
spectra of INS-1 cells treated with 0.125 mM palmitate. Spectral range 2380 – 
3170 cm-1. 
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6.3.2 Vehicle control-treated cells versus palmitate-treated cells (0.5 mM) 
6.3.2.1 Lipid distribution and concentration 
An experiment was conducted where four INS-1 cells exposed to the VC, 
and four cells exposed to 0.5 mM PA, for 24 hours, were imaged and 
subsequently analysed. The aim of this study was to determine whether changes 
in LD distribution and composition were dose-dependent. As with the cells 
exposed to 0.125 mM PA, the cells exposed to 0.5 mM PA were analysed using 
ImageJ software and the spectra of pixels corresponding to the band of interest 
at 2845 ± 10 cm-1 were subsequently averaged and normalised using cluster 
analysis, as described in section 5.6.1. The cells exposed to the VC showed the 
same lipid distribution as the cells from other data-sets (data not shown). The 
lipid area of cells exposed to 0.5 mM PA was less than that of VC-treated cells, 
similar to that of cells exposed to 0.125 mM PA, however the additional decrease 
was not significant (data not shown). By contrast to the cells exposed to 0.125 
mM PA, a slight yet insignificant decrease in the intensity of the pixels 
corresponding to lipid in the cells exposed to 0.5 mM PA was observed (data not 
shown). 
6.3.2.2 Lipid composition 
6.3.2.2.1 Peak fitting 
The spectra of cells exposed to 0.5 mM PA showed an interesting 
difference compared to the spectra of cells exposed to 0.125 mM PA. Figure 6.10 
shows the averaged and normalised spectra of four cells exposed to the VC. A 
visual comparison of figures 6.7 and 6.11 shows differences in the relative peak 
heights of the three most prominent peaks: ~ 2855 cm-1, ~ 2880 cm-1 and ~ 2940 
cm-1. Figure 6.11 shows the peak at 2880 cm-1 is relatively higher than the peak 
at 2940 cm-1. This, however, is not the case in figure 6.7, where the peak at 2880 
cm-1 is relatively higher than the peak at 2940 cm-1. 
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In the case for cells treated with 0.5 mM PA, equation 5.1 was employed 
to calculate the fold change in the AUC of the peak of interest (compare figures 
6.10 and 6.11): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑃𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.5 𝑚𝑀 𝑃𝐴 (2881.65 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(2)(2881.98 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
2594.63
2126.48
= 1.22 
(100𝑥
258
2594.63
) + (100𝑥
166
2126.48
) = 17.75 % 
1.22𝑥 (
17.75
100
) = 0.21655 = 0.22 
0.5 𝑚𝑀 𝑃𝐴 ÷ 𝑉𝐶(2) = 1.22 ± 0.22 
 
In conclusion, the uni-variate analysis found that the area of lipid was not 
significantly different compared to the VC, and that the intensity of this lipid 
decreased. These data suggest that the PA was metabolised. Interestingly, the 
fold change was greater in the spectrum of cells treated with 0.5 mM PA (1.22) 
compared to the cells treated with 0.125 mM PA (1.04) suggesting that PA is 
dose-dependently incorporated into LDs.  
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Figure 6.10 Peak fitting of spectrum representing INS-1 cells treated 
with the vehicle control (2) 
The spectra of four INS-1 cells treated with the vehicle control were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3050 cm-1. 
Peak-VC (2) for PA presence  
2881.65 cm-1 
Raman shift (cm-1) 
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Figure 6.11 Peak fitting of spectrum representing INS-1 cells treated with 
0.5 mM palmitate 
The spectra of four INS-1 cells treated with 0.5 mM palmitate were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3050 cm-1. 
Peak-0.5 mM PA 
2881.98 cm-1 
Raman shift (cm-1) 
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6.3.3 Vehicle control-treated cells versus oleic acid-treated cells (0.125 
mM) 
6.3.3.1 Lipid distribution and concentration 
Seven cells treated with 0.125 mM OA showed comparable lipid 
distribution to untreated cells. However, similar to 0.125 mM PA-treated cells, four 
cells exhibited differential lipid distribution whereby round structures were visible 
(compare figures 6.2 and 6.12). 
The total area of cells exposed to OA was larger compared to untreated 
cells, but not statistically significantly, and there were clear differences in the 
distribution of lipid within the cells exposed to OA (figure 6.13). 
There was a slight, but insignificant, decrease in the area of lipid within 
OA-treated cells, and the scatterplot showed a broader distribution of data points 
compared to untreated cells (figure 6.14). A similar trend was observed with the 
0.125 mM PA-treated cells (compare figures 6.4 and 6.14), yet the observation in 
the 0.125 mM PA-treated cells was statistically significant. 
There was a statistically significant increase in the integrated CH2 peak 
intensity in OA-treated cells despite the insignificant decrease in the area of lipid 
(p<0.05) (figure 6.15). This was similar to, but smaller than, the change seen in 
0.125 mM PA-treated cells (compare figures 6.5 and 6.15).  
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Figure 6.12 Raman maps showing distribution of lipid within oleic 
acid-treated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with 0.125 mM oleic acid for 24 hours. (a – i) The data represent cells 
imaged from six experiments. Eleven cells were imaged and pre-
processed using a WiTec 300r Raman microspectrometer. The yellow 
pixels correspond to lipid at the CH2 symmetric stretch vibration mode: 
2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) 
(e) 
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Figure 6.13 Total area of beta cells treated with oleic acid for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM oleic 
acid (OA; green). The number of pixels corresponding to each entire cell 
was calculated on ImageJ after the MaxEntropy algorithm was employed. 
The data represent six experiments conducted where a total of 16 VC-
treated cells and 11 OA-treated cells were acquired for ImageJ analysis. 
One-way ANOVA with Tukey’s multiple comparison test. (a) Total cell area 
versus treatment. Mean ± SEM. (b) Total cell area versus treatment. 
Minimum to maximum values ± error. 
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Figure 6.14 Percentage of intracellular lipid in beta cells treated with 
oleic acid for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM oleic 
acid (OA; green). The number of pixels corresponding to each entire cell 
and the lipid within each cell was calculated on ImageJ after the MaxEntropy 
algorithm was employed. The percentage of lipid in each cell was 
subsequently calculated. The data represent six experiments conducted 
where a total of 16 VC-treated cells and 11 OA-treated cells were acquired 
for ImageJ analysis. One-way ANOVA with Tukey’s multiple comparison 
test. (a) Lipid area versus treatment. Mean ± SEM. (b) Lipid area versus 
treatment. Minimum to maximum values ± error. 
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Figure 6.15 Intensity of intracellular lipid in beta cells treated with oleic 
acid for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate (OA; green). The intensity of the pixels corresponding to lipid 
within each cell was calculated on ImageJ after the MaxEntropy algorithm 
was employed. The data represent six experiments conducted where a total 
of 16 VC-treated cells and 11 OA-treated cells were acquired for ImageJ 
analysis. One-way ANOVA with Tukey’s multiple comparison test * 
(p<0.05). (a) Lipid intensity versus treatment. Mean ± SEM. (b) Lipid 
intensity versus treatment. Minimum to maximum values ± error. 
Treatment Mean +/- SEM
In
te
n
s
it
y
 (
a
u
.)
VC OA
0
50
100
150 *
Treatment Min to Max
In
te
n
s
it
y
 (
a
u
.)
VC OA
0
100
200
300 *
(a) (b) 
216 
 
6.3.3.2 Lipid composition 
6.3.3.2.1 Peak fitting 
In the case for cells treated with 0.125 mM OA, equation 5.1 was employed 
to calculate the fold change in the AUC of the peak of interest (compare figures 
6.6 and 6.16): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑂𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑂𝐴 (2853.05 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(1)(2852.13 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
289.49
232.67
= 1.24 
(100𝑥
98
289.49
) + (100𝑥
45
232.67
) = 53.19 % 
1.24𝑥 (
53.19
100
) = 0.659556 = 0.66 
0.125 𝑚𝑀 𝑂𝐴 ÷ 𝑉𝐶(1) = 1.24 ±  0.66 
 
6.3.3.2.2 Overlay of pure fatty acid spectra and cell spectra 
The full spectrum of pure OA was overlaid with the INS-1 cell spectrum 
after treatment with 0.125 mM OA (figure 6.17). It can be seen that some areas 
of both spectra overlap, as seen in figure 6.8, such as between 1400 cm-1 and 
1500 cm-1. However, other peaks overlap which are not present in figure 6.8, 
such as between 1250 cm-1 and 1350 cm-1, and between 1650 cm-1 and 1700 
cm-1. 
The C-H region of the cell spectrum between 2800 cm-1 and 3050 cm-1 is 
visible in figure 6.18. The peak at ~ 2852 cm-1 in the spectrum of pure OA is also 
present in the cell spectrum. Although the spectrum of pure PA also contains a 
peak at ~ 2852 cm-1, and the absolute height of this peak is the same in both pure 
PA and OA, it seemed appropriate to use the peak at ~ 2880 cm-1 to represent 
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PA and the peak at ~ 2852 cm-1 to represent OA. This was because: (1) the ratio 
of the peaks in the spectrum of pure PA were such that the absolute peak at ~ 
2880 cm-1 was higher than the absolute peak at ~ 2852 cm-1, and (2) the ratio of 
the peaks in the spectrum of pure OA were such that the absolute peak at ~ 2852 
cm-1 was higher than the absolute peak at ~ 2880 cm-1. In addition, the region in 
the spectrum of pure OA between 2880 cm-1 and 2920 cm-1 is complex and would 
have been difficult to distinguish within the cell spectrum. 
In conclusion the uni-variate analysis suggests that OA was not 
incorporated into NLDs, but instead suggests that OA partitions into lipid 
structures within the cell. However, the multi-variate analysis suggests that OA 
was present within the lipid of cells treated with 0.125 mM OA. This was based 
on the observed fold change value of 1.24. This suggests that OA was not 
metabolised but was instead incorporated into LDs.  
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Figure 6.16 Peak fitting of spectrum representing INS-1 cells treated with 
0.125 mM oleic acid 
The spectra of 11 INS-1 cells treated with 0.125 mM oleic acid were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3050 cm-1. 
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Figure 6.17 Full spectrum of pure oleic acid overlaid with cell spectrum 
after treatment with 0.125 mM oleic acid 
Red spectrum represents pure oleic acid. Black spectrum represents averaged 
spectra of cells treated with 0.125 mM oleic acid. Spectral range 0 – 3800 cm-1. 
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Figure 6.18 Spectrum of pure oleic acid overlaid with cell spectrum after 
treatment with 0.125 mM oleic acid 
Red spectrum represents pure oleic acid. Black spectrum represents averaged 
spectra of cells treated with 0.125 mM oleic acid. Spectral range 2360 – 3170 
cm-1. 
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6.3.4 Vehicle control-treated cells versus palmitate and oleic acid-treated 
cells combined (0.125 mM) 
6.3.4.1 Lipid distribution and concentration 
Similar to the observations made in cells treated with either 0.125 mM PA 
or 0.125 mM OA alone, ten cells exposed to both 0.125 mM PA and 0.125 mM 
OA combined exhibited differential lipid distribution compared to the untreated 
cells. However, five cells were comparable to the untreated cells (compare figures 
6.6 and 6.19). 
There was a statistically significant increase in the total area of cells 
treated with equimolar concentrations of PA and OA (p<0.05) (figure 6.20). This 
is likely to have been due to the presence of double the concentration of lipid 
within the cell compared to cells only exposed to one FA. 
Interestingly, even though the size of cells significantly increased of cells 
exposed to both PA and OA combined in equimolar concentrations, there was a 
statistically significant reduction in the space which the lipid occupied (p<0.01). 
These data support the hypothesis that OA shuttles PA into lipid droplets since 
the number of cells with lipid areas between 0 and 10 % increased from six (PA 
alone) (figure 6.3) to ten (figure 6.21). 
The intensity of the lipid within the cells exposed to both PA and OA 
combined increased significantly compared to the VC (p<0.001) (figure 6.22). 
This could have been be due to the presence of double the concentration of FA 
within the cells. These data correlate with the data shown in figure 6.21, whereby 
the area of lipid decreases, suggesting that OA shuttles PA into NLDs. The 
hypothesis that OA shuttles PA into NLDs would be further strengthened if the 
composition of PA within LDs increases. 
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6.3.4.2 Comparison between total cell area and area of lipid (1) 
The relationship between the total area of cells versus the area of lipid was 
compared from cells treated with non-esterified FAs and VC-treated cells (figure 
6.23). The absolute values, in pixels, as opposed to percentage values, were 
plotted. A positive correlation was observed, whereby larger cells contain more 
lipid. However, outliers may skew the data. Figure 6.23 shows the data 
corresponding to the cells treated with 0.125 mM PA. The trend is similar to that 
of the VC-treated cells, however, the 0.125 mM PA-treated cells are generally 
smaller than the VC-treated cells. It would also seem that these smaller PA-
treated cells contain less lipid. However, the single outlier may skew the data. 
This observation contradicts the observation in figure 6.3 which shows no 
significant difference between the total areas of PA- and VC-treated cells. Figure 
6.23 shows the data corresponding to the cells treated with 0.125 mM OA. There 
is no correlation between the total area of the cell and the lipid area within the 
INS-1 cells. Whether there is a correlation between these two parameters, with 
PA and OA combined, is not clear as the data for the VC is not clear-cut either.  
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Figure 6.19 Raman maps showing distribution of lipid within 
palmitate- and oleic acid-treated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with 0.125 mM palmitate and 0.125 mM oleic acid for 24 hours. (a – k) 
The data represent cells imaged from six experiments. Fourteen cells 
were imaged and pre-processed using a WiTec 300r Raman 
microspectrometer. The yellow pixels correspond to lipid at the CH2 
symmetric stretch vibration mode: 2845 ± 10 cm-1 spectral band. 
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Figure 6.20 Total area of beta cells treated with palmitate and oleic acid for 
24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 24 
hours with serum-free medium. Vehicle control-treated cells were exposed to 
BSA + EtOH (VC; blue). Cells were treated with 0.125 mM palmitate and 0.125 
mM oleic acid (PA+OA; yellow). The number of pixels corresponding to each 
entire cell was calculated on ImageJ after the MaxEntropy algorithm was 
employed. The data represent six experiments conducted where a total of 16 
VC-treated cells and 14 PA+OA-treated cells were acquired for ImageJ analysis 
* (p<0.05). One-way ANOVA with Tukey’s multiple comparison test. (a) Total cell 
area versus treatment. Mean ± SEM. (b) Total cell area versus treatment. 
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Figure 6.21 Percentage of intracellular lipid in beta cells treated with 
palmitate and oleic acid for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate and 0.125 mM oleic acid (PA+OA; yellow). The number of pixels 
corresponding to each entire cell and the lipid within each cell was 
calculated on ImageJ after the MaxEntropy algorithm was employed. The 
percentage of lipid in each cell was subsequently calculated. The data 
represent six experiments conducted where a total of 16 VC-treated cells 
and 14 PA+OA-treated cells were acquired for ImageJ analysis. One-way 
ANOVA with Tukey’s multiple comparison test ** (p<0.01). (a) Lipid area 
versus treatment. Mean ± SEM. (b) Lipid area versus treatment. Minimum 
to maximum values ± error. 
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Figure 6.22 Intensity of intracellular lipid in beta cells treated with 
palmitate and oleic acid for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 
24 hours with serum-free medium. Vehicle control-treated cells were 
exposed to BSA + EtOH (VC; blue). Cells were treated with 0.125 mM 
palmitate and 0.125 mM oleic acid (PA+OA; yellow). The intensity of the 
pixels corresponding to lipid within each cell was calculated on ImageJ after 
the MaxEntropy algorithm was employed. The data represent six 
experiments conducted where a total of 16 VC-treated cells and 14 PA+OA-
treated cells were acquired for ImageJ analysis. One-way ANOVA with 
Tukey’s multiple comparison test *** (p<0.001). (a) Lipid intensity versus 
treatment. Mean ± SEM. (b) Lipid intensity versus treatment. Minimum to 
maximum values ± error. 
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6.3.4.3 Lipid composition 
6.3.4.3.1 Peak fitting 
In the case for cells treated with 0.125 mM PA and 0.125 mM OA combined, 
equation 5.1 was employed to calculate the fold change in the AUC of the peak 
of interest (compare figures 6.6 and 6.24): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑃𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑃𝐴 (2883.44 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(1)(2885.99 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
2900.76
4214.09
= 0.69 
(100𝑥
240
2900.76
) + (100𝑥
314
4214.09
) = 15.72 % 
0.69𝑥 (
15.72
100
) = 0.108 = 0.12 
0.125 𝑚𝑀 𝑃𝐴 ÷ 𝑉𝐶(1) = 0.69 ±  0.12 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑂𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑂𝐴 (2852.15 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(1)(2852.13 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
469.71
232.67
= 2.02 
(100𝑥
106
469.71
) + (100𝑥
45
232.67
) = 41.91 % 
2.02𝑥 (
41.91
100
) = 0.846 =  0.85 
0.125 𝑚𝑀 𝑂𝐴 ÷ 𝑉𝐶(1) = 2.02 ± 0.85 
 
6.3.4.3.2 Overlay of pure fatty acid spectra and cell spectra 
The full spectrum of pure PA was overlaid with the INS-1 cell spectrum 
after treatment with 0.125 mM PA and 0.125 mM OA combined (figure 6.25). It 
can be seen that some areas of both spectra overlap, such as at ~ 1150 cm-1, 
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between 1400 – 1500 cm-1, and between 2800 cm-1 and 2900 cm-1, similar to the 
observations found in figure 6.8. 
The C-H region of the cell spectrum between 2800 cm-1 and 3050 cm-1 is 
visible in figure 6.26. The peak at ~ 2880 cm-1 in the spectrum of pure PA is also 
present in the cell spectrum. 
The full spectrum of pure OA was overlaid with the INS-1 cell spectrum 
after treatment with 0.125 mM PA and 0.125 mM OA combined (figure 6.27). It 
can be seen that many areas of both spectra overlap, as seen in figure 6.17, such 
as between 1250 cm-1 and 1350 cm-1, between 1400 cm-1 and 1500 cm-1, and 
between 1650 cm-1 and 1700 cm-1. 
The C-H region of the cell spectrum between 2800 cm-1 and 3050 cm-1 is 
visible in figure 6.28. The peak at ~ 2880 cm-1 in the spectrum of pure PA is also 
present in the cell spectrum. 
In conclusion, the uni-variate analysis suggests that OA shuttles PA into 
LDs. This was based upon the observation that the area of lipid decreases and 
the intensity of lipid increases. However, this effect was also found with cells 
treated with 0.125 mM PA alone, therefore rendering it difficult to determine 
whether OA is indeed able to have the effect on the cell as originally hypothesised. 
Therefore, the uni-variate analysis suggests that the mechanism by which OA is 
able to protect against PA-induced toxicity is not via the incorporation of PA into 
LDs, since this effect was observed with PA alone. These data suggest that the 
mechanism of protection of OA is via a different mechanism. Interestingly, the 
multi-variate analysis found that the presence of PA within LDs decreased (0.69 
fold change), yet the presence of OA increased (2.02 fold change). Why this 
occurred is not clear, however, it could either be suggested that: (1) OA is able 
to induce the breakdown of PA, (2) OA is able to upregulate desaturase enzymes 
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which convert PA into palmitoleate and are themselves incorporated into LDs, or 
(3) PA is able to shuttle OA into LDs.  
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Figure 6.24 Peak fitting of spectrum representing INS-1 cells treated with 
0.125 mM palmitate and 0.125 mM oleic acid 
The spectra of 14 INS-1 cells treated with 0.125 mM palmitate and 0.125 mM 
oleic acid combined were averaged (red line). Peak fitting was conducted 
(blue line) whereby six peaks were fitted to decompose the spectrum (green 
lines). Spectral range 2600 – 3050 cm-1. 
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Figure 6.25 Full spectrum of pure palmitate overlaid with cell spectrum 
after treatment with 0.125 mM palmitate and 0.125 mM oleic acid 
Red spectrum represents pure palmitate. Black spectrum represents 
averaged spectra of cells treated with 0.125 mM palmitate and 0.125 mM oleic 
acid combined. Spectral range 0 – 3800 cm-1. 
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Figure 6.26 Spectrum of pure palmitate overlaid with cell spectrum after 
treatment with 0.125 mM palmitate and 0.125 mM oleic acid 
Red spectrum represents pure palmitate. Black spectrum represents 
averaged spectra of cells treated with 0.125 mM palmitate and 0.125 mM oleic 
acid combined. Spectral range 2440 – 3060 cm-1. 
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Figure 6.27 Full spectrum of pure oleic acid overlaid with cell spectrum 
after treatment with 0.125 mM palmitate and 0.125 mM oleic acid 
Red spectrum represents pure oleic acid. Black spectrum represents 
averaged spectra of cells treated with 0.125 mM palmitate and 0.125 mM oleic 
acid combined. Spectral range 0 – 3800 cm-1. 
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Figure 6.28 Spectrum of pure oleic acid overlaid with cell spectrum after 
treatment with 0.125 mM palmitate and 0.125 mM oleic acid 
Red spectrum represents pure oleic acid. Black spectrum represents 
averaged spectra of cells treated with 0.125 mM palmitate and 0.125 mM oleic 
acid combined. Spectral range 2380 – 3080 cm-1. 
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6.3.5 Vehicle control-treated cells versus esterified FA-treated cells 
(0.125 mM) 
6.3.5.1 Lipid distribution and concentration 
The VC-treated cells presented here (figure 6.29) have the same lipid 
distribution as the cells previously shown in figure 6.6. VC-treated maps show a 
consistent distribution of lipid (bonds corresponding to the CH2 symmetric stretch 
vibration mode) throughout the cells. 
The cells treated with 0.125 mM MePA showed the same distribution of 
lipid as the untreated cells (compare figures 6.29 and 6.30). In addition, the cells 
treated with 0.125 mM MeOA showed the same distribution of lipid as the 
untreated and the MePA-treated cells (compare figures 6.29, 6.30 and 6.31). 
There was no statistically significant change in the total area of cells 
treated with esterified FAs compared to the untreated cells (figure 6.32). The 
range of data points of all esterified FA-treated cells was comparable to the 
untreated cells. These data were comparable to the cells treated with PA and OA 
alone (compare figures 6.3, 6.13 and 6.32). 
There was no statistically significant change in the area of lipid within cells 
treated with esterified FAs compared to the untreated cells (figure 6.33). There 
was also no change in the variation of the data points of cells (i.e. different 
population of cells were not observed) treated with MeOA, unlike the cells treated 
with OA (compare figures 6.14 and 6.33). On the other hand, a significant 
variation in lipid area was observed with PA, but not with MePA (compare figures 
6.4 and 6.33). These data suggest that esterified FAs are inert and are not 
incorporated into NLDs, probably due to their structural composition whereby the 
carboxyl oxygen atom is not biologically available for activation via CoA. 
There was no significant difference in intensity values between cells 
treated with esterified FAs compared to the untreated cells (figure 6.34). No 
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significant difference between MePA-treated cells and the untreated cells was 
observed, unlike between PA-treated cells and the untreated cells (figure 6.4). By 
contrast, cells exposed to MeOA exhibited the same trend as the cells treated 
with OA, however, two MeOA data points in this data-set have intensity values 
greater than 125 au (compare figures 6.15 and 6.34). It is not clear what the 
biological significance of these two data points are. It is possible that cosmic rays 
were not removed from the pixels within the maps, causing a spike in intensity. 
Since no statistical significance was observed between the lipid content of 
the maps esterified FA-treated cells and VC-treated cells, it can be suggested 
that either: (1) esterified FAs are not incorporated into NLDs, or (2) esterified FAs 
do not enter cells. Multi-variate data would add evidence to determine whether 
these hypotheses hold any truths. This would be done by determining whether 
peaks corresponding to pure PA and OA (peak fitting analysis) appear in the lipid 
of cells treated with MePA and MeOA, respectively. 
6.3.5.2 Comparison between total cell area and area of lipid (2) 
The relationship between the total area of cells versus the area of lipid was 
compared from cells treated with esterified FAs and VC-treated cells (figure 6.35). 
There was a positive correlation of the total cell area and the lipid area of 
untreated cells. Further, the VC data was comparable to all the cells exposed to 
esterified FAs, whereby there was no change in the range of data points. Given 
that the trend in data for the cells treated with the VC are identical in figures 6.23 
and 6.35, these data give confidence that the data from these two separate data-
sets are true. I can also be confident that the data for the non-esterified FAs (PA 
and OA alone) are true. 
Further, these data suggest that long-chain esterified SFAs, long-chain 
esterified UFAs and long-chain non-esterified UFAs, alone, do not affect the 
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distribution of LDs within INS-1 cells. By contrast, non-esterified SFAs, do affect 
the distribution of lipid within INS-1 cells (compare figures 6.23 and 6.35).  
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Figure 6.29 Raman maps showing distribution of lipid within 
untreated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with BSA and EtOH in serum-free medium for 24 hours. (a – j) The data 
represent cells imaged from three experiments. Ten cells were imaged 
and pre-processed using a WiTec 300r Raman microspectrometer. The 
yellow pixels correspond to lipid at the CH2 symmetric stretch vibration 
mode: 2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) 
(f) 
(e) 
(g) 
(h) (i) 
(j) 
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Figure 6.30 Raman maps showing distribution of lipid within methyl 
palmitate-treated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with 0.125 mM methyl palmitate for 24 hours. (a – i) The data represent 
cells imaged from three experiments. Nine cells were imaged and pre-
processed using a WiTec 300r Raman microspectrometer. The yellow 
pixels correspond to lipid at the CH2 symmetric stretch vibration mode: 
2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) 
(e) 
(f) 
(g) 
(h) 
(i) 
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Figure 6.31 Raman maps showing distribution of lipid within methyl 
oleate-treated beta cells 
INS-1 cells were treated for 24 hours with complete medium, then treated 
with 0.125 mM methyl oleate for 24 hours. (a – j) The data represent cells 
imaged from three experiments. Eleven cells were imaged and pre-
processed using a WiTec 300r Raman microspectrometer. The yellow 
pixels correspond to lipid at the CH2 symmetric stretch vibration mode: 
2845 ± 10 cm-1 spectral band. 
(a) (b) (c) 
(d) 
(e) 
(f) 
(h) 
(i) 
(g) 
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Figure 6.32 Total area of beta cells treated with esterified fatty acids for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 24 hours 
with serum-free medium and 0.125 mM fatty acid treatment: vehicle control (VC; BSA 
+ EtOH; blue), methyl palmitate (MePA; purple) and methyl oleate (MeOA; orange). 
The number of pixels corresponding to each entire cell was calculated on ImageJ after 
the MaxEntropy algorithm was employed. The data represent three experiments 
conducted where a total of nine VC-treated cells, eight MePA-treated cells and 11 
MeOA-treated cells were acquired for ImageJ analysis. One-way ANOVA with Tukey’s 
multiple comparison test. (a) Total cell area versus treatment. Mean ± SEM. (b) Total 
cell area versus treatment. Minimum to maximum values ± error. 
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Figure 6.33 Percentage of intracellular lipid in beta cells treated with esterified 
fatty acids for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 24 hours 
with serum-free medium and 0.125 mM fatty acid treatment: vehicle control (VC; BSA 
+ EtOH; blue), methyl palmitate (MePA; purple) and methyl oleate (MeOA; orange). 
The number of pixels corresponding to each entire cell and the lipid within each cell 
was calculated on ImageJ after the MaxEntropy algorithm was employed. The 
percentage of lipid in each cell was subsequently calculated. The data represent three 
experiments conducted where a total of nine VC-treated cells, eight MePA-treated cells 
and 11 MeOA-treated cells were acquired for ImageJ analysis. One-way ANOVA with 
Tukey’s multiple comparison test. (a) Lipid area versus treatment. Mean ± SEM. (b) 
Lipid area versus treatment. Minimum to maximum values ± error. 
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Figure 6.34 Intensity of intracellular lipid in beta cells treated with esterified fatty 
acids for 24 hours 
INS-1 cells were pre-treated with complete medium for 24 hours, then for 24 hours 
with serum-free medium and 0.125 mM fatty acid treatment: vehicle control (VC; BSA 
+ EtOH; blue), methyl palmitate (MePA; purple) and methyl oleate (MeOA; orange). 
The intensity of the pixels corresponding to lipid within each cell was calculated on 
ImageJ after the MaxEntropy algorithm was employed. The data represent three 
experiments conducted where a total of nine VC-treated cells, eight MePA-treated cells 
and 11 MeOA-treated cells were acquired for ImageJ analysis. One-way ANOVA with 
Tukey’s multiple comparison test. (a) Lipid intensity versus treatment. Mean ± SEM. 
(b) Lipid intensity versus treatment. Minimum to maximum values ± error. 
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6.3.5.3 Lipid composition 
6.3.5.3.1 Peak fitting 
In the case for cells treated with 0.125 mM MePA, equation 5.1 was 
employed to calculate the fold change in the AUC of the peak of interest (compare 
figures 6.36 and 6.37): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑃𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑀𝑒𝑃𝐴 (2880.43 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(3)(2880.98 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
2061.87
1890.16
= 1.09 
(100𝑥
1030
2061.87
) + (100𝑥
1053
1890.16
) = 105.66 % 
1.09𝑥 (
105.66
100
) = 1.15 
0.125 𝑚𝑀 𝑀𝑒𝑃𝐴 ÷ 𝑉𝐶(3) = 1.09 ± 1.15 
 
In the case for cells treated with 0.125 mM MeOA, equation 5.1 was 
employed to calculate the fold change in the AUC of the peak of interest (compare 
figures 6.36 and 6.38): 
 
𝑃𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝑂𝐴 =
𝐴𝑈𝐶 𝑓𝑜𝑟 0.125 𝑚𝑀 𝑀𝑒𝑂𝐴 (2853.52 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
𝐴𝑈𝐶 𝑓𝑜𝑟 𝑉𝐶(3)(2853.23 𝑐𝑚 − 1 𝑐𝑢𝑟𝑣𝑒 𝑐𝑒𝑛𝑡𝑟𝑒)
 
298.25
190.27
= 1.57 
(100𝑥
90
298.25
) + (100𝑥
85
190.27
) = 73.80 % 
1.57𝑥 (
73.80
100
) = 1.16 
0.125 𝑚𝑀 𝑀𝑒𝑂𝐴 ÷ 𝑉𝐶(3) = 1.57 ± 1.16 
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A detailed comparison of the spectra of pure PA and OA with the spectra 
from cells exposed to MePA and MeOA was not conducted. 
A summary of the peak fitting data for all treatments presented in this 
thesis can be found in table 6.1. 
The uni-variate analysis found no change in the total cell area, lipid area 
or lipid intensity of cells exposed to 0.125 mM MePA compared to the untreated 
cells. Since no change was observed in these parameters, it can be suggested 
that MePA does not enter cells. To correlate with this data, the multi-variate 
analysis found a fold change of only 1.09 of the decomposed cell spectra 
corresponding to MePA and spectra corresponding to the VC suggesting that 
MePA does not become incorporated into LDs. 
In addition, the uni-variate analysis found no change in the total cell area, 
lipid area or lipid intensity of cells exposed to 0.125 mM MeOA compared to the 
untreated cells. Because of this, these data, and the MePA data, suggest that 
these FAs do not become incorporated into LDs, possibly due to their chemical 
structures. These data have also led to the hypothesis that esterified FAs do not 
enter cells. This is because a displacement of the aqueous cytoplasmic content 
is likely to be observed when a hydrophobic structure enters the cell, even one 
which is not metabolised. In contrast, multi-variate analysis found a large fold 
increase between the decomposed peak of the cell spectrum of MeOA-treated 
cells and the VC-treated cells (1.57 fold change). These data suggest that OA 
becomes incorporated into LDs. However, whether MeOA partitions into LDs or 
whether endogenous OA becomes covalently incorporated into LDs is not clear. 
In addition, these data cannot conclude whether MeOA does or does not enter 
cells, however, it could be suggested that MeOA has an extracellular effect on 
the cell, whereby a signalling pathway initiated from outside the cell, by MeOA, 
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induces the intracellular production of OA, enabling OA to be subsequently 
incorporated into LDs.  
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Figure 6.36 Peak fitting of spectrum representing INS-1 cells treated with 
the vehicle control (3) 
The spectra of nine INS-1 cells treated with the vehicle control were averaged 
(red line). Peak fitting was conducted (blue line) whereby six peaks were fitted 
to decompose the spectrum (green lines). Spectral range 2600 – 3040 cm-1. 
Peak-VC (3) for PA presence 
2880.98 cm-1 
Peak-VC (3) for OA presence 
2853.23 cm-1 
Raman shift (cm-1) 
(a
.u
.)
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Figure 6.37 Peak fitting of spectrum representing INS-1 cells treated with 
0.125 mM methyl palmitate 
The spectra of eight INS-1 cells treated with 0.125 mM methyl palmitate were 
averaged (red line). Peak fitting was conducted (blue line) whereby six peaks 
were fitted to decompose the spectrum (green lines). Spectral range 2600 – 
3040 cm-1. 
Peak-0.125 mM PA 
2880.43 cm-1 
Raman shift (cm-1) 
(a
.u
.)
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Figure 6.38 Peak fitting of spectrum representing INS-1 cells treated with 
0.125 mM methyl oleate 
The spectra of 11 INS-1 cells treated with 0.125 mM methyl oleate were 
averaged (red line). Peak fitting was conducted (blue line) whereby six peaks 
were fitted to decompose the spectrum (green lines). Spectral range 2600 – 
3040 cm-1. 
 
Peak- 0.125 mM OA 
2853.52 cm-1 
Raman shift (cm-1) 
(a
.u
.)
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Summary of fold changes AUC 
AUC of peak from FA-treatment/ AUC of peak from VC = fold change 
Peak centre of curve of interest for PA presence: ~ 2881.65 cm-1 
 VC curve centre VC area FA curve centre FA area 
PA 0.125 mM 2885.99 cm-1 4214.09 2882.28 cm-1 4378.84 
PA 0.5 mM 2881.65 cm-1 2126.48 2881.98 cm-1 2594.63 
PA+OA 0.125 mM 2885.99 cm-1 4214.09 2883.44 cm-1 2900.76 
MePA 0.125 mM 2880.98 cm-1 1890.16 2852.64 cm-1 2061.87 
Treatment Fold change 
PA 0.125 mM/ VC = 4378.84/ 4214.09 1.04 ± 0.16 
PA 0.5 mM/ VC = 2594.63/ 2126.48 1.22 ± 0.22 
PA+OA 0.125 mM/ VC = 2900.76/ 4214.09 0.69 ± 0.12 
MePA 0.125 mM/ VC = 2061.87/ 1890.16 1.09 ± 1.15 
Peak centre of curve of interest for OA presence: ~ 2853.52 cm-1 
 VC curve centre VC area FA curve centre FA area 
OA 0.125 mM 2852.13 cm-1 232.67 2853.05 cm-1 289.49 
PA+OA 0.125 mM 2852.13 cm-1 232.67 2852.15 cm-1 469.71 
MeOA 0.125 mM 2853.23 cm-1 190.27 2853.52 cm-1 298.25 
Treatment Fold change 
OA 0.125 mM/ VC = 289.49/ 232.67 1.24 ± 0.66 
PA+OA 0.125 mM/ VC = 469.71/ 232.67 2.02 ± 0.85 
MeOA 0.125 mM/ VC = 298.25/ 190.27 1.57 ± 1.16 
  
Table 6.1 Summary of peak area changes after spectral decomposition of 
FA-treated spectra versus vehicle control-treated spectra 
The area of each decomposed peak of interest are presented in this table. The 
AUC from the spectrum corresponding to a FA treatment was divided by the 
corresponding AUC of the VC treatment. The resulting value represents the fold 
change and the error as SEM. 
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6.4 Discussion 
6.4.1 Uni-variate analysis 
6.4.1.1 Total cell area 
The total area of each 2D image was calculated for the purposes of 
determining whether the exposure of INS-1 cells to exogenous FAs (non-
esterified and esterified) affected the size of the cell. These data also allowed for 
the determination of the relative quantity of lipid within each cell, by means of 
calculating the percentage of area occupied by lipid within each cell. The absolute 
numbers of pixels corresponding to lipid can be found in figures 6.23 and 6.35. 
The total area of cells did not change upon exposure to 0.125 mM PA, OA, 
MePA or MeOA alone. However, there was a significant increase in the area of 
cells exposed to PA and OA in combination. This increase could be due to the 
physical presence of double the concentration of FAs within the cells. 
Interestingly, there was no difference in the total area of cells exposed to 0.5 mM 
PA compared to cells exposed to the VC. This suggests that the cause of the 
expanded cells exposed to PA and OA combined may not be due to the physical 
presence of double (or an increase in) the concentration of FAs, but may instead 
be due to the additional, specific presence of OA. It could otherwise be suggested 
that the reason why an increase in cell size was not observed of cells exposed to 
0.5 mM PA was because the additional PA was metabolised. Otherwise, had an 
increase in total cell area been observed, this might have suggested that the PA 
had not been metabolised and that it had instead displaced the aqueous contents 
in the cytoplasm. By contrast, the slight, yet insignificant, decrease in the total 
cell area of cells treated with 0.5 mM PA might be interpreted as a pre-/ apoptotic 
state of the cell, a change that might become more pronounced with a larger data-
set. It is apparent that these data are complex and can be overinterpreted. 
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Since the total area of cells exposed to 0.125 mM PA did not change, these 
data validate the chosen FA dose (0.125 mM) and time point (24 hours), and also 
provides confidence in the methodology. This is because cells exposed to harmful 
levels of PA normally reduce in size, a known characteristic of the process of 
apoptosis. In addition the detachment of cells from their substrate was observed 
when Schie et al. (2013) exposed HepG2 cells to 0.25 mM palmitic acid for 24 
hours. This occurred because the dose of FA the cells were exposed to was too 
high and resulted in palmitic acid-induced cell death. This was an error I wanted 
to avoid; I wanted to be sure that any changes observed in the PA-treated INS-1 
cells were not attributable to the cells undergoing apoptotic changes or due to 
any other factors. Since statistically significant cell-shrinkage was not observed 
in the INS-1 cells exposed to both 0.125 mM PA and 0.5 mM PA, any changes in 
lipid distribution cannot have been due to a result of a change in the size of the 
cell or due to advanced apoptotic changes. The data presented in this Chapter 
therefore represent changes in lipid distribution and composition that would occur 
in cells which are likely to be in the resting phase (G0+G1 phase) of the cell cycle. 
However, it should be noted, that the INS-1 cells exposed to both 0.125 mM and 
0.5 mM PA may have undergone pre-apoptotic changes, and this could be 
investigated further, as described in section 6.4.1.2. 
6.4.1.2 Lipid area 
The percentage of lipid within each 2D image of the cells was calculated 
to determine whether differential exogenous FAs affected intracellular lipid 
distribution (more specifically the area which the lipid occupied). 
Upon exposure to 0.125 mM PA, the percentage of lipid within cells 
decreased significantly. Interestingly, the scatterplot in figure 6.4 shows two 
populations of cells. One population, consisting of nine cells, is comparable to the 
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population of cells exposed to the VC. A second population of cells consists of 
six cells which contain significantly less lipid than the cells exposed to the VC. 
This observed heterogeneity of the cell population may be due to some cells 
(those which contain less lipid compared to the VC-treated cells) being less able 
to tolerate the exogenously supplied PA. However, why this might be the case is 
not clear as the cells with low percentages of lipid also have normal total cell 
areas (i.e. total cell areas which are comparable to VC-treated cells). The levels 
of the enzyme Δ-9-desaturase within these cells may play a role. As previously 
discussed in Chapter 1, these enzymes are responsible for the conversion of 
SFAs to UFAs. The presence of UFAs, which are preferentially metabolised over 
SFAs (Voet et al. 2000), may decrease within some cells. By contrast, some cells 
may have elevated levels of these enzymes, thus enabling them to convert PA 
into palmitoleate, thereby enabling them to tolerate the presence of elevated 
levels of PA and evade apoptosis. It must be noted, however, that beta-cell 
heterogeneity has previously been reported in vitro by Cao et al. (2016). 
Heterogeneity in the uptake of deuterated palmitic acid has also been observed 
in macrophage cells in vitro (Stiebing et al. 2014; Stiebing et al. 2017). The 
reviews by Benninger & Hodson (2018) and Pipeleers et al. (2017) highlight that 
differences in beta-cell responses in vivo may be due to various reasons, such 
as the phase of the cell cycle, and the degree to which cells are exposed to 
vascularisation. Although cells in vitro are not exposed to vasculature, other 
spatial factors, such as the seeding density, may affect whether some cells are 
exposed to more or less FAs than others. The hypothesis that the accumulation 
of lipid droplets might be subject to the phase of the cell cycle was suggested by 
Gocze & Freeman (1994). This is an interesting hypothesis since it suggests that 
the presence of certain FAs affects the cell cycle (as discussed in Chapter 4). 
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Based on the morphological requirements (cellular and nuclear) for choosing 
INS-1 cells to image (section 5.4) the cells imaged and analysed in this Chapter 
were most likely to be in the G0+G1 phase of the cell cycle. Therefore, the 
possibility that the two populations of cells observed when exposed to PA were 
due to the differential phases of the cell cycle is unlikely. In addition, it should be 
noted that the heterogeneity observed in the INS-1 cell population is likely to only 
have been observed due to the purposefully large number of cells mapped. 
Raman studies prior to the one presented in this thesis, for example conducted 
by Schie et al. (2013) and Stiebing et al. (2017) (where changes to lipid content 
were investigated), and Krafft et al. (2006) (where changes to nuclear content 
were investigated), did not study large number of cells. 
Although it can be assumed that the cells imaged, analysed and presented 
in this Chapter are in the resting phase of the cell cycle, some cells may in fact 
be pre-apoptotic, and therefore responsible for the two populations of cells 
observed. Further work to determine more conclusively whether INS-1 cells might 
be pre-apoptotic would involve staining cells with both PI and Annexin 5, then 
running the cells through flow cytometry to sort the positively and negatively 
staining cells. The pre-apoptotic cell population would consist of PI negative cells 
and Annexin 5 positive cells. These cells, once sorted would be fixed in a falcon 
tube, then added to a coverslip for mapping, as described in section 5.3.2. 
Alternatively, it may be possible to determine whether INS-1 cells were 
pre-apoptotic by measuring changes in the ratio of peaks specific to DNA 
nucleotides in Raman spectra by employing multi-variate analysis, as described 
by Krafft et al. (2006). Uni-variate analysis, as presented in this thesis to quantify 
the percentage of lipid within the cells, may also be employed to measure the 
area of nuclear material to indicate whether cells were pre-apoptotic. The area of 
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nuclear material would be compared to the total area of the cell. As a reduction 
in the size of a cell’s nucleus is indicative of pre-apoptosis (Krafft et al. 2006), 
researchers will have to ensure that cells with a reduced area of nuclear material, 
relative to untreated cells, do not also have a reduced total cell area. 
Exposing INS-1 cells to 0.125 mM OA did not change the percentage of 
lipid with these cells. In addition, the exposure of INS-1 cells to MePA and MeOA 
did not affect the percentage of intracellular lipid. Interestingly, two populations of 
cells were observed to OA-exposed cells, similar to the cells exposed to 0.125 
mM PA. Since OA alone is not toxic to INS-1 cells, it is therefore unlikely that the 
two populations of cells observed here came about as a result of some cells 
overexpressing the Δ-9-desaturase enzyme. In fact, the population of cells 
consisting of small percentages of lipid after being exposed to OA may be pre-
apoptotic. 
It has been previously suggested that the exposure of cardiomyocytes, 
HeLa cells CHO cells and INS-1 cells to OA increases their content within TAG/ 
LDs (Akoumi et al. 2017; Cao et al. 2016; Listenberger et al. 2003; Plötz et al. 
2016; Slipchenko et al. 2009). It has also been suggested that arachidonic acid, 
a polyunsaturated FA, becomes incorporated in LDs within neutrophil cells 
derived from PLB-985 cells (van Manen et al. 2005) and THP-1 macrophage cells 
(Stiebing et al. 2014). It could be suggested that the observed accumulation of 
lipid upon OA exposure could be due to cell-specific mechanisms. However, the 
results presented in this thesis using INS-1 cells do not support the results 
presented by Plötz et al. (2016) who also studied lipid accumulation in INS-1 cells 
exposed to OA. By contrast, in the INS-1 cells presented in this Chapter, it was 
observed that the lipid intensity of cells exposed to OA increased, yet the area of 
lipid did not change. Based on these observations, it could be suggested that 
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exogenously supplied OA does not change the content of LDs within INS-1 cells 
and therefore does not support the literature that suggests that OA induces the 
formation of LDs. However, whether these differences in LD formation are 
species-specific is unclear. 
Furthermore, Raman results presented in this thesis suggest that PA 
accumulates within INS-1 cells, an observation which is supported by the 
observations made by others, whereby deuterated palmitic acid was detected 
within the LDs of macrophage cells (Stiebing et al. 2014; Stiebing et al. 2017) and 
murine fibroblast-like 3T3-L1 cells (Slipchenko et al. 2009). 
To add an additional layer of complexity, exactly how it can be decided 
that a supposed cellular increase in LD content is quantified should be, in my 
view, be debated. For example, is an observed increase in lipid distribution a 
robust enough metric to study changes in LD formation? Do changes in lipid 
distribution necessarily have to couple with changes in lipid intensity? And to what 
extent is a change in lipid composition relevant? For example, could a decrease 
in lipid distribution and an increase in lipid intensity, as observed when INS-1 cells 
were exposed to 0.125 mM PA, be positively considered to correspond to an 
increase in intracellular LD content? Cao et al (2016), for example, suggest that 
when studying lipid accumulation in non-adipocyte cells, researchers should 
focus their attention to the number of LDs, not the size of LDs. By contrast, could 
merely a change in lipid composition constitute an increase in LD content? I 
believe that researchers need to come to a consensus when describing changes 
in intracellular LD content so as to not misinterpret findings. 
Interestingly, two populations of INS-1 cells were also observed when they 
were exposed to OA in combination with PA. Listenberger et al. (2003) suggests 
that OA is able to protect against PA-induced cytotoxicity by shuttling PA into LDs. 
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The Raman data presented in this thesis might suggest that the presence of both 
PA and OA in combination caused a significant decrease in the percentage of 
lipid within the INS-1 cells, inferring that this decrease might be due to OA 
shuttling PA into NLDs. However, it must be noted that since PA alone also had 
this effect on the cells, it cannot be assumed that the decrease seen in 
combination with OA is due to the presence of OA. Contrary to this, the 
mechanism of protection may indeed be via the shuttling of PA into LDs, a 
process which may occur at differential time points and/ or differential FA 
concentrations to those chosen for this study. 
Lastly it should be noted that it is difficult to distinguish between individual 
LDs within the INS-1 cells. Individual LDs may be present within the cells, 
however, due to the low resolution of the Raman technique (which is set by the 
diffraction limit), the LDs cannot be visualised individually. 
6.4.1.3 Lipid intensity 
The intensity of lipid within each cell was calculated automatically via 
ImageJ software and given an arbitrary value which was directly proportional to 
the concentration of intracellular lipid. These values were compared for each FA 
with which the cells were exposed to. 
The intensity of the lipid within cells exposed to PA was significantly higher 
than the cells exposed to the VC. A decrease in the area of lipid, coupled with an 
increase in the intensity of this lipid might indicate the accumulation of lipid, be 
that from endogenous FAs or exogenously supplied FAs, within a smaller area of 
space. 
Fluorescently labelled FAs imaged using confocal microscopy, unlike the 
use of Raman microspectroscopy, does not permit the evaluation of the 
concentration of molecules. Researchers have used BODIPY-PA to indicate 
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where PA might localise within the cell. BODIPY-PA is a molecule whereby PA is 
conjugated to BODIPY, a small molecule consisting of three ring structures which 
emits light at a certain wavelength when stimulated. Since this compound only 
acts as a proxy for visualising where PA localises within the cell, only minute (nM) 
concentrations are added to cells in combination with unlabelled PA. In addition, 
low concentrations of BODIPY-PA are employed to minimise any secondary 
effects from the large BODIPY molecule, such as the rate of uptake or cellular 
localisation, which this molecule might have on the cell. Since the fluorescence 
intensity of BODIPY is fixed and cannot be aggregated, changes in the 
concentration of BODIPY-PA cannot be calculated. Raman maps, however, 
depict the concentration of molecules of interest by providing a false colour 
representation of the intensity of the molecule of interest. As presented in this 
thesis, each pixel within each Raman map is coloured between black and yellow, 
whereby the brighter the yellow colour, the more molecules of interest there are 
- this is a measure of the concentration of the molecule of interest. This analysis 
is possible because labelled compounds are not employed in Raman 
microspectroscopy. Instead, the concentration of a molecule is calculated based 
on the vibrations detected and is measured from individual bonds within a 
molecule of interest - the greater the number of vibrations detected, the more 
profound the intensity value. Thus, the use of Raman microspectroscopy is 
possibly of greater benefit than the use of labelled FAs. 
The lipid intensity values for cells treated with 0.125 mM OA were 
significantly higher than those for VC-treated cells. This is an unusual observation 
because no change was observed in the area of lipid. This would suggest that 
OA does not affect the distribution of lipid within INS-1 cells. However, the 
exogenously-supplied OA might be able to partition within LDs, whereby it is not 
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esterified to glycerol to form TAG, and might account for the observed increase 
in lipid intensity. Multi-variate analysis is also likely to shed some light as to 
whether a change in the composition of LDs occurs upon the exposure of INS-1 
cells to OA. 
An evaluation of the change in concentration of ester bonds, via ImageJ 
analysis, would further test the hypothesis that OA molecules partition into LDs. 
This could be determined by quantifying changes in the intensity of pixels at the 
1742 cm-1 spectral band depicting ester bonds. No change in the intensity of the 
lipid at this band (versus the VC) might indicate that OA is indeed being 
partitioned into LDs. Alternatively, pixels in Raman maps corresponding to 
phosphodiester bonds (-O-P-O- moiety) at 1085 cm-1 or 1235 cm-1, as identified 
by Matthäus et al. (2008), can also be studied and quantified. Since exogenous 
FAs can be incorporated into phospholipids as well as lipid droplets, it might be 
of interest to compare the number of pixels which correspond to phosphodiester 
bonds with those corresponding to CH2 stretch vibrations within the alkyl chains 
of lipids. If pixels co-localise, it would suggest that the alkyl chain has been both 
esterified and phosphorylated. This would provide further evidence that the pixels 
detected in Raman maps correspond to phospholipids in LDS or membranes, 
and not to free FAs. 
A caveat to this, however, would be that this method would not be able to 
differentiate between endogenous FAs and exogenously supplied FAs. This 
problem might be solved by employing the use of deuterated FAs, as shown by, 
van Manen et al. (2005), Majzner et al. (2018), Slipchenko et al. (2009), Stiebing 
et al. (2014) and Stiebing et al. (2017), to measure the stretch vibration of C-D 
bonds of FAs. This would further our understanding of the localisation of 
exogenously supplied FAs. This is because exogenously supplied FAs serve 
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many intracellular purposes, thus understanding where they localise within cells, 
either whole or metabolised (broken down or modified), would help elucidate the 
link between the intracellular localisation of different FAs and the effects which 
they exert. However, over extended periods of time, such as over 6 hours which 
is when cells begin to degrade FAs (Dhayal & Morgan, unpublished work), 
deuterated components of the FAs may become incorporated into other cellular 
organelles. For example, these components may become incorporated into 
mitochondria upon their degradation, or may become incorporated into proteins. 
Thus, the Raman maps generated from and the LDs supposedly visualised may 
in fact originate from cellular components other than LDs. 
Further work might involve the use of deuterated FAs coupled with CARS, 
similar to the work conducted by Slipchenko et al. (2009) and Stiebing et al. 
(2017). A single vibrational frequency would be selected corresponding to C-D 
bonds and Raman maps generated. This would enable the visualisation of FAs 
over a period of seconds rather than the minutes it takes to generate a Raman 
map via the use of spontaneous Raman microspectroscopy, for example. In 
addition, the CARS maps would be of a higher resolution than the maps 
generated via spontaneous Raman microspectroscopy. CARS would generate 
uni-variate analysis, as described previously, and the analysis of these maps 
could be conducted with the methodology presented in this thesis (see Chapter 
5). Unfortunately, CARS cannot generate multi-variate data, however CARS data 
could be coupled with spontaneous Raman microspectroscopy or hyper-spectral 
analysis to generate multi-variate data. This would allow for a more detailed 
analysis of the composition of the intracellular material being analysed. In addition, 
using CARS, cells can be analysed live, and therefore the methodology employed 
to do this could be a variation of the methodology presented in this thesis. 
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Similarly, the use of alkyne FAs, where an alkyne (carbon-carbon triple 
bond) is present on the terminal carbon atom of the alkyl chain, could also be 
employed to study the localisation of exogenous FAs, as described by Jamieson 
et al. (2018), and could be compared with their non-alkyne counterparts. 
Although the use of non-labelled FAs are biologically and chemically 
relevant, Raman microspectroscopy cannot, at this point, determine whether a 
FA present within the cell was one which was there before the exogenous FA 
was supplied. Similarly, the use of non-labelled FAs cannot determine the 
localisation of exogenously supplied FAs, especially if the FAs in question are 
chemically identical. The use of deuterated FAs, versus the use of BODIPY dyes, 
however, is a technique which I would advocate the use of for furthering our 
understanding of intracellular lipid disposition. One step further might be to co-
localise exogenously supplied FAs (perhaps deuterated) with membranes of 
intracellular organelles, such as the ER or mitochondria using Raman 
microspectroscopy. However, careful consideration would need to be taken to 
ensure the appropriate Raman bands are chosen to be confident that only the 
components of interest are measured and quantified. 
As well as determining the fate of exogenously supplied FAs, it may also 
be of scientific interest to further investigate how endogenous LDs are 
synthesised. It has been suggested that LDs are synthesised from the 
endoplasmic reticulum (Wilfling et al. 2014). Although understanding where 
exogenous FAs are localised is important, as it can aid researchers to better 
understand dietary requirements to prevent the onset of certain diseases, 
understanding the mechanism by which endogenous LDs are synthesised would 
be equally important. This research may lead to the development of medicinal 
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drugs for people with metabolic conditions to regulate their capacity to produce 
excessive or faulty LDs. 
The intensity of intracellular lipid within cells exposed to both 0.125 mM 
PA and 0.125 mM OA combined was significantly higher than the lipid within VC-
treated cells. This could be because the cells had been exposed to double the 
quantity of FA compared to just one FA alone. However, it must also be noted 
that the lipid intensity values of cells exposed to PA and OA alone also increased 
significantly compared to the VC. Based on this observation, it is not possible to 
say whether an increase in lipid intensity was a result of OA shuttling PA into LDs, 
or whether this effect would have been expected regardless of which UFA the 
cells were exposed to. 
The intensity of lipid within cells exposed to 0.125 mM MePA and 0.125 
mM MeOA alone was comparable to the lipid of cells exposed to the VC. Since 
there is no evidence that cells can de-esterify the ester bond between the alkyl 
chain and the carboxyl oxygen, it must be assumed that this process of de-
esterification does not occur. If the cell were able to de-esterify esterified FAs, 
MePA would cause cell death. However, as shown in figure 3.11, MePA does not 
cause cell death in INS-1 cells. As there was no change in the total area of the 
cell, the lipid within the cells and their respective intensity values of cells exposed 
to MePA and MeOA, it could be suggested that esterified FAs do not affect the 
disposition of lipid within INS-1 cells. Again, it could be suggested that these FAs 
do not enter cells. Since non-esterified FAs affect the total area of the cell, the 
distribution of lipid within cells and their relative intensity values (although 
differential FAs have differential effects) I find it unusual that the esterified FAs 
have no effect on the cell whatsoever even though it is known that esterified FAs 
cannot be metabolised or incorporated into LDs because the carboxyl oxygen is 
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covalently bound to a methyl group. This is because I would still expect the 
esterified FAs, if they were capable of entering cells, to alter the total area of the 
cell or the distribution of endogenous lipid within the cell as a result of the 
displacement of the aqueous solution of the cytosol due to their physical presence. 
Since the physical presence of these esterified FAs does not affect the size of 
the cell or the lipid distribution, I therefore question whether these FAs enter cells. 
To investigate this further, peak fitting analysis might shed some light as to 
whether the disposition of LDs changes upon exposure to esterified FAs. 
Additional work to investigate whether esterified FAs are taken up by cells might 
involve the direct measurement of esterified FAs into cells. Kuhl & Spector (1970) 
reported that radiolabelled esterified FAs were taken up by Ehrlich ascites tumour 
cells (murine tutor cells) and cells of the rat heart, liver and kidney. The use of 
radiolabelled compounds might therefore clarify whether these FAs do indeed 
enter INS-1 cells. 
In conclusion, the data from the uni-variate analysis suggest that non-
esterified FAs at 0.125 mM, at a 24-hour time point, can affect the total area of 
the cell, lipid distribution and concentration. The data: (a) suggest that PA is 
shuttled into LDs. This is based on the observation that the lipid area decreases 
and the intensity of this lipid increases, (b) suggest that OA partitions into lipid 
structures, however, further analysis is required to substantiate this hypothesis, 
(c) cannot suggest whether OA is able to shuttle PA into LDs because the 
changes observed in lipid area and intensity were also observed in cells exposed 
to PA alone. Therefore, the Raman data presented here do not support the 
hypothesis that OA protects against PA-induced cytotoxicity by shuttling PA into 
LDs. The data suggest that the mechanism by which OA protects against PA-
induced cytotoxicity occurs via a different mechanism. 
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Even though the data presented in this Chapter cannot conclusively say 
whether OA is able to shuttle PA into NLDs, it might be of interest to investigate 
whether MeOA, in combination with PA, is able to affect lipid distribution and 
intensity. This is because it has been observed, in figure 3.11, that MeOA is able 
to protect against PA-induced cytotoxicity, albeit to a lesser extent than OA. If it 
is discovered that MeOA does not enter cells, it may be that MeOA protects 
against PA-induced toxicity via an extracellular mechanism. 
The data from the uni-variate analysis also suggest that esterified FAs at 
0.125 mM, at a 24 hour time point, do not affect the total area of the cell, lipid 
distribution or concentration. Although no changes in cell size, lipid distribution or 
lipid intensity were observed with esterified FAs, these data validate the 
methodology presented in Chapter 5. This is because even though these data 
cannot elucidate where these FAs localise within the cell and whether they can 
enter cells, the observation that no cellular lipid changes occur highlights the 
important structural requirements for the activation of FAs for their incorporation 
into LDs. 
6.4.2 Multi-variate analysis 
From the data presented in table 6.1 and from the spectra where the pure 
FAs were overlaid with the cell spectra, the following observations were made for 
each FA treatment regarding ‘peak fitting’ and ‘pure FA spectra and cell spectra’. 
These data allowed for the determination of lipid composition after cells were 
exposed to differential FAs for 24 hours. 
6.4.2.1 Peak fitting 
The fold change between the decomposed spectra of cells treated with 
0.125 mM PA and the VC (~ 2880 cm-1 peak centre) was 1.04. This is a very 
small change and suggests that PA was not incorporated into LDs. The fold 
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change between the decomposed spectra of cells treated with 0.5 mM PA and 
the VC (~ 2880 cm-1 peak centre) was 1.22. This change suggests that PA was 
incorporated into LDs. These data suggest that more PA was incorporated into 
LDs when cells were exposed to 0.5 mM PA versus 0.125 mM PA, and that the 
incorporation of PA into LDs is dose-dependent. This response does not correlate 
with the observation by Listenberger et al. (2013) whereby the researchers found 
no such effect in CHO cells exposed to 500 and 700 µM PA over a 6-hour time 
course. 
The fold change between the decomposed spectra of cells treated with 
0.125 mM OA and the VC (~ 2852 cm-1 peak centre) was 1.24. This change 
suggests that OA was incorporated into LDs. 
Regarding the combined treatment of 0.125 mM PA and 0.125 mM OA, 
the fold change between the decomposed spectra of cells treated with 0.125 mM 
PA and the VC (~ 2880 cm-1 peak centre) was 0.69. This change suggests that 
PA was not incorporated into LDs and was possibly removed from the LDs. The 
fold change between the decomposed spectra of cells treated with 0.125 mM OA 
and the VC (~ 2852 cm-1 peak centre) was 2.02. This change suggests that large 
quantities of OA was incorporated into LDs. The fold changes of PA (0.69) (~ 
2880 cm-1 peak centre) and OA (2.02) (~ 2852 cm-1 peak centre) are strikingly 
different. This is an interesting observation. These data suggest that less PA is 
incorporated into LDs, whereas more OA is incorporated into LDs. If this is the 
case, OA could be facilitating the breakdown of PA. However, why would more 
OA then be incorporated into LDs? What biological purpose would this serve? 
Alternatively, it could be suggested that PA is converted into palmitoleate via Δ-
9-desaturase enzymes. This could suggest that different populations of cells, as 
previously discussed, have varying levels of desaturase enzymes. Even more 
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controversially, it could be suggested that PA shuttles OA into LDs since less PA 
but more OA was found to be present in the lipid. 
The fold change between the decomposed spectra of cells treated with 
0.125 mM MePA and the VC (~ 2880 cm-1 peak centre) was 1.09. This change 
suggests that PA was not incorporated into LDs. This would be expected since 
esterified FAs cannot undergo activation via ACS and thus cannot be chemically, 
i.e. covalently, incorporated into LDs. These data also suggest that MePA does 
not partition into LDs. 
The fold change between the decomposed spectra of cells treated with 
0.125 mM MeOA and the VC (~ 2852 cm-1 peak centre) was 1.57. Interestingly, 
this change suggests that either OA or MeOA was incorporated into LDs. As 
suggested with the observation made with cells treated with OA alone, it might 
also be possible for MeOA to partition within lipid structures within LDs. 
6.4.2.1.1 Overlay of pure fatty acid spectra and cell spectra 
The peak at ~ 2880 cm-1 from pure PA was present in the cell spectra of 
cells treated with 0.125 mM PA. Had this peak not been present, it could have 
been suggested that PA had been metabolised. However, since the peak is 
present, it can be suggested that PA is present within the cell, possibly in the form 
of LDs. 
The peak at ~ 2852 cm-1 from pure OA was present in the cell spectra of 
cells treated with 0.125 mM OA. Since this peak was present in the cell spectrum, 
this suggests that OA was not metabolised. 
Regarding the combined treatment of 0.125 mM PA and 0.125 mM OA, 
the peak at ~ 2880 cm-1 from pure PA was present in the cell spectra of cells 
treated with both PA and OA. Had this peak not been present, it could have been 
suggested that PA had been metabolised. However, since the peak is present, it 
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can be suggested that PA is present within the cell, possibly in the form of LDs. 
The peak at ~ 2852 cm-1 from pure OA was present in the cell spectra where the 
cells were treated with both PA and OA. Since this peak was present in the cell 
spectrum, this suggests that OA was not metabolised. 
The conclusions from the multi-variate analysis suggest that: (1) PA is 
dose-dependently incorporated into LDs, (2) OA is incorporated into LDs, 
however, not via chemical incorporation, i.e. not covalently bound to glycerol, but 
instead might partition into lipid structures, such as LDs, (3) when cells are treated 
with equimolar concentrations of PA and OA in combination, the presence of PA 
decreases and the presence of OA increases. This suggests that OA might 
induce the breakdown of PA, or that OA might induce the conversion of PA into 
palmitoleate, or that PA might shuttle OA into LDs, and (4) MeOA but not MePA 
might partition into LDs. 
In the study presented in this thesis, the Raman spectra were normalised 
against the phenylalanine peak, similar to the study conducted by Krafft et al. 
(2006). Further work could involve normalising all the Raman spectra presented 
in this thesis against a peak other than the phenylalanine peak, and then 
subsequently reanalysing the data. Slipchenko et al. (2009), who studied LD 
formation in cells in vitro and in vivo, normalised their spectra against the 1445 
cm-1 peak in order to better understand the degree of unsaturation of the 
intracellular LDs. The researchers stated that the peak at 1445 cm-1 
corresponded to C-H bonds present in SFAs, and therefore all the spectra were 
normalised against this peak. Had this not been done, the researchers would not 
have been able to compare the relative changes in the degree of unsaturation of 
LDs in cells. Similarly, the peak at 1440 cm-1 was utilised by Chan et al. (2005). 
In contrast, however, this was not done for the same reason presented by 
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Slipchenko et al. (2009). Chan et al. (2005) stated that the peak at 1440 cm-1 
corresponded to bonds present in proteins. Since the researchers were focused 
on studying changes in the unsaturation content in LDs, the 1440 cm-1 peak 
corresponding to bonds in proteins, may have obscured any changes in the 
saturation content of the LDs they were studying. Despite this, the researchers 
compared the relative ratios of the peaks at 1654 cm-1 and 1445 cm-1 to determine 
whether the degree of unsaturation within intracellular LDs had increased. 
Lastly, if studies similar to the one presented in this thesis are conducted 
in the future but with deuterated FAs, careful consideration should be taken when 
normalising the spectra of intracellular LDs. In the study conducted by Stiebing 
et al. (2017), the researchers normalised the spectra against the peak at 2101 
cm-1 which corresponds to C-D bonds present within deuterated molecules. This 
peak was compared with the peak at 2850 cm-1 corresponding to C-H bonds 
present in lipids. This allowed for the determination of the ratio of deuterated and 
non-deuterated FA content within intracellular LDs. Although normalising Raman 
spectra does not change the absolute values within the spectra, relative 
differences in the heights of peaks can occur. Therefore, any conclusions drawn 
from Raman spectra should be carefully considered. 
In conclusion, the research presented in this Chapter show the complexity 
of the uni- and multi-variate data, the analysis process and the interpretation of 
the data. The additional questions which arose from this work highlight important 
steps to be taken to better understand intracellular lipid changes in cells exposed 
to non-esterified and esterified and FAs in INS-1 cells using Raman 
microspectroscopy.  
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7 Final discussion 
The mechanism(s) by which FAs influence cell viability and function have 
been explored in this thesis and this has been achieved in a number of ways. 
Initially, well-defined biological and pharmacological methods were employed to 
study cell viability while, later, the possibility was explored that spontaneous 
Raman microspectroscopy might shed some light on these processes in novel 
ways. This Chapter will summarise the findings presented in this thesis, the 
limitations arising from the techniques used, and it will outline the gaps in the field 
which have been explored and those that require further work. 
7.1 Structural requirements for fatty acid-mediated effects on 
cell viability 
Chapter 3 sought to investigate whether the entry of PA into the 
mitochondria in INS-1 beta cells and HCMec/D3 microvascular endothelial cells 
would be responsible for inducing cell death. This was achieved by using several 
pharmacological approaches including the study of the effects of etomoxir, 2-
BrPA and MePA. Etomoxir has a two-fold effect on the cell. It: (1) reduces the 
cytoplasmic pool of CoA, and (2) inhibits the activity of the enzyme CPT1 in the 
OMM. Studies employing etomoxir have reported that it can attenuate PA-
induced cell death (Chen et al. 1994; Diakogiannaki et al. 2007) and suggest that 
PA-induced cell death is caused by the entry of PA into the mitochondria. 
However, the fact that etomoxir also reduces the pool of CoA available for 
thioesterification has been overlooked by many researchers. Thus, any 
cytoprotection observed with etomoxir cannot necessarily be attributed to only 
one of the effects that it has on the cell. I found that etomoxir, when added in the 
absence of PA, was unable to induce cell death in either the INS-1 or HCMec/D3 
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cells. In combination with etomoxir, neither cell type were rescued from PA-
induced cell death. 
In addition to the use of etomoxir, I employed 2-BrPA to investigate the 
requirement for PA activation as a mechanism to induce cell death. Interestingly 
(and unexpectedly), 2-BrPA induced cell death in INS-1 cells but not in 
HCMec/D3 cells. Even more surprisingly, when INS-1 cells were exposed to both 
2-BrPA and PA, in combination, cell death was comparable to the untreated cells. 
These data suggest that both FAs compete for the cytoplasmic supply of CoA. 
When HCMec/D3 cells were exposed to both 2-BrPA and PA, in combination, 2-
BrPA was able to prevent PA-induced cell death. I hypothesise that the formation 
of 2-BrPA-CoA might prevent the formation of palmitoyl-carnitine and this, in turn, 
implies that elevated levels of palmitoyl-carnitine might be one of the toxic 
metabolites responsible for cell death. Further work could be undertaken to detect 
levels of intra- and extra-cellular palmitoyl-carnitine using mass spectrometry or 
with the use of biomarkers to verify this hypothesis, as described by Hulme et al. 
(2017). 
MePA was employed to investigate the structural requirements for PA-
induced cell death. Since the activation of FAs, with CoA, requires binding to the 
carboxyl oxygen of the FA, I sought to covalently block this group with a methyl 
group. The covalent binding of the carboxyl oxygen of the FA would prevent the 
activation of the FA with CoA. Not only would this prevent PA-CoA from entering 
the mitochondria, but it would also prevent PA-CoA from mediating other cellular 
changes. These include: (1) the synthesis of sphingolipids in the rough 
endoplasmic reticulum, (2) the palmitoylation of proteins in the Golgi apparatus, 
and (3) the formation of LDs. Thus, any observed cytoprotection from MePA 
cannot solely be attributed to its inability to enter mitochondria. In both cell types, 
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MePA was found to be non-toxic, and when combined with PA, it was not 
cytoprotective. These data suggest that the free carboxyl group of PA is essential 
for inducing toxicity. The free carboxyl group of PA may be required for binding 
with CoA, and may cause cytotoxicity if the levels of PA-CoA become elevated 
such that the cell cannot remove this from the cell. Whether PA-CoA itself is a 
toxic metabolite or whether this compound facilitates downstream effects on the 
cell is not clear from the studies presented in this thesis. The use of labelled CoA, 
by radioactive labelling for example, as described by Kuhl & Spector (1970), 
might be a possible way to detect the cellular localisation of PA when it binds to 
CoA. However, due to the size of CoA, it is unlikely that PA-CoA, labelled or 
unlabelled, would enter the cell. 
The structural requirements for OA-induced cytoprotection were 
investigated using the analogues RA and MeOA. MeOA, like MePA, has a methyl 
group covalently bound to the carboxyl oxygen, preventing OA from being 
activated by CoA. In both INS-1 and HCMec/D3 cells, both OA and MeOA were 
found to protect against PA-induced cell death. MeOA was found to be non-toxic 
and was also found to protect against PA-induced cell death, albeit to a lesser 
extent than OA. These data suggest that the activation of OA is not a requirement 
for inducing cytoprotection. These data also suggest that the mechanisms of OA- 
and MeOA-induced cytoprotection are differential. 
RA, an analogue of OA with a hydroxyl group on the alkyl chain, was found 
to be more toxic to both INS-1 and HCMec/D3 cells than PA. This response, 
though unexpected, shows the importance of keeping the alkyl chain of OA free 
to ensure it does not induce cell death, and so it can also protect against PA-
induced cell death. 
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7.2 Evaluation of the effects of fatty acids on the cell cycle 
Chapter 4 sought to determine whether PA-induced toxicity might be a result 
of PA preventing cells from entering the S and G2+M phases of the cell cycle. 
The normalised data show that the percentage of cells exposed to PA in the S 
and G2+M phases of the cell cycle was comparable to untreated cells, suggesting 
that PA does not inhibit proliferation in either INS-1 or HCMec/D3 cells. I also 
sought to determine whether OA might induce cytoprotection against PA-induced 
cell death by eliciting a pro-proliferative response. The data was comparable to 
the untreated cells, suggesting that OA is not capable of inducing a pro-
proliferative response in either INS-1 or HCMec/D3 cells. 
Although some studies have shown OA to induce a pro-proliferative 
(hyperplastic) response in islets, beta cells and smooth muscle cells (Brelje et al. 
2017; Diakogiannaki et al. 2007; Lamers et al. 2011), the methodologies are 
questionable. A critical review of the literature suggests that the use of BrdU, the 
gold standard of hyperplasia studies, has its limitations, of which the main 
concern is the temporal effects incurred when BrdU is applied to cells in different 
stages of cell growth. The method employed in this Chapter separated the 
percentage of cells into those in the G0+G1, S, G2+M phases as well as the non-
viable cell population, an aspect not possible in other assays. Importantly, the cell 
cycle method presented in this thesis normalised the viable cell population 
against the non-viable cell population (cells with intact plasma membranes but 
disrupted DNA). 
An alternative to the measurement of hyperplasia was suggested. Cell 
growth (hypertrophy) might be a more robust endpoint to study as opposed to 
hyperplasia. Since it has been observed in vivo that beta cells only replicate under 
certain conditions (Bonner-Weir et al. 2010; Nir et al. 2007; Wang et al. 2015b), I 
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suggest measuring hypertrophy as opposed to hyperplasia as a more robust 
representation of beta cell health. 
7.3 Development of a methodology using Raman 
microspectroscopy to study intracellular lipid disposition 
It has previously been shown that OA, not PA, induces the formation of lipid 
droplets in H9C2 cardiomyocytes (Akoumi et al. 2017), and that OA might be able 
to mitigate PA-induced cell death by shuttling PA into LDs (Diakogiannaki et al. 
2007; Listenberger et al. 2003). Thus, it was important to expose the INS-1 beta 
cells to these two FAs alone and in combination and determine whether 
spontaneous Raman microspectroscopy could elucidate any changes in 
intracellular lipid disposition (distribution, intensity and composition). The use of 
labelled FAs is controversial as they do not represent the true chemical 
composition of biologically available FAs. In addition, they may have the capacity 
to disrupt normal cellular process, resulting in detrimental secondary effects. 
Spontaneous Raman microspectroscopy, a label-free technique, was employed 
to avoid such detrimental cellular effects and to further our understanding of the 
changes in lipid disposition that occur when cells are exposed to differential FAs. 
Chapter 5 described the development of a methodology to study the distribution 
and composition of lipid within INS-1 cells exposed to PA, OA, alone and in 
combination, and their esterified analogues. After careful optimisation and 
validation, the chosen Raman band of interest to study lipid disposition was 2845 
± 10 cm-1, corresponding to the CH2 symmetric stretch vibration, a stretch 
vibration present within the alkyl chains of FAs. 
7.4 Use of Raman microspectroscopy to study the distribution 
and composition of lipid in beta cells 
As presented in Chapter 6, uni-variate analysis of Raman maps (2D maps 
of cells) involved quantifying the following parameters: (1) the total area of the 
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cell, (2) the area of lipid within the cell, and (3) the intensity of the lipid (a measure 
of lipid concentration), using ImageJ software. Multi-variate analysis of the lipid 
at 2845 ± 10 cm-1 involved conducting cluster analysis which was subsequently 
followed by spectral decomposition of averaged spectra per FA treatment and 
comparing them to the spectra of untreated cells. The aim of this analysis was to 
determine the composition of the intracellular lipid, and more specifically, 
determine whether the lipid consisted of stretch vibrations corresponding to PA 
or OA. 
INS-1 cells were exposed to 0.125 mM PA and 0.125 mM OA alone and in 
combination, and also their corresponding esterified analogues, for 24 hours. The 
employment of the corresponding esterified analogues proved important as these 
FAs are non-metabolisable, and hence should not, in theory, be incorporated into 
LDs, or any lipid structure for that matter (unless they are able to partition non-
covalently within the lipid structure). No change was observed in the distribution 
of lipid after the INS-1 cells were exposed to esterified FAs, suggesting that these 
FAs were not chemically incorporated into the lipid structures, and also highlights 
the importance of having the carboxyl oxygen free for activation with CoA. 
Unfortunately, it was not completely clear whether the lipid observed in the 
Raman maps were from LDs or other cellular components which also consist of 
FA alkly chains, such as membranes of organelles. One caveat is that the 
structure of LDs is still contested whereby it is not clear whether they contain a 
core of TAG and are surrounded by phospholipids or other types of lipids (Ohsaki 
Suzuki & Fujimoto 2014) and proteins (Ohsaki Suzuki & Fujimoto 2014; Welte 
2007; Wilfling et al. 2014). Based on data in the literature, it was assumed that 
the lipid observed in the Raman maps corresponded to lipid within LDs only. 
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The combined uni- and multi-variate data suggest that: (1) PA is dose-
dependently incorporated into LDs, (2) OA partitions into LDs, i.e. it is not 
covalently incorporated into LDs, (3) it is unlikely that OA is able to promote the 
shuttling of PA into LDs as there is only partial evidence (uni-variate data) of this, 
whereby the area of lipid increases within the cells exposed to both PA and OA. 
The multi-variate data suggest that the levels of PA decreased and the levels of 
OA increased within LDs, suggesting that PA might be able to shuttle OA into 
LDs. Based on these observations, it can be concluded that the Raman data do 
not support the hypothesis that OA protects against PA-induced cytotoxicity by 
shuttling PA into LDs, and (4) esterified FAs are not chemically incorporated into 
lipid droplets, and do not affect lipid distribution. In addition, MeOA, but not MePA, 
might partition into LDs, a suggestion based on the observation that no change 
in lipid distribution was observed in cells treated with these FAs, yet elevated 
levels of OA, but not of PA, were observed from the multi-variate analysis. 
Although the uni- and multi-variate data proved complex and time 
consuming to analyse, it can be concluded that spontaneous Raman 
microspectroscopy is a useful technique for studying intracellular lipid disposition. 
The technique is capable of providing data which can be quantified to calculate 
the area of cells, the percentage of lipid and its concentration, and the 
composition of the lipid, albeit from 2D maps of the cells. Ideally, 3D maps of cells 
would be analysed to obtain a better representation of the intracellular distribution 
of lipid of untreated and treated cells, however, this would add a considerable 
amount of time to the data-analysis process. 
Further work using spontaneous Raman microspectroscopy might seek to 
examine whether MeOA exerts similar effects on the distribution of PA when 
combined with OA. This would be of interest as it has been suggested in this 
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thesis that OA and MeOA might protect against PA-induced toxicity differentially, 
whereby MeOA might play an extracellular role as its ability to enter cells has 
been questioned. 
As the methodology presented in this thesis to study intracellular lipid 
disposition can be applied to any other adherent cell type, it would be of interest 
of investigate the cellular distribution of lipid and its composition within endothelial 
cells, as these cells are detrimentally affected in people with T2D (Horani & 
Mooradian 2003; Prasad et. al. 2014). The use of a label-free technique would 
allow researchers to better understand how intracellular lipids are handled in 
these cells after exposure to exogenously supplied FAs. 
The use of deuterated FAs in cellular systems, as described by van Manen 
et al. (2005), Majzner et al. (2018), Slipchenko et al. (2009), Stiebing et al. (2014) 
and Stiebing et al. (2017), or alkyne FAs, as described by Jamieson et al. (2018), 
would aid our understanding regarding the localisation of exogenously supplied 
FAs within cells. However, I do not believe that Raman technology is currently 
sufficient to visualise and quantify changes in the chemical composition of 
endogenous FAs upon exposure to exogenously supplied FAs, despite best-
efforts by researchers to differentiate between these FAs, such as Slipchenko et 
al. (2009). In fact, none of the methodologies and technologies that currently exist 
can answer some pertinent questions that have arisen from the work presented 
in this thesis. For example, what happens to the chemical composition of 
endogenous FAs and exogenously supplied FAs within LDs upon exposure to 
exogenous FAs? Do cells synthesise FAs upon exposure to certain exogenous 
FAs? And if so, how are the FAs utilised? Are they degraded for the production 
of energy or are they incorporated into LDs? Where do exogenous FAs localise 
once they are inside a cell and how are they handled by the cell? Do the FAs 
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undergo chain elongation/ shortening, chain saturation/ unsaturation, or do they 
bind to macromolecules such as proteins or sugars? Until precise changes in the 
chemical composition of both endogenous and exogenous molecules can be 
detected and quantified, research into the study of cellular LD disposition will 
move forwards very slowly. 
7.5 Final remarks 
The research and discussions presented in this thesis aimed to question 
existing hypotheses and the use of certain experimental techniques in order to 
progress our understanding of how cells handle FAs in vitro. The work undertaken 
here has, I believe, added sound knowledge to furthering our understanding of 
beta- and endothelial-cell biology, and has raised many additional questions that 
require answering. 
The pursuit to understand the mechanisms by which certain FAs cause cell 
death and how others can be cytoprotective has proven to be a difficult one, 
especially as the field of lipid research has been overlooked for so long. Though 
more work is required to progress the field, I am proud and humbled to have been 
able to contribute my time and thinking to this extraordinary scientific journey.  
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